![]()
Position Markers
QTLs in Region (GRCh38)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 597431198 | GWAS1527272_H | protein measurement QTL GWAS1527272 (human) | 8e-82 | protein measurement | 19 | 44908684 | 44908685 | Human | 407275589 | GWAS924565_H | white matter hyperintensity measurement QTL GWAS924565 (human) | 0.000003 | white matter hyperintensity measurement | 19 | 44908684 | 44908685 | Human | 407116864 | GWAS765840_H | phospholipid measurement, high density lipoprotein cholesterol measurement QTL GWAS765840 (human) | 6e-17 | Lewy body dementia | 19 | 44908684 | 44908685 | Human | 597431192 | GWAS1527266_H | protein measurement QTL GWAS1527266 (human) | 1e-460 | protein measurement | 19 | 44908684 | 44908685 | Human | 597283742 | GWAS1379816_H | triglycerides in IDL measurement QTL GWAS1379816 (human) | 1e-100 | triglycerides in IDL measurement | blood lipoprotein triglyceride level (CMO:0002685) | 19 | 44908684 | 44908685 | Human | 597152670 | GWAS1248744_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1248744 (human) | 1e-57 | protein measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597188497 | GWAS1284571_H | cholesterol in medium HDL measurement QTL GWAS1284571 (human) | 9e-39 | cholesterol in medium HDL measurement | 19 | 44908684 | 44908685 | Human | 597287827 | GWAS1383901_H | saturated fatty acids measurement QTL GWAS1383901 (human) | 5e-87 | fatty acid amount (VT:0010046) | 19 | 44908684 | 44908685 | Human | 597429142 | GWAS1525216_H | protein measurement QTL GWAS1525216 (human) | 7e-268 | protein measurement | 19 | 44908684 | 44908685 | Human | 597429143 | GWAS1525217_H | protein measurement QTL GWAS1525217 (human) | 4e-25 | protein measurement | 19 | 44908684 | 44908685 | Human | 597172115 | GWAS1268189_H | protein measurement QTL GWAS1268189 (human) | 6e-49 | protein measurement | 19 | 44908684 | 44908685 | Human | 597123996 | GWAS1220070_H | blood protein measurement QTL GWAS1220070 (human) | 2e-186 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 597019545 | GWAS1115619_H | cerebral amyloid angiopathy, neurofibrillary tangles measurement QTL GWAS1115619 (human) | 6e-35 | selenoprotein S measurement | 19 | 44908684 | 44908685 | Human | 597141401 | GWAS1237475_H | waist-hip ratio QTL GWAS1237475 (human) | 4e-15 | total cholesterol measurement, very low density lipoprotein cholesterol measurement | blood total cholesterol level (CMO:0000051) | 19 | 44908684 | 44908685 | Human | 407114827 | GWAS763803_H | low density lipoprotein triglyceride measurement QTL GWAS763803 (human) | 4e-11 | BMI-adjusted waist-hip ratio | 19 | 44908684 | 44908685 | Human | 597040025 | GWAS1136099_H | diet measurement QTL GWAS1136099 (human) | 5e-13 | eating behavior trait (VT:0001431) | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 597212055 | GWAS1308129_H | Lewy body dementia QTL GWAS1308129 (human) | 6e-17 | Lewy body dementia | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597138310 | GWAS1234384_H | high density lipoprotein cholesterol measurement QTL GWAS1234384 (human) | 8e-40 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 19 | 44908684 | 44908685 | Human | 597078916 | GWAS1174990_H | white matter hyperintensity measurement QTL GWAS1174990 (human) | 0.0000001 | COVID-19 | 19 | 44908684 | 44908685 | Human | 597431183 | GWAS1527257_H | protein measurement QTL GWAS1527257 (human) | 2e-27 | protein measurement | 19 | 44908684 | 44908685 | Human | 597093251 | GWAS1189325_H | Lewy body dementia, Lewy body dementia measurement QTL GWAS1189325 (human) | 1e-12 | protein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 19 | 44908684 | 44908685 | Human | 597142402 | GWAS1238476_H | high density lipoprotein cholesterol measurement QTL GWAS1238476 (human) | 1e-46 | protein measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597224335 | GWAS1320409_H | apolipoprotein B measurement QTL GWAS1320409 (human) | 6e-26 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 19 | 44908684 | 44908685 | Human | 597285765 | GWAS1381839_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1381839 (human) | 3e-52 | protein measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 596969397 | GWAS1088916_H | polyunsaturated fatty acid measurement QTL GWAS1088916 (human) | 9e-18 | free cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597589948 | GWAS1646808_H | type 2 diabetes mellitus QTL GWAS1646808 (human) | 6e-16 | type 2 diabetes mellitus | blood urea nitrogen level (CMO:0000049) | 19 | 44908684 | 44908685 | Human | 597432248 | GWAS1528322_H | protein measurement QTL GWAS1528322 (human) | 4e-99 | protein measurement | 19 | 44908684 | 44908685 | Human | 597429176 | GWAS1525250_H | protein measurement QTL GWAS1525250 (human) | 7e-16 | protein measurement | 19 | 44908684 | 44908685 | Human | 596957118 | GWAS1076637_H | CUB and zona pellucida-like domain-containing protein 1 measurement QTL GWAS1076637 (human) | 6e-35 | memory performance | 19 | 44908684 | 44908685 | Human | 597103547 | GWAS1199621_H | platelet crit QTL GWAS1199621 (human) | 6e-31 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 19 | 44908684 | 44908685 | Human | 597167028 | GWAS1263102_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1263102 (human) | 2e-45 | total cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597222325 | GWAS1318399_H | low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS1318399 (human) | 7e-27 | low density lipoprotein cholesterol measurement, lipid measurement | blood lipid measurement (CMO:0000050) | 19 | 44908684 | 44908685 | Human | 597222327 | GWAS1318401_H | low density lipoprotein cholesterol measurement QTL GWAS1318401 (human) | 5e-27 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597237678 | GWAS1333752_H | blood protein measurement QTL GWAS1333752 (human) | 3e-53 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 597594025 | GWAS1650885_H | blood urea nitrogen measurement QTL GWAS1650885 (human) | 2e-16 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 19 | 44908684 | 44908685 | Human | 597182368 | GWAS1278442_H | 3-hydroxybutyrate measurement QTL GWAS1278442 (human) | 4e-19 | protein measurement | 19 | 44908684 | 44908685 | Human | 597429153 | GWAS1525227_H | protein measurement QTL GWAS1525227 (human) | 3e-12 | protein measurement | 19 | 44908684 | 44908685 | Human | 597194712 | GWAS1290786_H | non-alcoholic fatty liver disease QTL GWAS1290786 (human) | 1e-11 | non-alcoholic fatty liver disease | 19 | 44908684 | 44908685 | Human | 597274589 | GWAS1370663_H | apolipoprotein E (isoform E3) measurement QTL GWAS1370663 (human) | 8e-20 | apolipoprotein E (isoform E3) measurement | 19 | 44908684 | 44908685 | Human | 597147602 | GWAS1243676_H | body composition measurement QTL GWAS1243676 (human) | 7e-31 | high density lipoprotein particle size measurement | 19 | 44908684 | 44908685 | Human | 597047248 | GWAS1143322_H | C-reactive protein measurement QTL GWAS1143322 (human) | 2e-1953 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 597429204 | GWAS1525278_H | protein measurement QTL GWAS1525278 (human) | 1e-352 | protein measurement | 19 | 44908684 | 44908685 | Human | 597224401 | GWAS1320475_H | apolipoprotein B measurement QTL GWAS1320475 (human) | 9e-23 | apolipoprotein B measurement | 19 | 44908684 | 44908685 | Human | 597287888 | GWAS1383962_H | cholesterol esters in large HDL measurement QTL GWAS1383962 (human) | 2e-77 | cholesterol esters in large HDL measurement | 19 | 44908684 | 44908685 | Human | 597223378 | GWAS1319452_H | low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1319452 (human) | 1e-22 | low density lipoprotein cholesterol measurement, phospholipid measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 407115797 | GWAS764773_H | very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS764773 (human) | 8e-11 | very low density lipoprotein cholesterol measurement, phospholipid measurement | 19 | 44908684 | 44908685 | Human | 597318600 | GWAS1414674_H | Rare dyslipidemia QTL GWAS1414674 (human) | 2e-31 | protein measurement | 19 | 44908684 | 44908685 | Human | 597123009 | GWAS1219083_H | blood protein measurement QTL GWAS1219083 (human) | 5e-57 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 407115795 | GWAS764771_H | very low density lipoprotein cholesterol measurement QTL GWAS764771 (human) | 9e-10 | blood urea nitrogen measurement | 19 | 44908684 | 44908685 | Human | 597429195 | GWAS1525269_H | protein measurement QTL GWAS1525269 (human) | 2e-41 | protein measurement | 19 | 44908684 | 44908685 | Human | 597030861 | GWAS1126935_H | Mental deterioration QTL GWAS1126935 (human) | 2e-14 | protein measurement | 19 | 44908684 | 44908685 | Human | 596969417 | GWAS1088936_H | polyunsaturated fatty acid measurement QTL GWAS1088936 (human) | 3e-20 | memory performance | 19 | 44908684 | 44908685 | Human | 597040075 | GWAS1136149_H | diet measurement QTL GWAS1136149 (human) | 1e-08 | eating behavior trait (VT:0001431) | blood uric acid level (CMO:0000501) | 19 | 44908684 | 44908685 | Human | 597432257 | GWAS1528331_H | protein measurement QTL GWAS1528331 (human) | 3e-207 | protein measurement | 19 | 44908684 | 44908685 | Human | 597303237 | GWAS1399311_H | level of ADP-ribosylation factor-like protein 2 in blood serum QTL GWAS1399311 (human) | 8e-21 | level of ADP-ribosylation factor-like protein 2 in blood serum | 19 | 44908684 | 44908685 | Human | 597432312 | GWAS1528386_H | protein measurement QTL GWAS1528386 (human) | 8e-556 | protein measurement | 19 | 44908684 | 44908685 | Human | 597432313 | GWAS1528387_H | protein measurement QTL GWAS1528387 (human) | 2e-62 | protein measurement | 19 | 44908684 | 44908685 | Human | 597246975 | GWAS1343049_H | amyloid-beta measurement QTL GWAS1343049 (human) | 7e-08 | amyloid-beta measurement | 19 | 44908684 | 44908685 | Human | 597286910 | GWAS1382984_H | 3-hydroxybutyrate measurement QTL GWAS1382984 (human) | 9e-20 | urine ketone body amount (VT:0010724) | 19 | 44908684 | 44908685 | Human | 597430261 | GWAS1526335_H | protein measurement QTL GWAS1526335 (human) | 4e-42 | protein measurement | 19 | 44908684 | 44908685 | Human | 597038076 | GWAS1134150_H | parental longevity QTL GWAS1134150 (human) | 9e-13 | total life span (VT:0001661) | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597318641 | GWAS1414715_H | N-palmitoyl-sphingosine (d18:1/16:0) measurement QTL GWAS1414715 (human) | 1e-26 | N-palmitoyl-sphingosine (d18:1/16:0) measurement | 19 | 44908684 | 44908685 | Human | 407118888 | GWAS767864_H | apolipoprotein B measurement QTL GWAS767864 (human) | 9e-23 | apolipoprotein B measurement | 19 | 44908684 | 44908685 | Human | 597038074 | GWAS1134148_H | parental longevity QTL GWAS1134148 (human) | 1e-68 | total life span (VT:0001661) | 19 | 44908684 | 44908685 | Human | 597180406 | GWAS1276480_H | obstructive sleep apnea QTL GWAS1276480 (human) | 5e-11 | obstructive sleep apnea | blood low density lipoprotein triglyceride level (CMO:0002687) | 19 | 44908684 | 44908685 | Human | 597431283 | GWAS1527357_H | protein measurement QTL GWAS1527357 (human) | 9e-17 | protein measurement | 19 | 44908684 | 44908685 | Human | 597143544 | GWAS1239618_H | liver fat measurement QTL GWAS1239618 (human) | 2e-29 | protein measurement | 19 | 44908684 | 44908685 | Human | 597433325 | GWAS1529399_H | protein measurement QTL GWAS1529399 (human) | 3e-90 | protein measurement | 19 | 44908684 | 44908685 | Human | 597304299 | GWAS1400373_H | level of kinetochore protein Spc25 in blood serum QTL GWAS1400373 (human) | 4e-112 | level of kinetochore protein Spc25 in blood serum | 19 | 44908684 | 44908685 | Human | 596960230 | GWAS1079749_H | liver fat measurement, liver disease biomarker QTL GWAS1079749 (human) | 6e-11 | liver fat measurement, liver disease biomarker | 19 | 44908684 | 44908685 | Human | 597431278 | GWAS1527352_H | protein measurement QTL GWAS1527352 (human) | 7e-421 | protein measurement | 19 | 44908684 | 44908685 | Human | 597430254 | GWAS1526328_H | protein measurement QTL GWAS1526328 (human) | 3e-512 | protein measurement | 19 | 44908684 | 44908685 | Human | 596959207 | GWAS1078726_H | hippocampal volume QTL GWAS1078726 (human) | 1e-10 | hippocampal volume | 19 | 44908684 | 44908685 | Human | 597430255 | GWAS1526329_H | protein measurement QTL GWAS1526329 (human) | 3e-219 | protein measurement | 19 | 44908684 | 44908685 | Human | 597073890 | GWAS1169964_H | parental longevity QTL GWAS1169964 (human) | 1e-27 | total life span (VT:0001661) | 19 | 44908684 | 44908685 | Human | 597613547 | GWAS1670407_H | family history of Alzheimer’s disease QTL GWAS1670407 (human) | 6e-119 | family history of Alzheimer’s disease | 19 | 44908684 | 44908685 | Human | 597430250 | GWAS1526324_H | protein measurement QTL GWAS1526324 (human) | 9e-129 | protein measurement | 19 | 44908684 | 44908685 | Human | 597111791 | GWAS1207865_H | Red cell distribution width QTL GWAS1207865 (human) | 2e-59 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 19 | 44908684 | 44908685 | Human | 597599205 | GWAS1656065_H | serum alanine aminotransferase measurement QTL GWAS1656065 (human) | 2e-41 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 19 | 44908684 | 44908685 | Human | 597432295 | GWAS1528369_H | protein measurement QTL GWAS1528369 (human) | 3e-39 | protein measurement | 19 | 44908684 | 44908685 | Human | 597433319 | GWAS1529393_H | protein measurement QTL GWAS1529393 (human) | 4e-198 | protein measurement | 19 | 44908684 | 44908685 | Human | 596959208 | GWAS1078727_H | cerebral amyloid deposition measurement QTL GWAS1078727 (human) | 3e-50 | cerebral amyloid deposition measurement | 19 | 44908684 | 44908685 | Human | 597093355 | GWAS1189429_H | cerebral amyloid deposition measurement QTL GWAS1189429 (human) | 8e-32 | cerebral cortex integrity trait (VT:0010923) | 19 | 44908684 | 44908685 | Human | 597192677 | GWAS1288751_H | memory performance QTL GWAS1288751 (human) | 1e-19 | protein measurement | 19 | 44908684 | 44908685 | Human | 597115669 | GWAS1211743_H | cerebral amyloid deposition measurement QTL GWAS1211743 (human) | 9e-30 | cerebral cortex integrity trait (VT:0010923) | 19 | 44908684 | 44908685 | Human | 597026582 | GWAS1122656_H | hippocampal volume QTL GWAS1122656 (human) | 2e-19 | blood protein amount (VT:0005416) | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597031697 | GWAS1127771_H | Alzheimer disease QTL GWAS1127771 (human) | 1e-76 | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 19 | 44908684 | 44908685 | Human | 597031696 | GWAS1127770_H | Alzheimer disease QTL GWAS1127770 (human) | 1e-64 | protein measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597031698 | GWAS1127772_H | Alzheimer disease QTL GWAS1127772 (human) | 1e-75 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597182239 | GWAS1278313_H | pregnancy-specific beta-1-glycoprotein 5 measurement QTL GWAS1278313 (human) | 1e-112 | pregnancy-specific beta-1-glycoprotein 5 measurement | 19 | 44908684 | 44908685 | Human | 407108811 | GWAS757787_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS757787 (human) | 7e-17 | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 596969245 | GWAS1088764_H | low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1088764 (human) | 1e-22 | low density lipoprotein cholesterol measurement, phospholipid measurement | 19 | 44908684 | 44908685 | Human | 597220112 | GWAS1316186_H | low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS1316186 (human) | 9e-27 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 407108810 | GWAS757786_H | low density lipoprotein cholesterol measurement QTL GWAS757786 (human) | 5e-26 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597026588 | GWAS1122662_H | memory performance QTL GWAS1122662 (human) | 2e-18 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 19 | 44908684 | 44908685 | Human | 597594900 | GWAS1651760_H | drug use measurement, gastroesophageal reflux disease QTL GWAS1651760 (human) | 8e-13 | blood protein amount (VT:0005416) | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597304080 | GWAS1400154_H | level of tumor protein p53-inducible protein 11 in blood serum QTL GWAS1400154 (human) | 6e-51 | level of tumor protein p53-inducible protein 11 in blood serum | 19 | 44908684 | 44908685 | Human | 597026585 | GWAS1122659_H | memory performance QTL GWAS1122659 (human) | 2e-13 | blood protein amount (VT:0005416) | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597220117 | GWAS1316191_H | omega-6 polyunsaturated fatty acid measurement QTL GWAS1316191 (human) | 5e-18 | omega-6 polyunsaturated fatty acid measurement | 19 | 44908684 | 44908685 | Human | 597265175 | GWAS1361249_H | taste liking measurement QTL GWAS1361249 (human) | 6e-15 | protein measurement | 19 | 44908684 | 44908685 | Human | 597269257 | GWAS1365331_H | taste liking measurement QTL GWAS1365331 (human) | 2e-09 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 597218058 | GWAS1314132_H | Alzheimer disease QTL GWAS1314132 (human) | 1e-53 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597220110 | GWAS1316184_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1316184 (human) | 4e-27 | free cholesterol measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597598982 | GWAS1655842_H | HbA1c measurement QTL GWAS1655842 (human) | 7e-20 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 19 | 44908684 | 44908685 | Human | 597031695 | GWAS1127769_H | Alzheimer disease QTL GWAS1127769 (human) | 6e-14 | memory performance | 19 | 44908684 | 44908685 | Human | 597031694 | GWAS1127768_H | Alzheimer disease QTL GWAS1127768 (human) | 1e-62 | neutrophil collagenase measurement | 19 | 44908684 | 44908685 | Human | 597098250 | GWAS1194324_H | C-reactive protein measurement QTL GWAS1194324 (human) | 2e-22 | esterified cholesterol measurement | 19 | 44908684 | 44908685 | Human | 407107806 | GWAS756782_H | intermediate density lipoprotein measurement QTL GWAS756782 (human) | 3e-23 | remnant cholesterol measurement | 19 | 44908684 | 44908685 | Human | 407107805 | GWAS756781_H | lipid measurement, intermediate density lipoprotein measurement QTL GWAS756781 (human) | 6e-23 | lipid measurement, intermediate density lipoprotein measurement | 19 | 44908684 | 44908685 | Human | 597579520 | GWAS1636380_H | high density lipoprotein cholesterol measurement QTL GWAS1636380 (human) | 1e-161 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597282619 | GWAS1378693_H | age-related macular degeneration QTL GWAS1378693 (human) | 9e-26 | age-related macular degeneration | 19 | 44908684 | 44908685 | Human | 407107808 | GWAS756784_H | phospholipid measurement, intermediate density lipoprotein measurement QTL GWAS756784 (human) | 4e-21 | mean reticulocyte volume | 19 | 44908684 | 44908685 | Human | 407106784 | GWAS755760_H | esterified cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS755760 (human) | 3e-26 | PDZK1-interacting protein 1 measurement | 19 | 44908684 | 44908685 | Human | 597590841 | GWAS1647701_H | Abdominal Aortic Aneurysm QTL GWAS1647701 (human) | 9e-23 | Abdominal Aortic Aneurysm | blood apoliprotein B level (CMO:0000522) | 19 | 44908684 | 44908685 | Human | 596982584 | GWAS1102103_H | memory performance QTL GWAS1102103 (human) | 6e-33 | memory performance | 19 | 44908684 | 44908685 | Human | 596970277 | GWAS1089796_H | low density lipoprotein cholesterol measurement QTL GWAS1089796 (human) | 6e-25 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597609262 | GWAS1666122_H | Hyperlipidemia QTL GWAS1666122 (human) | 1e-69 | Hyperlipidemia | 19 | 44908684 | 44908685 | Human | 596963109 | GWAS1082628_H | deoxycytidine kinase measurement QTL GWAS1082628 (human) | 7e-21 | deoxycytidine kinase measurement | 19 | 44908684 | 44908685 | Human | 597223209 | GWAS1319283_H | low density lipoprotein cholesterol measurement QTL GWAS1319283 (human) | 1e-23 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597419817 | GWAS1515891_H | urate measurement QTL GWAS1515891 (human) | 7e-13 | urate measurement | 19 | 44908684 | 44908685 | Human | 597223211 | GWAS1319285_H | polyunsaturated fatty acid measurement QTL GWAS1319285 (human) | 9e-18 | milk polyunsaturated fatty acid amount (VT:0010374) | blood cholesterol level (CMO:0002280) | 19 | 44908684 | 44908685 | Human | 597267244 | GWAS1363318_H | taste liking measurement QTL GWAS1363318 (human) | 8e-09 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 597152544 | GWAS1248618_H | executive function measurement QTL GWAS1248618 (human) | 7e-20 | memory performance | 19 | 44908684 | 44908685 | Human | 597036847 | GWAS1132921_H | beta-amyloid 1-42 measurement QTL GWAS1132921 (human) | 9e-11 | beta-amyloid 1-42 measurement | 19 | 44908684 | 44908685 | Human | 597223202 | GWAS1319276_H | esterified cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1319276 (human) | 3e-26 | protein measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597223205 | GWAS1319279_H | low density lipoprotein cholesterol measurement QTL GWAS1319279 (human) | 6e-25 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597341991 | GWAS1438065_H | gallstones, coronary artery disease QTL GWAS1438065 (human) | 4e-47 | gallstones, coronary artery disease | 19 | 44908684 | 44908685 | Human | 597123927 | GWAS1220001_H | blood protein measurement QTL GWAS1220001 (human) | 3e-111 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 597302110 | GWAS1398184_H | level of tubulin-specific chaperone A in blood serum QTL GWAS1398184 (human) | 1e-86 | level of tubulin-specific chaperone A in blood serum | 19 | 44908684 | 44908685 | Human | 597601110 | GWAS1657970_H | blood urea nitrogen measurement QTL GWAS1657970 (human) | 4e-22 | myocardial infarction | blood urea nitrogen level (CMO:0000049) | 19 | 44908684 | 44908685 | Human | 597072729 | GWAS1168803_H | C-reactive protein measurement QTL GWAS1168803 (human) | 7e-36 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 596969284 | GWAS1088803_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, esterified cholesterol measurement QTL GWAS1088803 (human) | 7e-09 | chylomicron measurement, very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597179209 | GWAS1275283_H | inactive gamma-glutamyltranspeptidase 2 measurement QTL GWAS1275283 (human) | 4e-225 | inactive gamma-glutamyltranspeptidase 2 measurement | 19 | 44908684 | 44908685 | Human | 597152578 | GWAS1248652_H | memory performance QTL GWAS1248652 (human) | 8e-321 | memory performance | 19 | 44908684 | 44908685 | Human | 596962114 | GWAS1081633_H | C-reactive protein measurement QTL GWAS1081633 (human) | 2e-22 | C-reactive protein measurement | 19 | 44908684 | 44908685 | Human | 597152576 | GWAS1248650_H | language measurement QTL GWAS1248650 (human) | 4e-206 | language measurement | 19 | 44908684 | 44908685 | Human | 597118799 | GWAS1214873_H | blood protein measurement QTL GWAS1214873 (human) | 3e-159 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 597152590 | GWAS1248664_H | language measurement QTL GWAS1248664 (human) | 3e-158 | language measurement | 19 | 44908684 | 44908685 | Human | 597152589 | GWAS1248663_H | executive function measurement QTL GWAS1248663 (human) | 2e-170 | executive function measurement | 19 | 44908684 | 44908685 | Human | 597152588 | GWAS1248662_H | executive function measurement QTL GWAS1248662 (human) | 9e-145 | executive function measurement | 19 | 44908684 | 44908685 | Human | 596954953 | GWAS1074472_H | Alzheimer disease, p-tau measurement, beta-amyloid 1-42 measurement, t-tau measurement QTL GWAS1074472 (human) | 0.000001 | age of onset of Parkinson disease | 19 | 44908684 | 44908685 | Human | 597152585 | GWAS1248659_H | language measurement QTL GWAS1248659 (human) | 3e-16 | protein measurement | 19 | 44908684 | 44908685 | Human | 597194567 | GWAS1290641_H | non-alcoholic fatty liver disease QTL GWAS1290641 (human) | 6e-16 | non-alcoholic fatty liver disease | 19 | 44908684 | 44908685 | Human | 596969332 | GWAS1088851_H | low density lipoprotein cholesterol measurement QTL GWAS1088851 (human) | 5e-27 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 596969328 | GWAS1088847_H | low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS1088847 (human) | 7e-27 | low density lipoprotein cholesterol measurement, lipid measurement | 19 | 44908684 | 44908685 | Human | 597602171 | GWAS1659031_H | coronary artery disease QTL GWAS1659031 (human) | 3e-12 | coronary artery disease | 19 | 44908684 | 44908685 | Human | 596969341 | GWAS1088860_H | intermediate density lipoprotein measurement QTL GWAS1088860 (human) | 3e-23 | remnant cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597430132 | GWAS1526206_H | protein measurement QTL GWAS1526206 (human) | 3e-358 | protein measurement | 19 | 44908684 | 44908685 | Human | 597341042 | GWAS1437116_H | serum alanine aminotransferase measurement QTL GWAS1437116 (human) | 2e-61 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 19 | 44908684 | 44908685 | Human | 597221236 | GWAS1317310_H | esterified cholesterol measurement, intermediate density lipoprotein measurement QTL GWAS1317310 (human) | 1e-25 | beta-soluble NSF attachment protein measurement | 19 | 44908684 | 44908685 | Human | 597221238 | GWAS1317312_H | free cholesterol measurement QTL GWAS1317312 (human) | 5e-16 | protein measurement | blood cholesterol level (CMO:0002280) | 19 | 44908684 | 44908685 | Human | 597304181 | GWAS1400255_H | level of methyltransferase BCDIN3D in blood serum QTL GWAS1400255 (human) | 6e-46 | level of methyltransferase BCDIN3D in blood serum | 19 | 44908684 | 44908685 | Human | 596970341 | GWAS1089860_H | free cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1089860 (human) | 4e-10 | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 596963173 | GWAS1082692_H | functional brain measurement QTL GWAS1082692 (human) | 6e-12 | functional brain measurement | 19 | 44908684 | 44908685 | Human | 597285729 | GWAS1381803_H | cholesterol esters in medium VLDL measurement QTL GWAS1381803 (human) | 1e-105 | cholesterol esters in medium VLDL measurement | 19 | 44908684 | 44908685 | Human | 597073559 | GWAS1169633_H | Lewy body dementia QTL GWAS1169633 (human) | 3e-64 | phospholipids in large HDL measurement | blood high density lipoprotein phospholipid level (CMO:0001565) | 19 | 44908684 | 44908685 | Human | 597260952 | GWAS1357026_H | dementia QTL GWAS1357026 (human) | 7e-305 | dementia | 19 | 44908684 | 44908685 | Human | 597429917 | GWAS1525991_H | protein measurement QTL GWAS1525991 (human) | 2e-86 | protein measurement | 19 | 44908684 | 44908685 | Human | 596954774 | GWAS1074293_H | beta-amyloid 1-42 measurement QTL GWAS1074293 (human) | 4e-17 | fatty acid measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 19 | 44908684 | 44908685 | Human | 596970129 | GWAS1089648_H | lipid measurement, intermediate density lipoprotein measurement QTL GWAS1089648 (human) | 6e-23 | lipid measurement, intermediate density lipoprotein measurement | 19 | 44908684 | 44908685 | Human | 597282462 | GWAS1378536_H | esterified cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1378536 (human) | 4e-89 | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597578391 | GWAS1635251_H | obesity QTL GWAS1635251 (human) | 7e-16 | obesity | 19 | 44908684 | 44908685 | Human | 407112014 | GWAS760990_H | apolipoprotein B measurement QTL GWAS760990 (human) | 6e-26 | apolipoprotein B measurement | 19 | 44908684 | 44908685 | Human | 596961950 | GWAS1081469_H | Lewy body dementia QTL GWAS1081469 (human) | 6e-17 | Lewy body dementia | 19 | 44908684 | 44908685 | Human | 597036699 | GWAS1132773_H | beta-amyloid 1-42 measurement QTL GWAS1132773 (human) | 6e-27 | beta-amyloid 1-42 measurement | 19 | 44908684 | 44908685 | Human | 597184150 | GWAS1280224_H | free cholesterol to total lipids in large VLDL percentage QTL GWAS1280224 (human) | 1e-59 | free cholesterol to total lipids in large VLDL percentage | 19 | 44908684 | 44908685 | Human | 597431948 | GWAS1528022_H | protein measurement QTL GWAS1528022 (human) | 2e-40 | protein measurement | 19 | 44908684 | 44908685 | Human | 597429901 | GWAS1525975_H | protein measurement QTL GWAS1525975 (human) | 1e-128 | protein measurement | 19 | 44908684 | 44908685 | Human | 597431950 | GWAS1528024_H | protein measurement QTL GWAS1528024 (human) | 2e-108 | protein measurement | 19 | 44908684 | 44908685 | Human | 597431951 | GWAS1528025_H | protein measurement QTL GWAS1528025 (human) | 8e-90 | protein measurement | 19 | 44908684 | 44908685 | Human | 597324431 | GWAS1420505_H | high density lipoprotein cholesterol measurement QTL GWAS1420505 (human) | 6e-256 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597267073 | GWAS1363147_H | apolipoprotein E (isoform E3) measurement QTL GWAS1363147 (human) | 1e-34 | protein measurement | 19 | 44908684 | 44908685 | Human | 597300866 | GWAS1396940_H | tubulin-specific chaperone A measurement QTL GWAS1396940 (human) | 5e-646 | tubulin-specific chaperone A measurement | 19 | 44908684 | 44908685 | Human | 597126797 | GWAS1222871_H | Alzheimer disease QTL GWAS1222871 (human) | 5e-36 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597267074 | GWAS1363148_H | apolipoprotein E (isoform E4) measurement QTL GWAS1363148 (human) | 8e-29 | apolipoprotein E (isoform E4) measurement | 19 | 44908684 | 44908685 | Human | 597429888 | GWAS1525962_H | protein measurement QTL GWAS1525962 (human) | 1e-107 | protein measurement | 19 | 44908684 | 44908685 | Human | 596970120 | GWAS1089639_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1089639 (human) | 9e-27 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597300871 | GWAS1396945_H | protein CEI measurement QTL GWAS1396945 (human) | 4e-159 | protein CEI measurement | 19 | 44908684 | 44908685 | Human | 597431937 | GWAS1528011_H | protein measurement QTL GWAS1528011 (human) | 1e-99 | protein measurement | 19 | 44908684 | 44908685 | Human | 597039752 | GWAS1135826_H | apolipoprotein A 1 measurement QTL GWAS1135826 (human) | 8e-311 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 19 | 44908684 | 44908685 | Human | 597172870 | GWAS1268944_H | C-reactive protein measurement QTL GWAS1268944 (human) | 4e-125 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 596956852 | GWAS1076371_H | protein measurement QTL GWAS1076371 (human) | 2e-12 | apolipoprotein E isoform E2 measurement | 19 | 44908684 | 44908685 | Human | 597428924 | GWAS1524998_H | protein measurement QTL GWAS1524998 (human) | 3e-224 | protein measurement | 19 | 44908684 | 44908685 | Human | 597606079 | GWAS1662939_H | HbA1c measurement QTL GWAS1662939 (human) | 4e-47 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 19 | 44908684 | 44908685 | Human | 596962998 | GWAS1082517_H | type 2 diabetes mellitus, coronary artery disease QTL GWAS1082517 (human) | 6e-65 | type 2 diabetes mellitus, coronary artery disease | 19 | 44908684 | 44908685 | Human | 597434046 | GWAS1530120_H | protein measurement QTL GWAS1530120 (human) | 6e-184 | protein measurement | 19 | 44908684 | 44908685 | Human | 597115573 | GWAS1211647_H | C-reactive protein measurement QTL GWAS1211647 (human) | 6e-363 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 407106918 | GWAS755894_H | very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS755894 (human) | 1e-19 | executive function measurement | 19 | 44908684 | 44908685 | Human | 597224126 | GWAS1320200_H | low density lipoprotein triglyceride measurement QTL GWAS1320200 (human) | 4e-14 | protein measurement | blood low density lipoprotein triglyceride level (CMO:0002687) | 19 | 44908684 | 44908685 | Human | 597036734 | GWAS1132808_H | t-tau measurement QTL GWAS1132808 (human) | 1e-13 | protein measurement | 19 | 44908684 | 44908685 | Human | 597297842 | GWAS1393916_H | leucine-rich repeat neuronal protein 1 measurement QTL GWAS1393916 (human) | 3e-418 | leucine-rich repeat neuronal protein 1 measurement | 19 | 44908684 | 44908685 | Human | 597306034 | GWAS1402108_H | coronary artery disease QTL GWAS1402108 (human) | 4e-38 | coronary artery disease | 19 | 44908684 | 44908685 | Human | 596954813 | GWAS1074332_H | Lewy body dementia, Lewy body dementia measurement QTL GWAS1074332 (human) | 1e-12 | very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597178034 | GWAS1274108_H | protein measurement QTL GWAS1274108 (human) | 1e-181 | protein measurement | 19 | 44908684 | 44908685 | Human | 597036733 | GWAS1132807_H | t-tau measurement QTL GWAS1132807 (human) | 2e-11 | body size trait (VT:0100005) | 19 | 44908684 | 44908685 | Human | 407116136 | GWAS765112_H | triglyceride measurement, intermediate density lipoprotein measurement QTL GWAS765112 (human) | 2e-12 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 597039803 | GWAS1135877_H | diet measurement QTL GWAS1135877 (human) | 5e-12 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 19 | 44908684 | 44908685 | Human | 596963001 | GWAS1082520_H | nuclear receptor-binding protein measurement QTL GWAS1082520 (human) | 1e-24 | nuclear receptor-binding protein measurement | 19 | 44908684 | 44908685 | Human | 597167797 | GWAS1263871_H | free cholesterol in small VLDL measurement QTL GWAS1263871 (human) | 3e-95 | blood VLDL cholesterol amount (VT:0005144) | 19 | 44908684 | 44908685 | Human | 597429938 | GWAS1526012_H | protein measurement QTL GWAS1526012 (human) | 2e-302 | protein measurement | 19 | 44908684 | 44908685 | Human | 597131961 | GWAS1228035_H | memory performance QTL GWAS1228035 (human) | 6e-21 | memory performance | 19 | 44908684 | 44908685 | Human | 597431987 | GWAS1528061_H | protein measurement QTL GWAS1528061 (human) | 4e-149 | protein measurement | 19 | 44908684 | 44908685 | Human | 597035686 | GWAS1131760_H | neurofibrillary tangles measurement QTL GWAS1131760 (human) | 5e-23 | neurofibrillary tangles measurement | 19 | 44908684 | 44908685 | Human | 597270185 | GWAS1366259_H | taste liking measurement QTL GWAS1366259 (human) | 4e-23 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 597428910 | GWAS1524984_H | protein measurement QTL GWAS1524984 (human) | 7e-60 | protein measurement | 19 | 44908684 | 44908685 | Human | 597103269 | GWAS1199343_H | serum alanine aminotransferase measurement QTL GWAS1199343 (human) | 5e-35 | matrix metalloproteinase 8 measurement | serum alanine aminotransferase activity level (CMO:0000575) | 19 | 44908684 | 44908685 | Human | 407116151 | GWAS765127_H | esterified cholesterol measurement QTL GWAS765127 (human) | 2e-22 | C-reactive protein measurement | 19 | 44908684 | 44908685 | Human | 597277356 | GWAS1373430_H | age-related macular degeneration, COVID-19 QTL GWAS1373430 (human) | 1e-44 | age-related macular degeneration, COVID-19 | 19 | 44908684 | 44908685 | Human | 597084832 | GWAS1180906_H | mean reticulocyte volume QTL GWAS1180906 (human) | 4e-21 | platelet quantity (VT:0003179) | body mass index (BMI) (CMO:0000105) | 19 | 44908684 | 44908685 | Human | 597434026 | GWAS1530100_H | protein measurement QTL GWAS1530100 (human) | 6e-358 | protein measurement | 19 | 44908684 | 44908685 | Human | 597431978 | GWAS1528052_H | protein measurement QTL GWAS1528052 (human) | 4e-12 | protein measurement | 19 | 44908684 | 44908685 | Human | 597434027 | GWAS1530101_H | protein measurement QTL GWAS1530101 (human) | 1e-244 | protein measurement | 19 | 44908684 | 44908685 | Human | 597429925 | GWAS1525999_H | protein measurement QTL GWAS1525999 (human) | 1e-33 | protein measurement | 19 | 44908684 | 44908685 | Human | 597214883 | GWAS1310957_H | Alzheimer disease QTL GWAS1310957 (human) | 2e-91 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 597035690 | GWAS1131764_H | neurofibrillary tangles measurement QTL GWAS1131764 (human) | 3e-31 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597113512 | GWAS1209586_H | amyloid-beta measurement QTL GWAS1209586 (human) | 6e-32 | amyloid-beta measurement | 19 | 44908684 | 44908685 | Human | 597175975 | GWAS1272049_H | Alzheimer disease, dementia, family history of Alzheimer’s disease QTL GWAS1272049 (human) | 6e-150 | Alzheimer disease, dementia, family history of Alzheimer’s disease | 19 | 44908684 | 44908685 | Human | 597283545 | GWAS1379619_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1379619 (human) | 5e-92 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597257947 | GWAS1354021_H | liver fat measurement QTL GWAS1354021 (human) | 1e-30 | apolipoprotein E isoform E2 measurement | 19 | 44908684 | 44908685 | Human | 597025494 | GWAS1121568_H | waist-hip ratio QTL GWAS1121568 (human) | 4e-37 | lipoprotein-associated phospholipase A(2) measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597250783 | GWAS1346857_H | C-reactive protein measurement QTL GWAS1346857 (human) | 6e-109 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 597432014 | GWAS1528088_H | protein measurement QTL GWAS1528088 (human) | 6e-30 | protein measurement | 19 | 44908684 | 44908685 | Human | 597103301 | GWAS1199375_H | amyloid-beta measurement QTL GWAS1199375 (human) | 2e-25 | cognitive function measurement | 19 | 44908684 | 44908685 | Human | 597103300 | GWAS1199374_H | Alzheimer disease QTL GWAS1199374 (human) | 0.0000003 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597288654 | GWAS1384728_H | total cholesterol in small VLDL QTL GWAS1384728 (human) | 2e-148 | total cholesterol in small VLDL | 19 | 44908684 | 44908685 | Human | 597586630 | GWAS1643490_H | family history of Alzheimer’s disease QTL GWAS1643490 (human) | 1e-169 | family history of Alzheimer’s disease | 19 | 44908684 | 44908685 | Human | 597428932 | GWAS1525006_H | protein measurement QTL GWAS1525006 (human) | 8e-49 | protein measurement | 19 | 44908684 | 44908685 | Human | 597434048 | GWAS1530122_H | protein measurement QTL GWAS1530122 (human) | 2e-60 | protein measurement | 19 | 44908684 | 44908685 | Human | 597429952 | GWAS1526026_H | protein measurement QTL GWAS1526026 (human) | 6e-95 | protein measurement | 19 | 44908684 | 44908685 | Human | 597127883 | GWAS1223957_H | C-reactive protein measurement QTL GWAS1223957 (human) | 3e-22 | linoleic acid measurement | blood free fatty acids level (CMO:0000117) | 19 | 44908684 | 44908685 | Human | 597433026 | GWAS1529100_H | protein measurement QTL GWAS1529100 (human) | 5e-114 | protein measurement | 19 | 44908684 | 44908685 | Human | 597026549 | GWAS1122623_H | p-tau measurement QTL GWAS1122623 (human) | 3e-18 | pancreas integrity trait (VT:0010560) | 19 | 44908684 | 44908685 | Human | 597228282 | GWAS1324356_H | low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1324356 (human) | 8e-23 | low density lipoprotein cholesterol measurement, phospholipid measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597026544 | GWAS1122618_H | t-tau measurement QTL GWAS1122618 (human) | 1e-20 | protein measurement | blood hemoglobin A1c level (CMO:0002786) | 19 | 44908684 | 44908685 | Human | 597172989 | GWAS1269063_H | C-reactive protein measurement QTL GWAS1269063 (human) | 4e-32 | protein measurement | 19 | 44908684 | 44908685 | Human | 406898985 | GWAS547961_H | platelet count QTL GWAS547961 (human) | 3e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 19 | 44908684 | 44908685 | Human | 597433079 | GWAS1529153_H | protein measurement QTL GWAS1529153 (human) | 7e-74 | protein measurement | 19 | 44908684 | 44908685 | Human | 597580531 | GWAS1637391_H | diabetic retinopathy QTL GWAS1637391 (human) | 3e-13 | diabetic retinopathy | disease progression measurement (CMO:0001110) | 19 | 44908684 | 44908685 | Human | 596963067 | GWAS1082586_H | PDZK1-interacting protein 1 measurement QTL GWAS1082586 (human) | 3e-26 | PDZK1-interacting protein 1 measurement | 19 | 44908684 | 44908685 | Human | 597254902 | GWAS1350976_H | Alzheimer disease QTL GWAS1350976 (human) | 2e-215 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597590769 | GWAS1647629_H | sign or symptom QTL GWAS1647629 (human) | 3e-19 | body size trait (VT:0100005) | 19 | 44908684 | 44908685 | Human | 597200616 | GWAS1296690_H | fat body mass QTL GWAS1296690 (human) | 5e-10 | body fat mass (VT:0010482) | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597289704 | GWAS1385778_H | triglycerides in very large HDL measurement QTL GWAS1385778 (human) | 3e-41 | blood HDL triglyceride amount (VT:0010698) | 19 | 44908684 | 44908685 | Human | 597223146 | GWAS1319220_H | low density lipoprotein cholesterol measurement QTL GWAS1319220 (human) | 5e-26 | protein measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597254893 | GWAS1350967_H | Alzheimer disease QTL GWAS1350967 (human) | 5e-122 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597270253 | GWAS1366327_H | type 2 diabetes mellitus QTL GWAS1366327 (human) | 3e-15 | type 2 diabetes mellitus | 19 | 44908684 | 44908685 | Human | 597434088 | GWAS1530162_H | protein measurement QTL GWAS1530162 (human) | 3e-937 | protein measurement | 19 | 44908684 | 44908685 | Human | 597026541 | GWAS1122615_H | beta-amyloid 1-42 measurement QTL GWAS1122615 (human) | 1e-51 | beta-amyloid 1-42 measurement | blood hemoglobin A1c level (CMO:0002786) | 19 | 44908684 | 44908685 | Human | 597432037 | GWAS1528111_H | protein measurement QTL GWAS1528111 (human) | 9e-80 | protein measurement | 19 | 44908684 | 44908685 | Human | 597123821 | GWAS1219895_H | blood protein measurement QTL GWAS1219895 (human) | 4e-52 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 597433057 | GWAS1529131_H | protein measurement QTL GWAS1529131 (human) | 6e-50 | protein measurement | 19 | 44908684 | 44908685 | Human | 407119301 | GWAS768277_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS768277 (human) | 4e-15 | waist-hip ratio | 19 | 44908684 | 44908685 | Human | 597588508 | GWAS1645368_H | macular degeneration QTL GWAS1645368 (human) | 3e-20 | milk polyunsaturated fatty acid amount (VT:0010374) | milk polyunsaturated fatty acid measurement (CMO:0000821) | 19 | 44908684 | 44908685 | Human | 596958743 | GWAS1078262_H | adult onset asthma, type 2 diabetes mellitus QTL GWAS1078262 (human) | 2e-10 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 407119296 | GWAS768272_H | very low density lipoprotein cholesterol measurement QTL GWAS768272 (human) | 1e-16 | angina pectoris | 19 | 44908684 | 44908685 | Human | 407119297 | GWAS768273_H | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement QTL GWAS768273 (human) | 4e-19 | 3-hydroxybutyrate measurement | 19 | 44908684 | 44908685 | Human | 597201439 | GWAS1297513_H | memory performance QTL GWAS1297513 (human) | 3e-20 | memory performance | 19 | 44908684 | 44908685 | Human | 597226002 | GWAS1322076_H | low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS1322076 (human) | 1e-24 | nuclear receptor-binding protein measurement | blood lipid measurement (CMO:0000050) | 19 | 44908684 | 44908685 | Human | 596970009 | GWAS1089528_H | omega-6 polyunsaturated fatty acid measurement QTL GWAS1089528 (human) | 5e-18 | omega-6 polyunsaturated fatty acid measurement | 19 | 44908684 | 44908685 | Human | 597226007 | GWAS1322081_H | low density lipoprotein triglyceride measurement QTL GWAS1322081 (human) | 5e-09 | low density lipoprotein triglyceride measurement | blood low density lipoprotein triglyceride level (CMO:0002687) | 19 | 44908684 | 44908685 | Human | 597140998 | GWAS1237072_H | apolipoprotein E measurement QTL GWAS1237072 (human) | 4e-09 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 19 | 44908684 | 44908685 | Human | 596969990 | GWAS1089509_H | fatty acid measurement QTL GWAS1089509 (human) | 7e-10 | fatty acid measurement | 19 | 44908684 | 44908685 | Human | 597608971 | GWAS1665831_H | heart disease QTL GWAS1665831 (human) | 1e-26 | N-palmitoyl-sphingosine (d18:1/16:0) measurement | 19 | 44908684 | 44908685 | Human | 597592585 | GWAS1649445_H | high density lipoprotein cholesterol measurement QTL GWAS1649445 (human) | 2e-263 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597585409 | GWAS1642269_H | high density lipoprotein cholesterol measurement QTL GWAS1642269 (human) | 1e-164 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597595649 | GWAS1652509_H | blood urea nitrogen measurement QTL GWAS1652509 (human) | 9e-28 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 19 | 44908684 | 44908685 | Human | 407114212 | GWAS763188_H | polyunsaturated fatty acid measurement QTL GWAS763188 (human) | 3e-20 | polyunsaturated fatty acid measurement | 19 | 44908684 | 44908685 | Human | 597270072 | GWAS1366146_H | type 2 diabetes mellitus QTL GWAS1366146 (human) | 7e-14 | protein measurement | 19 | 44908684 | 44908685 | Human | 597106229 | GWAS1202303_H | amygdala volume change measurement, age at assessment QTL GWAS1202303 (human) | 6e-08 | age at onset, Parkinson disease | 19 | 44908684 | 44908685 | Human | 597428792 | GWAS1524866_H | protein measurement QTL GWAS1524866 (human) | 5e-167 | protein measurement | 19 | 44908684 | 44908685 | Human | 407108075 | GWAS757051_H | low density lipoprotein triglyceride measurement QTL GWAS757051 (human) | 4e-14 | low density lipoprotein triglyceride measurement | 19 | 44908684 | 44908685 | Human | 597430836 | GWAS1526910_H | protein measurement QTL GWAS1526910 (human) | 1e-50 | protein measurement | 19 | 44908684 | 44908685 | Human | 596970047 | GWAS1089566_H | low density lipoprotein cholesterol measurement QTL GWAS1089566 (human) | 5e-26 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597600820 | GWAS1657680_H | body mass index QTL GWAS1657680 (human) | 1e-25 | beta-soluble NSF attachment protein measurement | blood total cholesterol level (CMO:0000051) | 19 | 44908684 | 44908685 | Human | 597284402 | GWAS1380476_H | esterified cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1380476 (human) | 5e-52 | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597219891 | GWAS1315965_H | triglyceride measurement, high density lipoprotein cholesterol measurement QTL GWAS1315965 (human) | 6e-12 | triglyceride measurement, high density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597090875 | GWAS1186949_H | type 2 diabetes mellitus QTL GWAS1186949 (human) | 4e-28 | type 2 diabetes mellitus | 19 | 44908684 | 44908685 | Human | 597294644 | GWAS1390718_H | type 2 diabetes mellitus, coronary artery disease QTL GWAS1390718 (human) | 6e-65 | type 2 diabetes mellitus, coronary artery disease | 19 | 44908684 | 44908685 | Human | 597429809 | GWAS1525883_H | protein measurement QTL GWAS1525883 (human) | 1e-31 | protein measurement | 19 | 44908684 | 44908685 | Human | 597589552 | GWAS1646412_H | cerebrovascular disorder QTL GWAS1646412 (human) | 5e-14 | cerebrovascular disorder | 19 | 44908684 | 44908685 | Human | 597428787 | GWAS1524861_H | protein measurement QTL GWAS1524861 (human) | 1e-37 | protein measurement | 19 | 44908684 | 44908685 | Human | 597429804 | GWAS1525878_H | protein measurement QTL GWAS1525878 (human) | 1e-136 | protein measurement | 19 | 44908684 | 44908685 | Human | 597042724 | GWAS1138798_H | neuritic plaque measurement QTL GWAS1138798 (human) | 3e-24 | protein measurement | blood apoliprotein B level (CMO:0000522) | 19 | 44908684 | 44908685 | Human | 597300782 | GWAS1396856_H | PH and SEC7 domain-containing protein 1 measurement QTL GWAS1396856 (human) | 2e-96 | PH and SEC7 domain-containing protein 1 measurement | 19 | 44908684 | 44908685 | Human | 596958753 | GWAS1078272_H | Parkinson disease, disease progression measurement QTL GWAS1078272 (human) | 3e-13 | non-alcoholic fatty liver disease | 19 | 44908684 | 44908685 | Human | 597283375 | GWAS1379449_H | phospholipids in medium HDL measurement QTL GWAS1379449 (human) | 3e-63 | blood HDL phospholipid amount (VT:0010504) | 19 | 44908684 | 44908685 | Human | 596963875 | GWAS1083394_H | waist circumference QTL GWAS1083394 (human) | 1e-16 | angina pectoris | 19 | 44908684 | 44908685 | Human | 596958755 | GWAS1078274_H | white matter hyperintensity measurement QTL GWAS1078274 (human) | 0.0000002 | white matter hyperintensity measurement | 19 | 44908684 | 44908685 | Human | 597192224 | GWAS1288298_H | non-alcoholic fatty liver disease QTL GWAS1288298 (human) | 5e-08 | non-alcoholic fatty liver disease | 19 | 44908684 | 44908685 | Human | 597588517 | GWAS1645377_H | glucose measurement QTL GWAS1645377 (human) | 1e-15 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 19 | 44908684 | 44908685 | Human | 597602850 | GWAS1659710_H | family history of Alzheimer’s disease QTL GWAS1659710 (human) | 4e-32 | family history of Alzheimer’s disease | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 597602851 | GWAS1659711_H | family history of Alzheimer’s disease QTL GWAS1659711 (human) | 7e-51 | family history of Alzheimer’s disease | 19 | 44908684 | 44908685 | Human | 407106946 | GWAS755922_H | very low density lipoprotein cholesterol measurement QTL GWAS755922 (human) | 3e-21 | very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597031511 | GWAS1127585_H | Alzheimer disease QTL GWAS1127585 (human) | 2e-30 | pancreas integrity trait (VT:0010560) | 19 | 44908684 | 44908685 | Human | 597614173 | GWAS1671033_H | family history of Alzheimer’s disease QTL GWAS1671033 (human) | 3e-62 | family history of Alzheimer’s disease | 19 | 44908684 | 44908685 | Human | 597234268 | GWAS1330342_H | blood protein measurement QTL GWAS1330342 (human) | 7e-32 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 597430873 | GWAS1526947_H | protein measurement QTL GWAS1526947 (human) | 2e-172 | protein measurement | 19 | 44908684 | 44908685 | Human | 597166672 | GWAS1262746_H | serum alanine aminotransferase measurement QTL GWAS1262746 (human) | 4e-40 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 19 | 44908684 | 44908685 | Human | 597428817 | GWAS1524891_H | protein measurement QTL GWAS1524891 (human) | 8e-33 | protein measurement | 19 | 44908684 | 44908685 | Human | 597079640 | GWAS1175714_H | C-reactive protein measurement QTL GWAS1175714 (human) | 8e-10 | neurofilament light chain measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 597430866 | GWAS1526940_H | protein measurement QTL GWAS1526940 (human) | 2e-858 | protein measurement | 19 | 44908684 | 44908685 | Human | 597031514 | GWAS1127588_H | Alzheimer disease QTL GWAS1127588 (human) | 6e-43 | level of alpha-N-acetylneuraminide alpha-2,8-sialyltransferase in blood serum | 19 | 44908684 | 44908685 | Human | 597609036 | GWAS1665896_H | family history of Alzheimer’s disease QTL GWAS1665896 (human) | 1e-70 | family history of Alzheimer’s disease | 19 | 44908684 | 44908685 | Human | 597584456 | GWAS1641316_H | diabetes mellitus QTL GWAS1641316 (human) | 1e-11 | pancreas integrity trait (VT:0010560) | blood low density lipoprotein triglyceride level (CMO:0002687) | 19 | 44908684 | 44908685 | Human | 596962892 | GWAS1082411_H | beta-soluble NSF attachment protein measurement QTL GWAS1082411 (human) | 1e-25 | beta-soluble NSF attachment protein measurement | 19 | 44908684 | 44908685 | Human | 597224000 | GWAS1320074_H | fatty acid measurement QTL GWAS1320074 (human) | 4e-13 | low density lipoprotein triglyceride measurement | blood low density lipoprotein triglyceride level (CMO:0002687) | 19 | 44908684 | 44908685 | Human | 597606980 | GWAS1663840_H | total cholesterol measurement QTL GWAS1663840 (human) | 4e-11 | body size trait (VT:0100005) | blood low density lipoprotein triglyceride level (CMO:0002687) | 19 | 44908684 | 44908685 | Human | 597067338 | GWAS1163412_H | triglyceride measurement QTL GWAS1163412 (human) | 0.000001 | age of onset of stroke disorder | blood triglyceride level (CMO:0000118) | 19 | 44908684 | 44908685 | Human | 1331657 | COPD9_H | Chronic obstructive pulmonary disease QTL 9 (human) | 1.94 | Chronic airflow obstruction | post-bronchodilator FEV1 | 19 | 31021760 | 57021760 | Human | 597119561 | GWAS1215635_H | blood protein measurement QTL GWAS1215635 (human) | 2e-76 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 597067337 | GWAS1163411_H | triglyceride measurement QTL GWAS1163411 (human) | 9e-34 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 19 | 44908684 | 44908685 | Human | 597121608 | GWAS1217682_H | blood protein measurement QTL GWAS1217682 (human) | 2e-127 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 19 | 44908684 | 44908685 | Human | 597288568 | GWAS1384642_H | fatty acid measurement QTL GWAS1384642 (human) | 2e-73 | fatty acid measurement | 19 | 44908684 | 44908685 | Human | 597428861 | GWAS1524935_H | protein measurement QTL GWAS1524935 (human) | 2e-47 | protein measurement | 19 | 44908684 | 44908685 | Human | 597135985 | GWAS1232059_H | hip fracture QTL GWAS1232059 (human) | 4e-11 | 1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1) measurement, cerebrospinal fluid biomarker measurement | 19 | 44908684 | 44908685 | Human | 597059199 | GWAS1155273_H | BMI-adjusted waist-hip ratio QTL GWAS1155273 (human) | 3e-19 | protein measurement | 19 | 44908684 | 44908685 | Human | 597609079 | GWAS1665939_H | liver disease QTL GWAS1665939 (human) | 9e-27 | free cholesterol measurement, low density lipoprotein cholesterol measurement | blood cholesterol level (CMO:0002280) | 19 | 44908684 | 44908685 | Human | 596949627 | GWAS1069146_H | Red cell distribution width QTL GWAS1069146 (human) | 8e-26 | killer cell immunoglobulin-like receptor 2DL5A measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 19 | 44908684 | 44908685 | Human | 407272882 | GWAS921858_H | parental longevity QTL GWAS921858 (human) | 3e-83 | total life span (VT:0001661) | 19 | 44908684 | 44908685 | Human | 597131887 | GWAS1227961_H | memory performance QTL GWAS1227961 (human) | 1e-17 | protein measurement | 19 | 44908684 | 44908685 | Human | 597430882 | GWAS1526956_H | protein measurement QTL GWAS1526956 (human) | 2e-138 | protein measurement | 19 | 44908684 | 44908685 | Human | 407166395 | GWAS815371_H | obsolete_red blood cell distribution width QTL GWAS815371 (human) | 2e-59 | obsolete_red blood cell distribution width | 19 | 44908684 | 44908685 | Human | 596954731 | GWAS1074250_H | dementia QTL GWAS1074250 (human) | 7e-305 | dementia | 19 | 44908684 | 44908685 | Human | 597430883 | GWAS1526957_H | protein measurement QTL GWAS1526957 (human) | 1e-32 | protein measurement | 19 | 44908684 | 44908685 | Human | 597605790 | GWAS1662650_H | Cognitive impairment QTL GWAS1662650 (human) | 8e-130 | Cognitive impairment | 19 | 44908684 | 44908685 | Human | 597433756 | GWAS1529830_H | protein measurement QTL GWAS1529830 (human) | 9e-28 | protein measurement | 19 | 44908684 | 44908685 | Human | 597605791 | GWAS1662651_H | amnesia QTL GWAS1662651 (human) | 2e-67 | amnesia | 19 | 44908684 | 44908685 | Human | 597579167 | GWAS1636027_H | overnutrition, obesity QTL GWAS1636027 (human) | 5e-17 | overnutrition, obesity | 19 | 44908684 | 44908685 | Human | 406922819 | GWAS571795_H | obsolete_red blood cell distribution width QTL GWAS571795 (human) | 8e-26 | killer cell immunoglobulin-like receptor 2DL5A measurement | 19 | 44908684 | 44908685 | Human | 597605788 | GWAS1662648_H | nervous system disease QTL GWAS1662648 (human) | 3e-15 | type 2 diabetes mellitus | 19 | 44908684 | 44908685 | Human | 597177754 | GWAS1273828_H | tRNA (guanine-N(7)-)-methyltransferase measurement QTL GWAS1273828 (human) | 3e-75 | tRNA (guanine-N(7)-)-methyltransferase measurement | 19 | 44908684 | 44908685 | Human | 597605789 | GWAS1662649_H | nervous system disease QTL GWAS1662649 (human) | 8e-166 | nervous system disease | 19 | 44908684 | 44908685 | Human | 597085587 | GWAS1181661_H | type 2 diabetes mellitus QTL GWAS1181661 (human) | 2e-26 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597605787 | GWAS1662647_H | delirium QTL GWAS1662647 (human) | 2e-22 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 597297559 | GWAS1393633_H | lysophosphatidylcholine 20:1 measurement QTL GWAS1393633 (human) | 9e-09 | ceramide measurement | 19 | 44908684 | 44908685 | Human | 597432723 | GWAS1528797_H | protein measurement QTL GWAS1528797 (human) | 5e-21 | protein measurement | 19 | 44908684 | 44908685 | Human | 597283208 | GWAS1379282_H | high density lipoprotein cholesterol measurement QTL GWAS1379282 (human) | 2e-69 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 407082587 | GWAS731563_H | cognitive decline measurement QTL GWAS731563 (human) | 0.000007 | cognitive behavior trait (VT:0010450) | 19 | 44908684 | 44908685 | Human | 597432708 | GWAS1528782_H | protein measurement QTL GWAS1528782 (human) | 1e-116 | protein measurement | 19 | 44908684 | 44908685 | Human | 597172608 | GWAS1268682_H | leucine-rich repeat neuronal protein 1 measurement QTL GWAS1268682 (human) | 8e-1394 | leucine-rich repeat neuronal protein 1 measurement | 19 | 44908684 | 44908685 | Human | 407160415 | GWAS809391_H | Alzheimer disease, amyloid-beta measurement QTL GWAS809391 (human) | 5e-14 | Alzheimer disease, amyloid-beta measurement | 19 | 44908684 | 44908685 | Human | 597043597 | GWAS1139671_H | brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement QTL GWAS1139671 (human) | 3e-33 | brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement | 19 | 44908684 | 44908685 | Human | 597284226 | GWAS1380300_H | high density lipoprotein cholesterol measurement QTL GWAS1380300 (human) | 2e-155 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 407116377 | GWAS765353_H | low density lipoprotein cholesterol measurement QTL GWAS765353 (human) | 2e-26 | type 2 diabetes mellitus | 19 | 44908684 | 44908685 | Human | 407116378 | GWAS765354_H | low density lipoprotein triglyceride measurement QTL GWAS765354 (human) | 1e-11 | non-alcoholic fatty liver disease | 19 | 44908684 | 44908685 | Human | 597042568 | GWAS1138642_H | white matter hyperintensity measurement QTL GWAS1138642 (human) | 1e-09 | Alzheimer disease | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 596979120 | GWAS1098639_H | age-related macular degeneration QTL GWAS1098639 (human) | 9e-26 | age-related macular degeneration | 19 | 44908684 | 44908685 | Human | 597593531 | GWAS1650391_H | macular degeneration QTL GWAS1650391 (human) | 8e-17 | macular degeneration | 19 | 44908684 | 44908685 | Human | 597283263 | GWAS1379337_H | C-reactive protein measurement QTL GWAS1379337 (human) | 1e-1420 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 407108201 | GWAS757177_H | linoleic acid measurement QTL GWAS757177 (human) | 3e-22 | C-reactive protein measurement | 19 | 44908684 | 44908685 | Human | 597079485 | GWAS1175559_H | white matter hyperintensity measurement QTL GWAS1175559 (human) | 0.000005 | white matter hyperintensity measurement | 19 | 44908684 | 44908685 | Human | 597266857 | GWAS1362931_H | apolipoprotein E isoform E2 measurement QTL GWAS1362931 (human) | 5e-43 | apolipoprotein E isoform E2 measurement | 19 | 44908684 | 44908685 | Human | 597587375 | GWAS1644235_H | sign or symptom QTL GWAS1644235 (human) | 4e-19 | urine ketone body amount (VT:0010724) | 19 | 44908684 | 44908685 | Human | 597030311 | GWAS1126385_H | physical activity measurement QTL GWAS1126385 (human) | 0.0000005 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 19 | 44908684 | 44908685 | Human | 597030305 | GWAS1126379_H | physical activity measurement QTL GWAS1126379 (human) | 6e-13 | wellness/fitness trait (VT:1000152) | blood uric acid level (CMO:0000501) | 19 | 44908684 | 44908685 | Human | 597139873 | GWAS1235947_H | dementia, Parkinson disease, disease progression measurement QTL GWAS1235947 (human) | 2e-15 | protein measurement | 19 | 44908684 | 44908685 | Human | 407108218 | GWAS757194_H | triglyceride measurement, intermediate density lipoprotein measurement QTL GWAS757194 (human) | 1e-12 | Lewy body dementia, Lewy body dementia measurement | 19 | 44908684 | 44908685 | Human | 597587362 | GWAS1644222_H | family history of Alzheimer’s disease QTL GWAS1644222 (human) | 6e-53 | family history of Alzheimer’s disease | 19 | 44908684 | 44908685 | Human | 596963753 | GWAS1083272_H | hip fracture QTL GWAS1083272 (human) | 4e-11 | BMI-adjusted waist-hip ratio | 19 | 44908684 | 44908685 | Human | 407083644 | GWAS732620_H | hyperopia QTL GWAS732620 (human) | 0.0000001 | COVID-19 | 19 | 44908684 | 44908685 | Human | 597594589 | GWAS1651449_H | glucose measurement QTL GWAS1651449 (human) | 4e-35 | glucose measurement | blood glucose level (CMO:0000046) | 19 | 44908684 | 44908685 | Human | 597038544 | GWAS1134618_H | high density lipoprotein cholesterol measurement QTL GWAS1134618 (human) | 7e-180 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597620184 | GWAS1677044_H | nervous system disease QTL GWAS1677044 (human) | 3e-148 | nervous system disease | 19 | 44908684 | 44908685 | Human | 597069265 | GWAS1165339_H | triglyceride measurement QTL GWAS1165339 (human) | 1e-39 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 596969938 | GWAS1089457_H | free cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1089457 (human) | 3e-14 | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 596957663 | GWAS1077182_H | 3-hydroxybutyrate measurement QTL GWAS1077182 (human) | 4e-19 | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597250514 | GWAS1346588_H | familial hyperlipidemia QTL GWAS1346588 (human) | 3e-226 | familial hyperlipidemia | 19 | 44908684 | 44908685 | Human | 597042651 | GWAS1138725_H | refractive error QTL GWAS1138725 (human) | 4e-08 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 597172693 | GWAS1268767_H | protein measurement QTL GWAS1268767 (human) | 2e-16 | angina pectoris | 19 | 44908684 | 44908685 | Human | 596969946 | GWAS1089465_H | apolipoprotein B measurement QTL GWAS1089465 (human) | 9e-23 | apolipoprotein B measurement | 19 | 44908684 | 44908685 | Human | 1559110 | SCL22_H | Serum cholesterol level QTL 22 (human) | 3.59 | 0.000241 | Lipid level | LDL cholesterol | 19 | 31907594 | 57907594 | Human | 407114262 | GWAS763238_H | very low density lipoprotein cholesterol measurement QTL GWAS763238 (human) | 6e-18 | amyloid-beta measurement | 19 | 44908684 | 44908685 | Human | 597592524 | GWAS1649384_H | high density lipoprotein cholesterol measurement QTL GWAS1649384 (human) | 4e-30 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 596969922 | GWAS1089441_H | low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1089441 (human) | 8e-23 | low density lipoprotein cholesterol measurement, phospholipid measurement | 19 | 44908684 | 44908685 | Human | 407114264 | GWAS763240_H | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement QTL GWAS763240 (human) | 2e-17 | p-tau measurement | 19 | 44908684 | 44908685 | Human | 407094815 | GWAS743791_H | waist-hip ratio QTL GWAS743791 (human) | 4e-18 | intelligence | waist to hip ratio (WHR) (CMO:0000020) | 19 | 44908684 | 44908685 | Human | 597129674 | GWAS1225748_H | cerebral amyloid angiopathy QTL GWAS1225748 (human) | 9e-16 | protein measurement | 19 | 44908684 | 44908685 | Human | 597042673 | GWAS1138747_H | neurofibrillary tangles measurement QTL GWAS1138747 (human) | 4e-20 | memory performance | blood urea nitrogen level (CMO:0000049) | 19 | 44908684 | 44908685 | Human | 597196273 | GWAS1292347_H | high density lipoprotein cholesterol measurement QTL GWAS1292347 (human) | 6e-56 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 596955643 | GWAS1075162_H | physical activity measurement QTL GWAS1075162 (human) | 4e-09 | fall | 19 | 44908684 | 44908685 | Human | 597289449 | GWAS1385523_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1385523 (human) | 1e-97 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 407116342 | GWAS765318_H | low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS765318 (human) | 4e-24 | blood protein measurement | 19 | 44908684 | 44908685 | Human | 597136869 | GWAS1232943_H | 1-stearoyl-GPE (18:0) measurement QTL GWAS1232943 (human) | 8e-19 | 1-stearoyl-GPE (18:0) measurement | 19 | 44908684 | 44908685 | Human | 407116350 | GWAS765326_H | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement QTL GWAS765326 (human) | 9e-15 | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597043690 | GWAS1139764_H | cerebral amyloid angiopathy QTL GWAS1139764 (human) | 5e-25 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 596963605 | GWAS1083124_H | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement QTL GWAS1083124 (human) | 2e-21 | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597334299 | GWAS1430373_H | dementia QTL GWAS1430373 (human) | 3e-10 | dementia | 19 | 44908684 | 44908685 | Human | 596963600 | GWAS1083119_H | non-alcoholic fatty liver disease QTL GWAS1083119 (human) | 1e-11 | non-alcoholic fatty liver disease | 19 | 44908684 | 44908685 | Human | 407117506 | GWAS766482_H | low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS766482 (human) | 1e-22 | low density lipoprotein cholesterol measurement, phospholipid measurement | 19 | 44908684 | 44908685 | Human | 597585177 | GWAS1642037_H | type 2 diabetes mellitus QTL GWAS1642037 (human) | 7e-42 | type 2 diabetes mellitus | 19 | 44908684 | 44908685 | Human | 597287185 | GWAS1383259_H | triglycerides in medium LDL measurement QTL GWAS1383259 (human) | 3e-124 | blood LDL triglyceride amount (VT:0010699) | 19 | 44908684 | 44908685 | Human | 597334290 | GWAS1430364_H | Alzheimer disease QTL GWAS1430364 (human) | 9e-14 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 407114445 | GWAS763421_H | low density lipoprotein cholesterol measurement QTL GWAS763421 (human) | 1e-23 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 597430550 | GWAS1526624_H | protein measurement QTL GWAS1526624 (human) | 3e-123 | protein measurement | 19 | 44908684 | 44908685 | Human | 597433618 | GWAS1529692_H | protein measurement QTL GWAS1529692 (human) | 9e-50 | protein measurement | 19 | 44908684 | 44908685 | Human | 407114452 | GWAS763428_H | low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS763428 (human) | 8e-23 | low density lipoprotein cholesterol measurement, phospholipid measurement | 19 | 44908684 | 44908685 | Human | 597585166 | GWAS1642026_H | diabetes mellitus, Drugs used in diabetes use measurement QTL GWAS1642026 (human) | 2e-14 | pancreas integrity trait (VT:0010560) | serum gamma-glutamyltransferase activity level (CMO:0002241) | 19 | 44908684 | 44908685 | Human | 407114453 | GWAS763429_H | low density lipoprotein triglyceride measurement QTL GWAS763429 (human) | 5e-11 | obstructive sleep apnea | 19 | 44908684 | 44908685 | Human | 597430543 | GWAS1526617_H | protein measurement QTL GWAS1526617 (human) | 8e-39 | protein measurement | 19 | 44908684 | 44908685 | Human | 596959491 | GWAS1079010_H | glomerular filtration rate QTL GWAS1079010 (human) | 8e-37 | glomerular filtration rate | 19 | 44908684 | 44908685 | Human | 597460228 | GWAS1556302_H | age of onset of Parkinson disease QTL GWAS1556302 (human) | 0.000009 | age of onset of Parkinson disease | 19 | 44908684 | 44908685 | Human | 597032206 | GWAS1128280_H | Alzheimer disease QTL GWAS1128280 (human) | 2e-303 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597429504 | GWAS1525578_H | protein measurement QTL GWAS1525578 (human) | 6e-204 | protein measurement | 19 | 44908684 | 44908685 | Human | 597592382 | GWAS1649242_H | high density lipoprotein cholesterol measurement QTL GWAS1649242 (human) | 4e-29 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597431612 | GWAS1527686_H | protein measurement QTL GWAS1527686 (human) | 9e-169 | protein measurement | 19 | 44908684 | 44908685 | Human | 597430589 | GWAS1526663_H | protein measurement QTL GWAS1526663 (human) | 3e-326 | protein measurement | 19 | 44908684 | 44908685 | Human | 597037364 | GWAS1133438_H | parental longevity QTL GWAS1133438 (human) | 7e-19 | glycerophosphocholine amount (VT:0011004) | 19 | 44908684 | 44908685 | Human | 597221691 | GWAS1317765_H | low density lipoprotein cholesterol measurement QTL GWAS1317765 (human) | 6e-24 | protein measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597037363 | GWAS1133437_H | parental longevity QTL GWAS1133437 (human) | 7e-46 | total life span (VT:0001661) | 19 | 44908684 | 44908685 | Human | 596980016 | GWAS1099535_H | memory performance QTL GWAS1099535 (human) | 6e-21 | memory performance | 19 | 44908684 | 44908685 | Human | 597298495 | GWAS1394569_H | cardiotrophin-1 measurement QTL GWAS1394569 (human) | 4e-148 | cardiotrophin-1 measurement | 19 | 44908684 | 44908685 | Human | 597429561 | GWAS1525635_H | protein measurement QTL GWAS1525635 (human) | 6e-81 | protein measurement | 19 | 44908684 | 44908685 | Human | 596959550 | GWAS1079069_H | glomerular filtration rate QTL GWAS1079069 (human) | 8e-41 | glomerular filtration rate | 19 | 44908684 | 44908685 | Human | 597308715 | GWAS1404789_H | level of hemoglobin subunit theta-1 in blood serum QTL GWAS1404789 (human) | 9e-56 | protein measurement | 19 | 44908684 | 44908685 | Human | 597296430 | GWAS1392504_H | ceramide measurement QTL GWAS1392504 (human) | 0.0000009 | ceramide measurement | 19 | 44908684 | 44908685 | Human | 597432618 | GWAS1528692_H | protein measurement QTL GWAS1528692 (human) | 7e-136 | protein measurement | 19 | 44908684 | 44908685 | Human | 597019948 | GWAS1116022_H | neuritic plaque measurement, cerebral amyloid angiopathy QTL GWAS1116022 (human) | 5e-40 | neuritic plaque measurement, cerebral amyloid angiopathy | 19 | 44908684 | 44908685 | Human | 597149998 | GWAS1246072_H | triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1246072 (human) | 3e-58 | triglyceride measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597289252 | GWAS1385326_H | fatty acid measurement QTL GWAS1385326 (human) | 8e-30 | fatty acid measurement | 19 | 44908684 | 44908685 | Human | 597019947 | GWAS1116021_H | neuritic plaque measurement, neurofibrillary tangles measurement QTL GWAS1116021 (human) | 3e-47 | neuritic plaque measurement, neurofibrillary tangles measurement | 19 | 44908684 | 44908685 | Human | 597213529 | GWAS1309603_H | high density lipoprotein cholesterol measurement QTL GWAS1309603 (human) | 1e-142 | protein measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597429597 | GWAS1525671_H | protein measurement QTL GWAS1525671 (human) | 1e-134 | protein measurement | 19 | 44908684 | 44908685 | Human | 597149014 | GWAS1245088_H | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1245088 (human) | 5e-54 | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 407111311 | GWAS760287_H | low density lipoprotein cholesterol measurement QTL GWAS760287 (human) | 5e-27 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597303633 | GWAS1399707_H | level of forkhead box protein O1 in blood serum QTL GWAS1399707 (human) | 5e-29 | level of forkhead box protein O1 in blood serum | 19 | 44908684 | 44908685 | Human | 597429591 | GWAS1525665_H | protein measurement QTL GWAS1525665 (human) | 6e-153 | protein measurement | 19 | 44908684 | 44908685 | Human | 597171540 | GWAS1267614_H | vacuolar protein sorting-associated protein 29 measurement QTL GWAS1267614 (human) | 7e-176 | vacuolar protein sorting-associated protein 29 measurement | 19 | 44908684 | 44908685 | Human | 407111305 | GWAS760281_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS760281 (human) | 9e-27 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597431633 | GWAS1527707_H | protein measurement QTL GWAS1527707 (human) | 9e-82 | protein measurement | 19 | 44908684 | 44908685 | Human | 597094745 | GWAS1190819_H | high density lipoprotein cholesterol measurement QTL GWAS1190819 (human) | 1e-14 | protein measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597037383 | GWAS1133457_H | parental longevity QTL GWAS1133457 (human) | 1e-74 | total life span (VT:0001661) | 19 | 44908684 | 44908685 | Human | 407111318 | GWAS760294_H | fatty acid measurement QTL GWAS760294 (human) | 4e-17 | ADP-ribosylation factor-like protein 1 measurement | 19 | 44908684 | 44908685 | Human | 407006865 | GWAS655841_H | insomnia measurement QTL GWAS655841 (human) | 2e-08 | sleep behavior trait (VT:0001501) | 19 | 44908684 | 44908685 | Human | 407111312 | GWAS760288_H | low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS760288 (human) | 4e-26 | protein measurement | 19 | 44908684 | 44908685 | Human | 596962624 | GWAS1082143_H | ADP-ribosylation factor-like protein 1 measurement QTL GWAS1082143 (human) | 1e-19 | memory performance | 19 | 44908684 | 44908685 | Human | 597605706 | GWAS1662566_H | frontotemporal dementia QTL GWAS1662566 (human) | 1e-30 | liver lipid amount (VT:0010764) | liver fat morphological measurement (CMO:0002187) | 19 | 44908684 | 44908685 | Human | 597605704 | GWAS1662564_H | Alzheimer disease QTL GWAS1662564 (human) | 2e-46 | mean corpuscular volume | 19 | 44908684 | 44908685 | Human | 407111315 | GWAS760291_H | low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS760291 (human) | 7e-27 | low density lipoprotein cholesterol measurement, lipid measurement | 19 | 44908684 | 44908685 | Human | 597605705 | GWAS1662565_H | Alzheimer disease QTL GWAS1662565 (human) | 3e-267 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597221696 | GWAS1317770_H | lipid measurement, intermediate density lipoprotein measurement QTL GWAS1317770 (human) | 6e-23 | lipid measurement, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 19 | 44908684 | 44908685 | Human | 407119517 | GWAS768493_H | free cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS768493 (human) | 6e-11 | liver fat measurement, liver disease biomarker | 19 | 44908684 | 44908685 | Human | 596963661 | GWAS1083180_H | blood protein measurement QTL GWAS1083180 (human) | 4e-24 | blood protein measurement | 19 | 44908684 | 44908685 | Human | 597605700 | GWAS1662560_H | dementia QTL GWAS1662560 (human) | 4e-56 | dementia | 19 | 44908684 | 44908685 | Human | 597605698 | GWAS1662558_H | cognitive disorder QTL GWAS1662558 (human) | 5e-306 | cognitive disorder | 19 | 44908684 | 44908685 | Human | 597605699 | GWAS1662559_H | dementia QTL GWAS1662559 (human) | 2e-21 | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | blood lipid measurement (CMO:0000050) | 19 | 44908684 | 44908685 | Human | 597044552 | GWAS1140626_H | Abnormality of refraction QTL GWAS1140626 (human) | 3e-17 | pancreas integrity trait (VT:0010560) | 19 | 44908684 | 44908685 | Human | 597225798 | GWAS1321872_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1321872 (human) | 7e-25 | free cholesterol measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597605697 | GWAS1662557_H | cognitive disorder QTL GWAS1662557 (human) | 5e-18 | omega-6 polyunsaturated fatty acid measurement | 19 | 44908684 | 44908685 | Human | 597607806 | GWAS1664666_H | body weight QTL GWAS1664666 (human) | 2e-29 | liver lipid amount (VT:0010764) | liver fat morphological measurement (CMO:0002187) | 19 | 44908684 | 44908685 | Human | 596963701 | GWAS1083220_H | C-reactive protein measurement QTL GWAS1083220 (human) | 3e-22 | C-reactive protein measurement | 19 | 44908684 | 44908685 | Human | 407114406 | GWAS763382_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS763382 (human) | 4e-27 | free cholesterol measurement, low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597592442 | GWAS1649302_H | high density lipoprotein cholesterol measurement QTL GWAS1649302 (human) | 3e-298 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597620090 | GWAS1676950_H | mental or behavioural disorder QTL GWAS1676950 (human) | 3e-37 | mental or behavioural disorder | 19 | 44908684 | 44908685 | Human | 597583226 | GWAS1640086_H | mean corpuscular hemoglobin concentration QTL GWAS1640086 (human) | 8e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 19 | 44908684 | 44908685 | Human | 407112353 | GWAS761329_H | very low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS761329 (human) | 3e-13 | non-alcoholic fatty liver disease | 19 | 44908684 | 44908685 | Human | 597056880 | GWAS1152954_H | Alzheimer disease QTL GWAS1152954 (human) | 5e-286 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597620088 | GWAS1676948_H | Cognitive impairment QTL GWAS1676948 (human) | 2e-131 | Cognitive impairment | 19 | 44908684 | 44908685 | Human | 597620089 | GWAS1676949_H | amnesia QTL GWAS1676949 (human) | 4e-73 | amnesia | 19 | 44908684 | 44908685 | Human | 407106219 | GWAS755195_H | very low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS755195 (human) | 2e-21 | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 407114415 | GWAS763391_H | intermediate density lipoprotein measurement QTL GWAS763391 (human) | 2e-23 | blood protein measurement | 19 | 44908684 | 44908685 | Human | 596963705 | GWAS1083224_H | p-tau measurement QTL GWAS1083224 (human) | 3e-25 | p-tau measurement | 19 | 44908684 | 44908685 | Human | 407112362 | GWAS761338_H | very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS761338 (human) | 9e-12 | level of Sterol ester (27:1/20:2) in blood serum | 19 | 44908684 | 44908685 | Human | 407119531 | GWAS768507_H | very low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS768507 (human) | 1e-10 | Sphingomyelin (d18:2/14:0, d18:1/14:1) measurement | 19 | 44908684 | 44908685 | Human | 596963684 | GWAS1083203_H | cortical thickness QTL GWAS1083203 (human) | 5e-10 | fat body mass | 19 | 44908684 | 44908685 | Human | 407106225 | GWAS755201_H | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement QTL GWAS755201 (human) | 1e-21 | free cholesterol measurement, low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597176682 | GWAS1272756_H | apolipoprotein B measurement QTL GWAS1272756 (human) | 2e-78 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 19 | 44908684 | 44908685 | Human | 597433711 | GWAS1529785_H | protein measurement QTL GWAS1529785 (human) | 6e-370 | protein measurement | 19 | 44908684 | 44908685 | Human | 407114416 | GWAS763392_H | omega-6 polyunsaturated fatty acid measurement QTL GWAS763392 (human) | 5e-18 | omega-6 polyunsaturated fatty acid measurement | 19 | 44908684 | 44908685 | Human | 407114418 | GWAS763394_H | free cholesterol measurement QTL GWAS763394 (human) | 5e-16 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 596969827 | GWAS1089346_H | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement QTL GWAS1089346 (human) | 1e-21 | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597148000 | GWAS1244074_H | antihyperlipidemic drug use measurement QTL GWAS1244074 (human) | 1e-308 | antihyperlipidemic drug use measurement | 19 | 44908684 | 44908685 | Human | 596969833 | GWAS1089352_H | very low density lipoprotein cholesterol measurement QTL GWAS1089352 (human) | 3e-21 | very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597152107 | GWAS1248181_H | memory performance QTL GWAS1248181 (human) | 4e-51 | glomerular filtration rate | 19 | 44908684 | 44908685 | Human | 597152105 | GWAS1248179_H | memory performance QTL GWAS1248179 (human) | 3e-374 | memory performance | 19 | 44908684 | 44908685 | Human | 597026154 | GWAS1122228_H | health study participation QTL GWAS1122228 (human) | 5e-19 | protein measurement | serum alanine aminotransferase activity level (CMO:0000575) | 19 | 44908684 | 44908685 | Human | 597587102 | GWAS1643962_H | drug use measurement, memory impairment QTL GWAS1643962 (human) | 1e-36 | longevity | 19 | 44908684 | 44908685 | Human | 597103767 | GWAS1199841_H | amyloid-beta measurement QTL GWAS1199841 (human) | 5e-24 | protein measurement | 19 | 44908684 | 44908685 | Human | 596964502 | GWAS1084021_H | p-tau measurement QTL GWAS1084021 (human) | 2e-17 | p-tau measurement | 19 | 44908684 | 44908685 | Human | 597587100 | GWAS1643960_H | drug use measurement, dementia QTL GWAS1643960 (human) | 4e-62 | drug use measurement, dementia | 19 | 44908684 | 44908685 | Human | 407105344 | GWAS754320_H | low density lipoprotein cholesterol measurement QTL GWAS754320 (human) | 6e-25 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 596964503 | GWAS1084022_H | taste liking measurement QTL GWAS1084022 (human) | 1e-23 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 597587101 | GWAS1643961_H | memory impairment QTL GWAS1643961 (human) | 2e-56 | memory impairment | 19 | 44908684 | 44908685 | Human | 597598363 | GWAS1655223_H | high density lipoprotein cholesterol measurement QTL GWAS1655223 (human) | 1e-323 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 19 | 44908684 | 44908685 | Human | 407119683 | GWAS768659_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS768659 (human) | 7e-25 | free cholesterol measurement, low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597619862 | GWAS1676722_H | delirium QTL GWAS1676722 (human) | 8e-24 | delirium | 19 | 44908684 | 44908685 | Human | 596975769 | GWAS1095288_H | Red cell distribution width QTL GWAS1095288 (human) | 2e-59 | Red cell distribution width | 19 | 44908684 | 44908685 | Human | 597103769 | GWAS1199843_H | amyloid-beta measurement QTL GWAS1199843 (human) | 5e-17 | amyloid-beta measurement | 19 | 44908684 | 44908685 | Human | 597035161 | GWAS1131235_H | sugar consumption measurement QTL GWAS1131235 (human) | 3e-11 | glycerophosphocholine amount (VT:0011004) | blood total cholesterol level (CMO:0000051) | 19 | 44908684 | 44908685 | Human | 597587089 | GWAS1643949_H | dementia QTL GWAS1643949 (human) | 5e-97 | dementia | 19 | 44908684 | 44908685 | Human | 597103768 | GWAS1199842_H | amyloid-beta measurement QTL GWAS1199842 (human) | 4e-33 | Alzheimer's disease biomarker measurement | 19 | 44908684 | 44908685 | Human | 597262473 | GWAS1358547_H | amyloid-beta measurement QTL GWAS1358547 (human) | 9e-72 | blood lipid amount (VT:0003949) | 19 | 44908684 | 44908685 | Human | 597120135 | GWAS1216209_H | blood protein measurement QTL GWAS1216209 (human) | 2e-23 | intermediate density lipoprotein measurement | 19 | 44908684 | 44908685 | Human | 597162117 | GWAS1258191_H | Alzheimer disease, age at onset QTL GWAS1258191 (human) | 4e-497 | Alzheimer disease, age at onset | 19 | 44908684 | 44908685 | Human | 597262474 | GWAS1358548_H | amyloid-beta measurement QTL GWAS1358548 (human) | 1e-47 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597225611 | GWAS1321685_H | esterified cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1321685 (human) | 3e-25 | p-tau measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597609610 | GWAS1666470_H | drug use measurement, memory impairment QTL GWAS1666470 (human) | 1e-34 | apolipoprotein E (isoform E3) measurement | 19 | 44908684 | 44908685 | Human | 597609611 | GWAS1666471_H | memory impairment QTL GWAS1666471 (human) | 2e-48 | memory impairment | 19 | 44908684 | 44908685 | Human | 597609606 | GWAS1666466_H | drug use measurement, dementia QTL GWAS1666466 (human) | 5e-72 | drug use measurement, dementia | 19 | 44908684 | 44908685 | Human | 597606535 | GWAS1663395_H | serum alanine aminotransferase measurement QTL GWAS1663395 (human) | 3e-67 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 19 | 44908684 | 44908685 | Human | 597609607 | GWAS1666467_H | dementia QTL GWAS1666467 (human) | 1e-113 | dementia | 19 | 44908684 | 44908685 | Human | 597619842 | GWAS1676702_H | frontotemporal dementia QTL GWAS1676702 (human) | 8e-37 | frontotemporal dementia | 19 | 44908684 | 44908685 | Human | 597072011 | GWAS1168085_H | low density lipoprotein cholesterol measurement QTL GWAS1168085 (human) | 4e-71 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597280900 | GWAS1376974_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1376974 (human) | 1e-40 | protein measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597348487 | GWAS1444561_H | body mass index QTL GWAS1444561 (human) | 6e-10 | protein measurement | blood uric acid level (CMO:0000501) | 19 | 44908684 | 44908685 | Human | 597262471 | GWAS1358545_H | p-tau measurement QTL GWAS1358545 (human) | 1e-94 | p-tau measurement | 19 | 44908684 | 44908685 | Human | 596963508 | GWAS1083027_H | 3-hydroxybutyrate measurement QTL GWAS1083027 (human) | 2e-23 | blood protein measurement | 19 | 44908684 | 44908685 | Human | 597596346 | GWAS1653206_H | C-reactive protein measurement QTL GWAS1653206 (human) | 7e-13 | C-reactive protein measurement | blood uric acid level (CMO:0000501) | 19 | 44908684 | 44908685 | Human | 597607606 | GWAS1664466_H | family history of Alzheimer’s disease QTL GWAS1664466 (human) | 4e-108 | family history of Alzheimer’s disease | 19 | 44908684 | 44908685 | Human | 597111995 | GWAS1208069_H | Alzheimer disease, family history of Alzheimer’s disease QTL GWAS1208069 (human) | 1e-300 | late-onset Alzheimers disease | 19 | 44908684 | 44908685 | Human | 597118138 | GWAS1214212_H | non-alcoholic fatty liver disease QTL GWAS1214212 (human) | 3e-13 | protein measurement | 19 | 44908684 | 44908685 | Human | 597583025 | GWAS1639885_H | mean corpuscular hemoglobin concentration QTL GWAS1639885 (human) | 4e-12 | body mass (VT:0001259) | body weight (CMO:0000012) | 19 | 44908684 | 44908685 | Human | 597348533 | GWAS1444607_H | Abdominal Aortic Aneurysm QTL GWAS1444607 (human) | 5e-39 | protein measurement | 19 | 44908684 | 44908685 | Human | 596969636 | GWAS1089155_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1089155 (human) | 4e-27 | free cholesterol measurement, low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 596964512 | GWAS1084031_H | taste liking measurement QTL GWAS1084031 (human) | 5e-16 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 597091489 | GWAS1187563_H | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration QTL GWAS1187563 (human) | 2e-42 | phospholipids:total lipids ratio | 19 | 44908684 | 44908685 | Human | 597130415 | GWAS1226489_H | hippocampal volume QTL GWAS1226489 (human) | 1e-15 | protein measurement | 19 | 44908684 | 44908685 | Human | 597596325 | GWAS1653185_H | family history of Alzheimer’s disease QTL GWAS1653185 (human) | 3e-150 | family history of Alzheimer’s disease | 19 | 44908684 | 44908685 | Human | 597178533 | GWAS1274607_H | integral membrane protein 2B measurement QTL GWAS1274607 (human) | 8e-16 | protein measurement | 19 | 44908684 | 44908685 | Human | 597023915 | GWAS1119989_H | high density lipoprotein cholesterol measurement QTL GWAS1119989 (human) | 3e-50 | cerebral cortex integrity trait (VT:0010923) | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597023914 | GWAS1119988_H | high density lipoprotein cholesterol measurement QTL GWAS1119988 (human) | 6e-47 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597430492 | GWAS1526566_H | protein measurement QTL GWAS1526566 (human) | 1e-92 | protein measurement | 19 | 44908684 | 44908685 | Human | 407084802 | GWAS733778_H | parental longevity QTL GWAS733778 (human) | 4e-57 | total life span (VT:0001661) | 19 | 44908684 | 44908685 | Human | 597596383 | GWAS1653243_H | diabetes mellitus, Drugs used in diabetes use measurement QTL GWAS1653243 (human) | 6e-21 | pancreas integrity trait (VT:0010560) | 19 | 44908684 | 44908685 | Human | 407106310 | GWAS755286_H | low density lipoprotein triglyceride measurement QTL GWAS755286 (human) | 4e-13 | functional brain measurement | 19 | 44908684 | 44908685 | Human | 407115532 | GWAS764508_H | esterified cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS764508 (human) | 2e-10 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597430484 | GWAS1526558_H | protein measurement QTL GWAS1526558 (human) | 3e-129 | protein measurement | 19 | 44908684 | 44908685 | Human | 596963524 | GWAS1083043_H | brain measurement QTL GWAS1083043 (human) | 4e-15 | waist-hip ratio | 19 | 44908684 | 44908685 | Human | 596969668 | GWAS1089187_H | low density lipoprotein cholesterol measurement QTL GWAS1089187 (human) | 6e-24 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597578957 | GWAS1635817_H | high density lipoprotein cholesterol measurement QTL GWAS1635817 (human) | 7e-144 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597191887 | GWAS1287961_H | hippocampal volume QTL GWAS1287961 (human) | 6e-09 | insomnia | 19 | 44908684 | 44908685 | Human | 596955340 | GWAS1074859_H | type 2 diabetes mellitus QTL GWAS1074859 (human) | 2e-26 | memory performance | 19 | 44908684 | 44908685 | Human | 596962505 | GWAS1082024_H | brain measurement QTL GWAS1082024 (human) | 8e-11 | brain measurement | 19 | 44908684 | 44908685 | Human | 597284036 | GWAS1380110_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1380110 (human) | 4e-82 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 596963573 | GWAS1083092_H | amyloid-beta measurement QTL GWAS1083092 (human) | 6e-18 | amyloid-beta measurement | 19 | 44908684 | 44908685 | Human | 597285112 | GWAS1381186_H | free cholesterol in medium HDL measurement QTL GWAS1381186 (human) | 9e-54 | blood HDL cholesterol amount (VT:0000184) | 19 | 44908684 | 44908685 | Human | 597431549 | GWAS1527623_H | protein measurement QTL GWAS1527623 (human) | 6e-345 | protein measurement | 19 | 44908684 | 44908685 | Human | 596953334 | GWAS1072853_H | neuritic plaque measurement QTL GWAS1072853 (human) | 5e-20 | free cholesterol measurement, intermediate density lipoprotein measurement | 19 | 44908684 | 44908685 | Human | 597431545 | GWAS1527619_H | protein measurement QTL GWAS1527619 (human) | 2e-49 | protein measurement | 19 | 44908684 | 44908685 | Human | 596963571 | GWAS1083090_H | hippocampal volume QTL GWAS1083090 (human) | 6e-09 | insomnia | 19 | 44908684 | 44908685 | Human | 597595383 | GWAS1652243_H | blood urea nitrogen measurement QTL GWAS1652243 (human) | 2e-27 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 19 | 44908684 | 44908685 | Human | 596963582 | GWAS1083101_H | valine measurement QTL GWAS1083101 (human) | 9e-10 | brain connectivity measurement | 19 | 44908684 | 44908685 | Human | 596957434 | GWAS1076953_H | obstructive sleep apnea QTL GWAS1076953 (human) | 5e-11 | memory performance | 19 | 44908684 | 44908685 | Human | 596958459 | GWAS1077978_H | phospholipids:total lipids ratio QTL GWAS1077978 (human) | 2e-42 | phospholipids:total lipids ratio | 19 | 44908684 | 44908685 | Human | 596969722 | GWAS1089241_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1089241 (human) | 7e-17 | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 596956389 | GWAS1075908_H | platelet count QTL GWAS1075908 (human) | 4e-21 | mean reticulocyte volume | 19 | 44908684 | 44908685 | Human | 597283050 | GWAS1379124_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1379124 (human) | 1e-54 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597578986 | GWAS1635846_H | Hyperlipidemia QTL GWAS1635846 (human) | 1e-59 | blood VLDL cholesterol amount (VT:0005144) | 19 | 44908684 | 44908685 | Human | 596969698 | GWAS1089217_H | low density lipoprotein triglyceride measurement QTL GWAS1089217 (human) | 4e-14 | low density lipoprotein triglyceride measurement | 19 | 44908684 | 44908685 | Human | 597171425 | GWAS1267499_H | cigarettes per day measurement QTL GWAS1267499 (human) | 1e-18 | protein measurement | 19 | 44908684 | 44908685 | Human | 407119672 | GWAS768648_H | low density lipoprotein triglyceride measurement QTL GWAS768648 (human) | 5e-09 | low density lipoprotein triglyceride measurement | 19 | 44908684 | 44908685 | Human | 597099755 | GWAS1195829_H | C-reactive protein measurement QTL GWAS1195829 (human) | 2e-140 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 596969704 | GWAS1089223_H | apolipoprotein B measurement QTL GWAS1089223 (human) | 6e-26 | apolipoprotein B measurement | 19 | 44908684 | 44908685 | Human | 597180645 | GWAS1276719_H | tubulin-specific chaperone A measurement QTL GWAS1276719 (human) | 2e-1609 | tubulin-specific chaperone A measurement | 19 | 44908684 | 44908685 | Human | 407119674 | GWAS768650_H | fatty acid measurement QTL GWAS768650 (human) | 6e-09 | taste liking measurement | 19 | 44908684 | 44908685 | Human | 407111482 | GWAS760458_H | triglyceride measurement, high density lipoprotein cholesterol measurement QTL GWAS760458 (human) | 6e-12 | functional brain measurement | 19 | 44908684 | 44908685 | Human | 597284071 | GWAS1380145_H | triglycerides in large LDL measurement QTL GWAS1380145 (human) | 1e-115 | blood LDL triglyceride amount (VT:0010699) | 19 | 44908684 | 44908685 | Human | 597430499 | GWAS1526573_H | protein measurement QTL GWAS1526573 (human) | 4e-214 | protein measurement | 19 | 44908684 | 44908685 | Human | 596963349 | GWAS1082868_H | functional brain measurement QTL GWAS1082868 (human) | 4e-13 | functional brain measurement | 19 | 44908684 | 44908685 | Human | 597296155 | GWAS1392229_H | lysophosphatidylcholine 20:0 measurement QTL GWAS1392229 (human) | 0.000008 | lysophosphatidylcholine 20:0 measurement | 19 | 44908684 | 44908685 | Human | 597181465 | GWAS1277539_H | protein measurement QTL GWAS1277539 (human) | 2e-1534 | protein measurement | 19 | 44908684 | 44908685 | Human | 597586973 | GWAS1643833_H | C-reactive protein measurement QTL GWAS1643833 (human) | 1e-16 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 407115712 | GWAS764688_H | low density lipoprotein cholesterol measurement QTL GWAS764688 (human) | 6e-24 | low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597430296 | GWAS1526370_H | protein measurement QTL GWAS1526370 (human) | 4e-30 | protein measurement | 19 | 44908684 | 44908685 | Human | 407115713 | GWAS764689_H | esterified cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS764689 (human) | 3e-25 | p-tau measurement | 19 | 44908684 | 44908685 | Human | 597201950 | GWAS1298024_H | memory performance QTL GWAS1298024 (human) | 6e-33 | memory performance | 19 | 44908684 | 44908685 | Human | 597430298 | GWAS1526372_H | protein measurement QTL GWAS1526372 (human) | 4e-31 | protein measurement | 19 | 44908684 | 44908685 | Human | 597296157 | GWAS1392231_H | lysophosphatidylcholine 20:1 measurement QTL GWAS1392231 (human) | 0.000006 | lysophosphatidylcholine 20:1 measurement | 19 | 44908684 | 44908685 | Human | 597433364 | GWAS1529438_H | protein measurement QTL GWAS1529438 (human) | 8e-338 | protein measurement | 19 | 44908684 | 44908685 | Human | 597154847 | GWAS1250921_H | Alzheimer disease, Lewy body dementia QTL GWAS1250921 (human) | 1e-52 | Alzheimer disease, Lewy body dementia | 19 | 44908684 | 44908685 | Human | 407113677 | GWAS762653_H | very low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS762653 (human) | 5e-10 | fat body mass | 19 | 44908684 | 44908685 | Human | 597023772 | GWAS1119846_H | low density lipoprotein cholesterol measurement QTL GWAS1119846 (human) | 5e-15 | protein measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597171217 | GWAS1267291_H | fatty acid measurement QTL GWAS1267291 (human) | 2e-123 | triglyceride measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597432342 | GWAS1528416_H | protein measurement QTL GWAS1528416 (human) | 5e-309 | protein measurement | 19 | 44908684 | 44908685 | Human | 597172244 | GWAS1268318_H | DCN1-like protein 5 measurement QTL GWAS1268318 (human) | 2e-441 | DCN1-like protein 5 measurement | 19 | 44908684 | 44908685 | Human | 597038107 | GWAS1134181_H | parental longevity QTL GWAS1134181 (human) | 2e-28 | total life span (VT:0001661) | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597433361 | GWAS1529435_H | protein measurement QTL GWAS1529435 (human) | 1e-29 | protein measurement | 19 | 44908684 | 44908685 | Human | 597023771 | GWAS1119845_H | low density lipoprotein cholesterol measurement QTL GWAS1119845 (human) | 2e-164 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597096473 | GWAS1192547_H | high density lipoprotein cholesterol measurement QTL GWAS1192547 (human) | 2e-58 | protein measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 596969476 | GWAS1088995_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1088995 (human) | 7e-25 | free cholesterol measurement, low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597262348 | GWAS1358422_H | amyloid-beta measurement QTL GWAS1358422 (human) | 1e-379 | amyloid-beta measurement | 19 | 44908684 | 44908685 | Human | 596957186 | GWAS1076705_H | C-reactive protein measurement QTL GWAS1076705 (human) | 6e-109 | C-reactive protein measurement | 19 | 44908684 | 44908685 | Human | 597027853 | GWAS1123927_H | neuritic plaque measurement QTL GWAS1123927 (human) | 5e-20 | cerebral cortex integrity trait (VT:0010923) | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 19 | 44908684 | 44908685 | Human | 597246976 | GWAS1343050_H | amyloid-beta measurement QTL GWAS1343050 (human) | 0.0000004 | COVID-19 | 19 | 44908684 | 44908685 | Human | 597170177 | GWAS1266251_H | protein measurement QTL GWAS1266251 (human) | 4e-26 | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597586946 | GWAS1643806_H | C-reactive protein measurement QTL GWAS1643806 (human) | 2e-12 | C-reactive protein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 19 | 44908684 | 44908685 | Human | 407113689 | GWAS762665_H | free cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS762665 (human) | 4e-10 | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597087243 | GWAS1183317_H | adult onset asthma, type 2 diabetes mellitus QTL GWAS1183317 (human) | 2e-10 | Alzheimer disease | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597429250 | GWAS1525324_H | protein measurement QTL GWAS1525324 (human) | 4e-388 | protein measurement | 19 | 44908684 | 44908685 | Human | 597182470 | GWAS1278544_H | PH and SEC7 domain-containing protein 1 measurement QTL GWAS1278544 (human) | 6e-20 | protein measurement | 19 | 44908684 | 44908685 | Human | 596969524 | GWAS1089043_H | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement QTL GWAS1089043 (human) | 9e-15 | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597432381 | GWAS1528455_H | protein measurement QTL GWAS1528455 (human) | 3e-35 | protein measurement | 19 | 44908684 | 44908685 | Human | 597431352 | GWAS1527426_H | protein measurement QTL GWAS1527426 (human) | 6e-29 | protein measurement | 19 | 44908684 | 44908685 | Human | 597588025 | GWAS1644885_H | type 2 diabetes mellitus QTL GWAS1644885 (human) | 1e-31 | type 2 diabetes mellitus | 19 | 44908684 | 44908685 | Human | 597433403 | GWAS1529477_H | protein measurement QTL GWAS1529477 (human) | 3e-81 | protein measurement | 19 | 44908684 | 44908685 | Human | 597321779 | GWAS1417853_H | high density lipoprotein cholesterol measurement QTL GWAS1417853 (human) | 1e-497 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597124158 | GWAS1220232_H | blood protein measurement QTL GWAS1220232 (human) | 4e-24 | blood protein amount (VT:0005416) | blood cholesterol level (CMO:0002280) | 19 | 44908684 | 44908685 | Human | 597102654 | GWAS1198728_H | myocardial infarction QTL GWAS1198728 (human) | 4e-22 | myocardial infarction | 19 | 44908684 | 44908685 | Human | 597038138 | GWAS1134212_H | parental longevity QTL GWAS1134212 (human) | 5e-22 | total life span (VT:0001661) | 19 | 44908684 | 44908685 | Human | 597301301 | GWAS1397375_H | estrogen sulfotransferase measurement QTL GWAS1397375 (human) | 3e-34 | estrogen sulfotransferase measurement | 19 | 44908684 | 44908685 | Human | 597433395 | GWAS1529469_H | protein measurement QTL GWAS1529469 (human) | 4e-60 | protein measurement | 19 | 44908684 | 44908685 | Human | 597301295 | GWAS1397369_H | epididymis-specific alpha-mannosidase measurement QTL GWAS1397369 (human) | 8e-12 | epididymis-specific alpha-mannosidase measurement | 19 | 44908684 | 44908685 | Human | 597175341 | GWAS1271415_H | triglycerides in LDL measurement QTL GWAS1271415 (human) | 9e-51 | blood LDL triglyceride amount (VT:0010699) | 19 | 44908684 | 44908685 | Human | 597301292 | GWAS1397366_H | adhesion G-protein coupled receptor F1 measurement QTL GWAS1397366 (human) | 7e-30 | adhesion G-protein coupled receptor F1 measurement | 19 | 44908684 | 44908685 | Human | 597154849 | GWAS1250923_H | Alzheimer disease QTL GWAS1250923 (human) | 1e-69 | Alzheimer disease | 19 | 44908684 | 44908685 | Human | 597184558 | GWAS1280632_H | triglycerides to total lipids in large VLDL percentage QTL GWAS1280632 (human) | 2e-33 | blood VLDL triglyceride amount (VT:0010700) | 19 | 44908684 | 44908685 | Human | 596957230 | GWAS1076749_H | protein measurement QTL GWAS1076749 (human) | 4e-26 | low density lipoprotein cholesterol measurement, phospholipid measurement | 19 | 44908684 | 44908685 | Human | 597432359 | GWAS1528433_H | protein measurement QTL GWAS1528433 (human) | 5e-472 | protein measurement | 19 | 44908684 | 44908685 | Human | 597144620 | GWAS1240694_H | body mass index QTL GWAS1240694 (human) | 3e-36 | body mass index | body mass index (BMI) (CMO:0000105) | 19 | 44908684 | 44908685 | Human | 597595169 | GWAS1652029_H | high density lipoprotein cholesterol measurement QTL GWAS1652029 (human) | 2e-23 | blood protein amount (VT:0005416) | blood lipid measurement (CMO:0000050) | 19 | 44908684 | 44908685 | Human | 407107459 | GWAS756435_H | total cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS756435 (human) | 1e-25 | beta-soluble NSF attachment protein measurement | 19 | 44908684 | 44908685 | Human | 597218392 | GWAS1314466_H | intermediate density lipoprotein measurement QTL GWAS1314466 (human) | 3e-23 | protein measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597277785 | GWAS1373859_H | age-related macular degeneration, COVID-19 QTL GWAS1373859 (human) | 2e-44 | age-related macular degeneration, COVID-19 | 19 | 44908684 | 44908685 | Human | 597106775 | GWAS1202849_H | amygdala volume change measurement, age at assessment QTL GWAS1202849 (human) | 8e-08 | amygdala volume change measurement, age at assessment | 19 | 44908684 | 44908685 | Human | 597169241 | GWAS1265315_H | high density lipoprotein cholesterol measurement QTL GWAS1265315 (human) | 3e-30 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597280863 | GWAS1376937_H | high density lipoprotein cholesterol measurement QTL GWAS1376937 (human) | 2e-68 | total lipids in large HDL | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597186655 | GWAS1282729_H | phospholipids:total lipids ratio QTL GWAS1282729 (human) | 7e-66 | phospholipids:total lipids ratio | 19 | 44908684 | 44908685 | Human | 597068894 | GWAS1164968_H | total cholesterol measurement QTL GWAS1164968 (human) | 1e-123 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 19 | 44908684 | 44908685 | Human | 597068895 | GWAS1164969_H | total cholesterol measurement QTL GWAS1164969 (human) | 3e-14 | protein measurement | body mass index (BMI) (CMO:0000105) | 19 | 44908684 | 44908685 | Human | 597606487 | GWAS1663347_H | HbA1c measurement QTL GWAS1663347 (human) | 5e-47 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 19 | 44908684 | 44908685 | Human | 597118046 | GWAS1214120_H | hippocampal volume QTL GWAS1214120 (human) | 1e-10 | Sphingomyelin (d18:2/14:0, d18:1/14:1) measurement | blood lipid measurement (CMO:0000050) | 19 | 44908684 | 44908685 | Human | 407106445 | GWAS755421_H | very low density lipoprotein cholesterol measurement QTL GWAS755421 (human) | 7e-21 | deoxycytidine kinase measurement | 19 | 44908684 | 44908685 | Human | 597057625 | GWAS1153699_H | Alzheimer disease QTL GWAS1153699 (human) | 4e-43 | blood lipid amount (VT:0003949) | 19 | 44908684 | 44908685 | Human | 597432403 | GWAS1528477_H | protein measurement QTL GWAS1528477 (human) | 4e-48 | protein measurement | 19 | 44908684 | 44908685 | Human | 407106451 | GWAS755427_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, esterified cholesterol measurement QTL GWAS755427 (human) | 7e-09 | chylomicron measurement, very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597027908 | GWAS1123982_H | neuritic plaque measurement QTL GWAS1123982 (human) | 9e-25 | carboxypeptidase e measurement | blood lipid measurement (CMO:0000050) | 19 | 44908684 | 44908685 | Human | 597153862 | GWAS1249936_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1249936 (human) | 2e-50 | blood LDL triglyceride amount (VT:0010699) | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597288013 | GWAS1384087_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1384087 (human) | 2e-97 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597178446 | GWAS1274520_H | tumor protein p53-inducible protein 11 measurement QTL GWAS1274520 (human) | 2e-228 | tumor protein p53-inducible protein 11 measurement | 19 | 44908684 | 44908685 | Human | 597071951 | GWAS1168025_H | high density lipoprotein cholesterol measurement QTL GWAS1168025 (human) | 2e-24 | remnant cholesterol measurement | serum alanine aminotransferase activity level (CMO:0000575) | 19 | 44908684 | 44908685 | Human | 597115982 | GWAS1212056_H | C-reactive protein measurement QTL GWAS1212056 (human) | 4e-328 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 597168193 | GWAS1264267_H | total lipids in small VLDL QTL GWAS1264267 (human) | 4e-96 | total lipids in small VLDL | 19 | 44908684 | 44908685 | Human | 597432387 | GWAS1528461_H | protein measurement QTL GWAS1528461 (human) | 4e-35 | protein measurement | 19 | 44908684 | 44908685 | Human | 596964470 | GWAS1083989_H | level of Sterol ester (27:1/20:2) in blood serum QTL GWAS1083989 (human) | 9e-12 | level of Sterol ester (27:1/20:2) in blood serum | 19 | 44908684 | 44908685 | Human | 597284991 | GWAS1381065_H | total cholesterol change measurement, high density lipoprotein cholesterol measurement QTL GWAS1381065 (human) | 9e-73 | blood cholesterol amount (VT:0000180) | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 597065852 | GWAS1161926_H | low density lipoprotein cholesterol measurement QTL GWAS1161926 (human) | 3e-187 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597065850 | GWAS1161924_H | low density lipoprotein cholesterol measurement QTL GWAS1161924 (human) | 0.0000002 | white matter hyperintensity measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597065851 | GWAS1161925_H | low density lipoprotein cholesterol measurement QTL GWAS1161925 (human) | 0.000002 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 597067897 | GWAS1163971_H | total cholesterol measurement QTL GWAS1163971 (human) | 2e-57 | free cholesterol in large HDL measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 19 | 44908684 | 44908685 | Human | 407116725 | GWAS765701_H | low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS765701 (human) | 1e-24 | nuclear receptor-binding protein measurement | 19 | 44908684 | 44908685 | Human | 597235816 | GWAS1331890_H | blood protein measurement QTL GWAS1331890 (human) | 8e-13 | high density lipoprotein cholesterol measurement | 19 | 44908684 | 44908685 | Human | 597172331 | GWAS1268405_H | protein measurement QTL GWAS1268405 (human) | 2e-12 | protein measurement | 19 | 44908684 | 44908685 | Human | 407113648 | GWAS762624_H | free cholesterol measurement QTL GWAS762624 (human) | 9e-18 | polyunsaturated fatty acid measurement | 19 | 44908684 | 44908685 | Human | 596960352 | GWAS1079871_H | glomerular filtration rate QTL GWAS1079871 (human) | 4e-51 | glomerular filtration rate | 19 | 44908684 | 44908685 | Human | 597068896 | GWAS1164970_H | total cholesterol measurement QTL GWAS1164970 (human) | 3e-08 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 19 | 44908684 | 44908685 | Human | 597068897 | GWAS1164971_H | total cholesterol measurement QTL GWAS1164971 (human) | 1e-145 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 19 | 44908684 | 44908685 | Human | 597606505 | GWAS1663365_H | serum alanine aminotransferase measurement QTL GWAS1663365 (human) | 7e-68 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 19 | 44908684 | 44908685 | Human | 597168239 | GWAS1264313_H | C-reactive protein measurement QTL GWAS1264313 (human) | 2e-53 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 19 | 44908684 | 44908685 | Human | 597279843 | GWAS1375917_H | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1375917 (human) | 5e-33 | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 19 | 44908684 | 44908685 | Human | 596969582 | GWAS1089101_H | low density lipoprotein triglyceride measurement QTL GWAS1089101 (human) | 5e-09 | low density lipoprotein triglyceride measurement | 19 | 44908684 | 44908685 | Human | 407117753 | GWAS766729_H | fatty acid measurement QTL GWAS766729 (human) | 7e-10 | fatty acid measurement | 19 | 44908684 | 44908685 | Human | 596964459 | GWAS1083978_H | apolipoprotein E measurement QTL GWAS1083978 (human) | 1e-39 | C-reactive protein measurement | 19 | 44908684 | 44908685 | Human | |
Additional Information
GWAS QTLs Related by Peak Marker
Data has come from the GWAS Catalog | ![]() |
|
The highlighted row represents the current QTL |
QTL | GWAS Catalog Study | Disease Trait | Study Size | Risk Allele | Risk Allele Frequency | P Value | P Value MLOG | Peak Marker | Reported Odds Ratio or Beta-coefficient | Ontology Accession | PubMed |
GWAS1115619_H | GCST005517 | Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy) | 3,135 European ancestry Alzheimer's diseases cases, 463 European ancestry controls | ? | NR | 6E-35 | 34.222 | rs429358 | N/A | cerebral amyloid angiopathy (EFO:0006790) neurofibrillary tangles measurement (EFO:0006797) |
PMID:29458411 |
GWAS1116021_H | GCST005516 | Neuritic plaques or neurofibrillary tangles (pleiotropy) | 3,135 European ancestry Alzheimer's disease cases, 463 European ancestry controls | ? | NR | 3E-47 | 46.523 | rs429358 | N/A | neuritic plaque measurement (EFO:0006798) neurofibrillary tangles measurement (EFO:0006797) |
PMID:29458411 |
GWAS1116022_H | GCST005515 | Neuritic plaques or cerebral amyloid angiopathy (pleiotropy) | 3,135 European ancestry Alzheimer's disease cases, 463 European ancestry controls | ? | NR | 5E-40 | 39.302 | rs429358 | N/A | neuritic plaque measurement (EFO:0006798) cerebral amyloid angiopathy (EFO:0006790) |
PMID:29458411 |
None Available | GCST008598 | Longevity (age >90th survival percentile) | 11,262 European ancestry cases, 25,483 European ancestry controls | T | 0.87 | 1E-56 | 56 | rs429358 | 1.67 | PMID:31413261 | |
None Available | GCST008601 | Longevity (age >99th survival percentile) | 3,484 European ancestry cases, 2,178 East Asian ancestry cases, 25,483 European ancestry controls, 2,299 East Asian ancestry controls | T | 0.87 | 1E-36 | 36 | rs429358 | 1.8181818 | PMID:31413261 | |
None Available | GCST008600 | Longevity (age >90th survival percentile) | 11,262 European ancestry cases, 2,178 East Asian ancestry cases, 177 African American cases, 25,483 European ancestry controls, 2,299 East Asian ancestry controls, 211 African American controls. | T | 0.87 | 1E-61 | 61 | rs429358 | 1.6666665 | PMID:31413261 | |
None Available | GCST008599 | Longevity (age >99th survival percentile) | 3,484 European ancestry cases, 25,483 European ancestry controls | T | 0.87 | 4E-34 | 33.398 | rs429358 | 1.92 | PMID:31413261 | |
GWAS547961_H | GCST004603 | Platelet count | 166,066 European ancestry individuals | C | 0.1415 | 3E-9 | 8.523 | rs429358 | 0.0301972 | platelet count (EFO:0004309) |
PMID:27863252 |
GWAS1635251_H | GCST90475762 | Obesity (PheCode 278.1) | 169,600 European ancestry cases, 244,254 European ancestry controls | T | 0.8597 | 7E-16 | 15.155 | rs429358 | 0.04449 | obesity (EFO:0001073) |
PMID:39024449 |
GWAS1635817_H | GCST90479631 | high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed) | 113,085 African American or Afro-Caribbean individuals, 54,914 Hispanic or Latin American individuals, 6,005 East Asian ancestry individuals, 404,121 European ancestry individuals | T | 0.8471 | 7E-144 | 143.155 | rs429358 | 0.1024 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39024449 |
GWAS1635846_H | GCST90475727 | Mixed hyperlipidemia (PheCode 272.13) | 98,406 European ancestry cases, 315,322 European ancestry controls | T | 0.8604 | 1E-59 | 59 | rs429358 | 0.115 | Hyperlipidemia (HP:0003077) |
PMID:39024449 |
GWAS1636027_H | GCST90475759 | Overweight, obesity and other hyperalimentation (PheCode 278) | 187,880 European ancestry cases, 218,356 European ancestry controls | T | 0.8598 | 5E-17 | 16.302 | rs429358 | 0.04718 | obesity (EFO:0001073) |
PMID:39024449 |
GWAS1636380_H | GCST90479633 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | 113,085 African American or Afro-Caribbean individuals, 54,914 Hispanic or Latin American individuals, 6,005 East Asian ancestry individuals, 404,121 European ancestry individuals | T | 0.8471 | 1E-161 | 161 | rs429358 | 0.1096 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39024449 |
GWAS1637391_H | GCST90475689 | Diabetic retinopathy (PheCode 250.7) | 29,668 European ancestry cases, 402,541 European ancestry controls | T | 0.8595 | 3E-13 | 12.523 | rs429358 | 0.08541 | diabetic retinopathy (EFO:0003770) |
PMID:39024449 |
GWAS1119845_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.868 | 2E-164 | 163.699 | rs429358 | 0.199 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS1119846_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.885 | 5E-15 | 14.302 | rs429358 | 0.186 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS1119988_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.868 | 6E-47 | 46.222 | rs429358 | 0.084 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS1119989_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | NR | 3E-50 | 49.523 | rs429358 | 0.08 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS1639885_H | GCST90479669 | mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed) | 114,857 African American or Afro-Caribbean individuals, 55,793 Hispanic or Latin American individuals, 5,943 East Asian ancestry individuals, 407,343 European ancestry individuals | T | 0.8472 | 4E-12 | 11.398 | rs429358 | 0.0248 | mean corpuscular hemoglobin concentration (EFO:0004528) |
PMID:39024449 |
GWAS1640086_H | GCST90479670 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | 114,851 African American or Afro-Caribbean individuals, 55,797 Hispanic or Latin American individuals, 5,942 East Asian ancestry individuals, 407,345 European ancestry individuals | T | 0.8472 | 8E-12 | 11.097 | rs429358 | 0.02493 | mean corpuscular hemoglobin concentration (EFO:0004528) |
PMID:39024449 |
GWAS1641316_H | GCST90479589 | Diabetes / "Sugar" | 16,718 African American or Afro-Caribbean cases, 38,787 African American or Afro-Caribbean controls, 8,910 Hispanic or Latin American cases, 20,404 Hispanic or Latin American controls, 1,007 East Asian ancestry cases, 2,540 East Asian ancestry controls, 80,160 European ancestry cases, 235,508 European ancestry controls | T | 0.8537 | 1E-11 | 11 | rs429358 | 0.05904 | diabetes mellitus (EFO:0000400) |
PMID:39024449 |
GWAS1121568_H | GCST008996 | Waist-hip ratio | 697,734 European ancestry individuals | T | 0.8459 | 4E-37 | 36.398 | rs429358 | 0.0346 | waist-hip ratio (EFO:0004343) |
PMID:30239722 |
GWAS1642026_H | GCST90479588 | Takes medication for Diabetes/sugar? | 13,958 African American or Afro-Caribbean cases, 41,547 African American or Afro-Caribbean controls, 7,497 Hispanic or Latin American cases, 21,817 Hispanic or Latin American controls, 852 East Asian ancestry cases, 2,695 East Asian ancestry controls, 67,092 European ancestry cases, 248,576 European ancestry controls | T | 0.8537 | 2E-14 | 13.699 | rs429358 | 0.06873 | diabetes mellitus (EFO:0000400) Drugs used in diabetes use measurement (EFO:0009924) |
PMID:39024449 |
GWAS1642037_H | GCST90492734 | Type 2 diabetes | 50,251 African American cases, 103,909 African American controls, 88,109 East Asian ancestry cases, 339,395 East Asian ancestry controls, 242,283 European ancestry cases, 1,569,734 European ancestry controls, 29,375 Hispanic cases, 59,368 Hispanic controls, 1,602 South African ancestry cases, 976 South African ancestry controls, 16,832 South Asian ancestry cases, 33,767 South Asian ancestry controls | T | 0.85709 | 7E-42 | 41.155 | rs429358 | N/A | PMID:38374256 | |
GWAS1642269_H | GCST90479632 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | 113,085 African American or Afro-Caribbean individuals, 54,914 Hispanic or Latin American individuals, 6,005 East Asian ancestry individuals, 404,121 European ancestry individuals | T | 0.8471 | 1E-164 | 164 | rs429358 | 0.1119 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39024449 |
GWAS1122228_H | GCST008550 | Mental health study participation (completed survey) | 122,647 British ancestry cases, 248,781 British ancestry controls | C | 0.15 | 5E-19 | 18.302 | rs429358 | 0.013306 | health study participation (EFO:0010130) |
PMID:31263887 |
GWAS1122615_H | GCST007012 | Cerebrospinal fluid AB1-42 levels | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 1E-51 | 51 | rs429358 | 0.8 | beta-amyloid 1-42 measurement (EFO:0004670) |
PMID:29274321 |
GWAS1122618_H | GCST007007 | Cerebrospinal fluid t-tau levels | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 1E-20 | 20 | rs429358 | 0.55 | t-tau measurement (EFO:0004760) |
PMID:29274321 |
GWAS1122623_H | GCST007008 | Cerebrospinal fluid p-tau levels | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 3E-18 | 17.523 | rs429358 | 0.51 | p-tau measurement (EFO:0004763) |
PMID:29274321 |
GWAS1122656_H | GCST007009 | Hippocampal volume | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 2E-19 | 18.699 | rs429358 | 0.47 | hippocampal volume (EFO:0005035) |
PMID:29274321 |
GWAS1122659_H | GCST007011 | Logical memory (immediate recall) | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 2E-13 | 12.699 | rs429358 | 0.36 | memory performance (EFO:0004874) |
PMID:29274321 |
GWAS1122662_H | GCST007010 | Logical memory (delayed recall) | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 2E-18 | 17.699 | rs429358 | 0.42 | memory performance (EFO:0004874) |
PMID:29274321 |
GWAS1643490_H | GCST90479579 | Biological Father: Alzheimer's / Other Dementia | 2,411 African American or Afro-Caribbean cases, 53,094 African American or Afro-Caribbean controls, 19,600 European ancestry cases, 296,068 European ancestry controls, 1,591 Hispanic or Latin American cases, 27,723 Hispanic or Latin American controls | T | 0.8532 | 1E-169 | 169 | rs429358 | 0.3501 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1123927_H | GCST008829 | Neuritic plaque | 2,701 European ancestry men, 3,275 European ancestry women | C | 0.258405 | 5E-20 | 19.302 | rs429358 | 1.113172 | neuritic plaque measurement (EFO:0006798) |
PMID:31497858 |
GWAS1123982_H | GCST008822 | Neuritic plaque | 2,701 European ancestry men | C | 0.258035 | 9E-25 | 24.046 | rs429358 | 1.232879 | neuritic plaque measurement (EFO:0006798) |
PMID:31497858 |
GWAS1643806_H | GCST90479565 | C-reactive protein (CRP, dL, mean, inv-norm transformed) | 7,924 African American or Afro-Caribbean individuals, 20,588 European ancestry individuals, 3,602 Hispanic or Latin American individuals | T | 0.8527 | 2E-12 | 11.699 | rs429358 | 0.08074 | C-reactive protein measurement (EFO:0004458) |
PMID:39024449 |
GWAS1643833_H | GCST90479566 | C-reactive protein (CRP, dL, minimum, inv-norm transformed) | 7,913 African American or Afro-Caribbean individuals, 20,574 European ancestry individuals, 3,596 Hispanic or Latin American individuals | T | 0.8526 | 1E-16 | 16 | rs429358 | 0.09492 | C-reactive protein measurement (EFO:0004458) |
PMID:39024449 |
None Available | GCST90479567 | C-reactive protein (CRP, L, minimum, inv-norm transformed) | 5,042 African American or Afro-Caribbean individuals, 26,471 European ancestry individuals, 3,407 Hispanic or Latin American individuals | T | 0.8577 | 2E-12 | 11.699 | rs429358 | 0.07904 | C-reactive protein measurement (EFO:0004458) |
PMID:39024449 |
GWAS1643949_H | GCST90475542 | Dementia (includes Alzheimer's, Vascular, etc.) | 4,040 European ancestry cases, 311,628 European ancestry controls | T | 0.8619 | 5E-97 | 96.302 | rs429358 | 0.6234 | PMID:39024449 | |
GWAS1643960_H | GCST90475543 | Takes medication for Dementia (includes Alzheimer's, Vascular, etc.)? | 2,486 European ancestry cases, 313,182 European ancestry controls | T | 0.8619 | 4E-62 | 61.398 | rs429358 | 0.6266 | drug use measurement (EFO:0007010) |
PMID:39024449 |
GWAS1643961_H | GCST90475544 | Memory loss or impairment | 31,336 European ancestry cases, 284,332 European ancestry controls | T | 0.8619 | 2E-56 | 55.699 | rs429358 | 0.1837 | memory impairment (EFO:0001072) |
PMID:39024449 |
GWAS1643962_H | GCST90475545 | Takes medication for memory loss or impairment? | 5,175 European ancestry cases, 310,493 European ancestry controls | T | 0.8619 | 1E-36 | 36 | rs429358 | 0.3404 | drug use measurement (EFO:0007010) memory impairment (EFO:0001072) |
PMID:39024449 |
GWAS1644222_H | GCST90475550 | Biological Grandparent (paternal): Alzheimer's / Other Dementia | 14,118 European ancestry cases, 301,550 European ancestry controls | T | 0.8619 | 6E-53 | 52.222 | rs429358 | 0.2569 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1644235_H | GCST90475556 | Symptoms concerning nutrition, metabolism, and development (PheCode 1002) | 23,728 European ancestry cases, 402,423 European ancestry controls | T | 0.8601 | 4E-19 | 18.398 | rs429358 | 0.118 | sign or symptom (EFO:0003765) |
PMID:39024449 |
GWAS1126379_H | GCST006097 | Moderate to vigorous physical activity levels | 377,234 European ancestry individuals | T | 0.85 | 6E-13 | 12.222 | rs429358 | 0.022 | physical activity measurement (EFO:0008002) |
PMID:29899525 |
GWAS1126385_H | GCST006098 | Vigorous physical activity | 98,060 European ancestry active cases, 162,995 European ancestry inactive controls | C | NR | 5E-7 | 6.302 | rs429358 | N/A | physical activity measurement (EFO:0008002) |
PMID:29899525 |
None Available | GCST008998 | Waist-hip ratio | 316,772 European ancestry male individuals | T | 0.8459 | 4E-37 | 36.398 | rs429358 | 0.0346 | waist-hip ratio (EFO:0004343) |
PMID:30239722 |
GWAS1126935_H | GCST003901 | Cognitive decline (age-related) | 3,964 African American ancestry individuals. | ? | NR | 2E-14 | 13.699 | rs429358 | 0.01 | Mental deterioration (HP:0001268) |
PMID:28078323 |
GWAS1127585_H | GCST008437 | Alzheimer's disease in hypertension-negative individuals | 796 European ancestry cases, 4,010 European ancestry controls | ? | 0.210 | 2E-30 | 29.699 | rs429358 | 5.24 | PMID:31055733 | |
GWAS1127588_H | GCST008438 | Alzheimer's disease in hypertension | 1,262 European ancestry cases, 9,608 European ancestry controls | ? | 0.147 | 6E-43 | 42.222 | rs429358 | 3.26 | PMID:31055733 | |
GWAS1127768_H | GCST009020 | Alzheimer's disease | 4,120 European ancestry cases, 3,289 European ancestry controls | C | 0.17 | 1E-62 | 62 | rs429358 | 2.27 | PMID:31473137 | |
GWAS1127769_H | GCST009025 | Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+) | 1,168 Spanish ancestry cases, 3,289 Spanish ancestry controls | C | 0.17 | 6E-14 | 13.222 | rs429358 | 1.69 | PMID:31473137 | |
GWAS1127770_H | GCST009022 | Alzheimer’s disease (clinical subgroup AD+) | 3,797 Spanish ancestry cases, 3,289 Spanish ancestry controls | C | 0.17 | 1E-64 | 64 | rs429358 | 2.39 | PMID:31473137 | |
GWAS1127771_H | GCST009023 | Alzheimer’s disease (clinical subgroup AD++) | 2,611 Spanish ancestry cases, 3,289 Spanish ancestry controls | C | 0.17 | 1E-76 | 76 | rs429358 | 2.71 | PMID:31473137 | |
GWAS1127772_H | GCST009024 | Alzheimer’s disease (clinical subgroup AD+++) | 1,854 Spanish ancestry cases, 3,289 Spanish ancestry controls | C | 0.17 | 1E-75 | 75 | rs429358 | 2.92 | PMID:31473137 | |
GWAS1644885_H | GCST90475667 | Type 2 diabetes (PheCode 250.2) | 154,194 European ancestry cases, 278,454 European ancestry controls | T | 0.8599 | 1E-31 | 31 | rs429358 | 0.06467 | PMID:39024449 | |
None Available | GCST90475658 | Diabetes mellitus (PheCode 250) | 154,958 European ancestry cases, 276,347 European ancestry controls | T | 0.8599 | 2E-30 | 29.699 | rs429358 | 0.06364 | diabetes mellitus (EFO:0000400) |
PMID:39024449 |
GWAS1128280_H | GCST009019 | Alzheimer's disease | 4,120 Spanish ancestry cases, 11,999 cases, 3,289 Spanish ancestry controls, 9,236 controls | ? | NR | 2E-303 | 302.699 | rs429358 | 3.21 | PMID:31473137 | |
None Available | GCST90475673 | Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) | 28,561 European ancestry cases, 402,796 European ancestry controls | T | 0.8595 | 1E-11 | 11 | rs429358 | 0.07972 | diabetic eye disease (EFO:0009486) |
PMID:39024449 |
None Available | GCST90479625 | Glucose (fasting status unknown, maximum, inv-norm transformed) | 117,850 African American or Afro-Caribbean individuals, 57,272 Hispanic or Latin American individuals, 6,318 East Asian ancestry individuals, 419,671 European ancestry individuals | T | 0.8472 | 3E-13 | 12.523 | rs429358 | 0.02608 | glucose measurement (EFO:0004468) |
PMID:39024449 |
GWAS1645368_H | GCST90475851 | Macular degeneration, dry (PheCode 362.21) | 27,144 European ancestry cases, 412,580 European ancestry controls | T | 0.8596 | 3E-20 | 19.523 | rs429358 | 0.1244 | macular degeneration (EFO:0009606) |
PMID:39024449 |
GWAS1645377_H | GCST90479626 | Glucose (fasting status unknown, mean, inv-norm transformed) | 118,233 African American or Afro-Caribbean individuals, 57,284 Hispanic or Latin American individuals, 6,317 East Asian ancestry individuals, 419,946 European ancestry individuals | T | 0.8472 | 1E-15 | 15 | rs429358 | 0.02954 | glucose measurement (EFO:0004468) |
PMID:39024449 |
GWAS1646412_H | GCST90475985 | Cerebrovascular disease (PheCode 433) | 69,894 European ancestry cases, 349,486 European ancestry controls | T | 0.86 | 5E-14 | 13.302 | rs429358 | 0.06043 | cerebrovascular disorder (EFO:0003763) |
PMID:39024449 |
None Available | GCST90479739 | Biological Grandparent (paternal): Alzheimer's / Other Dementia | 1,577 African American or Afro-Caribbean cases, 53,928 African American or Afro-Caribbean controls, 14,118 European ancestry cases, 301,550 European ancestry controls, 1,043 Hispanic or Latin American cases, 28,271 Hispanic or Latin American controls | T | 0.8532 | 1E-59 | 59 | rs429358 | 0.2477 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
None Available | GCST90475993 | Aortic aneurysm (PheCode 442.1) | 22,049 European ancestry cases, 419,651 European ancestry controls | T | 0.8599 | 2E-19 | 18.699 | rs429358 | 0.1198 | aortic aneurysm (EFO:0001666) |
PMID:39024449 |
None Available | GCST90475992 | Other aneurysm (PheCode 442) | 24,982 European ancestry cases, 414,741 European ancestry controls | T | 0.8599 | 2E-19 | 18.699 | rs429358 | 0.1146 | aneurysm (EFO:0009659) |
PMID:39024449 |
GWAS1646808_H | GCST90479885 | Type 2 diabetes (PheCode 250.2) | 51,551 African American or Afro-Caribbean cases, 64,463 African American or Afro-Caribbean controls, 22,274 Hispanic or Latin American cases, 35,406 Hispanic or Latin American controls, 2,272 East Asian ancestry cases, 4,333 East Asian ancestry controls, 154,194 European ancestry cases, 278,454 European ancestry controls | T | 0.8481 | 6E-16 | 15.222 | rs429358 | 0.05446 | PMID:39024449 | |
GWAS1131235_H | GCST010496 | Relative sugar intake | 175,253 European ancestry individuals | ? | NR | 3E-11 | 10.523 | rs429358 | 0.028 | sugar consumption measurement (EFO:0010158) |
PMID:32393786 |
None Available | GCST009379 | Type 2 diabetes | 74,124 European ancestry cases, 824,006 European ancestry controls | T | 0.8458 | 3E-18 | 17.523 | rs429358 | 1.08 | PMID:30297969 | |
GWAS1131760_H | GCST008830 | Neurofibrillary tangles | 3,275 European ancestry women | C | 0.263094 | 5E-23 | 22.302 | rs429358 | 1.257302 | neurofibrillary tangles measurement (EFO:0006797) |
PMID:31497858 |
GWAS1131764_H | GCST008821 | Neurofibrillary tangles | 2,701 European ancestry men | C | 0.260771 | 3E-31 | 30.523 | rs429358 | 1.500561 | neurofibrillary tangles measurement (EFO:0006797) |
PMID:31497858 |
GWAS1132773_H | GCST006996 | Cerebrospinal AB1-42 levels in mild cognitive impairment | 581 European ancestry MCI dementia cases | C | 0.25 | 6E-27 | 26.222 | rs429358 | 0.77 | beta-amyloid 1-42 measurement (EFO:0004670) |
PMID:29274321 |
GWAS1132807_H | GCST006998 | Cerebrospinal fluid p-tau levels in mild cognitive impairment | 581 European ancestry mild cognitive impairment cases | C | 0.25 | 2E-11 | 10.699 | rs429358 | 0.53 | t-tau measurement (EFO:0004760) |
PMID:29274321 |
GWAS1132808_H | GCST006997 | Cerebrospinal fluid t-tau levels in mild cognitive impairment | 581 European ancestry cases | C | 0.25 | 1E-13 | 13 | rs429358 | 0.57 | t-tau measurement (EFO:0004760) |
PMID:29274321 |
GWAS1132921_H | GCST007001 | Cerebrospinal AB1-42 levels in normal cognition | 305 European ancestry cognitively normal individuals | C | 0.25 | 9E-11 | 10.046 | rs429358 | 0.84 | beta-amyloid 1-42 measurement (EFO:0004670) |
PMID:29274321 |
GWAS1680347_H | GCST90479892 | Diabetes mellitus (PheCode 250) | 51,802 African American or Afro-Caribbean cases, 63,903 African American or Afro-Caribbean controls, 22,361 Hispanic or Latin American cases, 35,203 Hispanic or Latin American controls, 2,276 East Asian ancestry cases, 4,318 East Asian ancestry controls, 154,958 European ancestry cases, 276,347 European ancestry controls | T | 0.8481 | 2E-15 | 14.699 | rs429358 | 0.05349 | diabetes mellitus (EFO:0000400) |
PMID:39024449 |
GWAS1133437_H | GCST006698 | Parental longevity (both parents in top 10%) | 7,182 cases, 79,767 controls | T | 0.842 | 7E-46 | 45.155 | rs429358 | 0.0388 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS1133438_H | GCST006699 | Parental longevity (mother's age at death) | 246,941 British ancestry individuals | T | 0.842 | 7E-19 | 18.155 | rs429358 | 0.0336 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS1133457_H | GCST006697 | Parental longevity (combined parental attained age, Martingale residuals) | 389,166 British ancestry individuals | T | 0.845 | 1E-74 | 74 | rs429358 | 0.0566 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS1647629_H | GCST90479756 | Symptoms concerning nutrition, metabolism, and development (PheCode 1002) | 9,389 African American or Afro-Caribbean cases, 104,151 African American or Afro-Caribbean controls, 2,337 Hispanic or Latin American cases, 54,830 Hispanic or Latin American controls, 208 East Asian ancestry cases, 6,443 East Asian ancestry controls, 23,728 European ancestry cases, 402,423 European ancestry controls | T | 0.8485 | 3E-19 | 18.523 | rs429358 | 0.09835 | sign or symptom (EFO:0003765) |
PMID:39024449 |
GWAS1647701_H | GCST90475994 | Abdominal aortic aneurysm (PheCode 442.11) | 16,289 European ancestry cases, 427,111 European ancestry controls | T | 0.8599 | 9E-23 | 22.046 | rs429358 | 0.1531 | Abdominal Aortic Aneurysm (EFO:0004214) |
PMID:39024449 |
GWAS1134148_H | GCST006696 | Parental longevity (mother's attained age) | 412,937 British ancestry individuals | T | NR | 1E-68 | 68 | rs429358 | N/A | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS1134150_H | GCST006700 | Parental longevity (father's age at death) | 317,652 British ancestry individuals | T | 0.842 | 9E-13 | 12.046 | rs429358 | 0.0262 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS1134181_H | GCST006701 | Parental longevity (father's attained age) | 415,311 British ancestry individuals | T | NR | 2E-28 | 27.699 | rs429358 | N/A | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS1134212_H | GCST006702 | Parental longevity (combined parental age at death) | 208,118 British ancestry individuals | T | 0.842077 | 5E-22 | 21.302 | rs429358 | 0.0436 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS1134618_H | GCST010242 | HDL cholesterol levels | 403,943 European ancestry individuals | T | 0.845675 | 7E-180 | 179.155 | rs429358 | 0.0754686 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:32203549 |
GWAS1135826_H | GCST010241 | Apolipoprotein A1 levels | 393,193 European ancestry individuals | T | 0.845522 | 8E-311 | 310.097 | rs429358 | 0.102369 | apolipoprotein A 1 measurement (EFO:0004614) |
PMID:32203549 |
GWAS1135877_H | GCST010133 | Lamb consumption | 335,576 European ancestry individuals | ? | NR | 5E-12 | 11.302 | rs429358 | 0.0232225 | diet measurement (EFO:0008111) |
PMID:32066663 |
GWAS1136099_H | GCST010143 | Meat-related diet | 154,123 European ancestry men, 181,453 European ancestry women | ? | NR | 5E-13 | 12.302 | rs429358 | 0.0242948 | diet measurement (EFO:0008111) |
PMID:32066663 |
None Available | GCST90476045 | Diseases of esophagus (PheCode 530) | 189,441 European ancestry cases, 223,867 European ancestry controls | T | 0.8599 | 4E-12 | 11.398 | rs429358 | 0.04037 | esophageal disease (EFO:0009544) |
PMID:39024449 |
GWAS1136149_H | GCST010143 | Meat-related diet | 154,123 European ancestry men, 181,453 European ancestry women | ? | NR | 1E-8 | 8 | rs429358 | 0.0261231 | diet measurement (EFO:0008111) |
PMID:32066663 |
GWAS1138642_H | GCST010101 | White matter hyperintensities | 39,011 European ancestry individuals, 2,099 African ancestry individuals, 795 Hispanic individuals, 3,299 Asian ancestry individuals | T | NR | 1E-9 | 9 | rs429358 | 6.061 | white matter hyperintensity measurement (EFO:0005665) |
PMID:32358547 |
GWAS1138725_H | GCST010378 | Spherical equivalent | 95,827 European ancestry individuals | C | NR | 4E-8 | 7.398 | rs429358 | 0.09 | PMID:32352494 | |
GWAS1138747_H | GCST90012826 | Neurofibrillary tangles | 909 European ancestry individuals | T | 0.85 | 4E-20 | 19.398 | rs429358 | 0.27 | neurofibrillary tangles measurement (EFO:0006797) |
PMID:28322283 |
None Available | GCST90012827 | Diffuse plaques | 909 European ancestry individuals | T | 0.86 | 1E-20 | 20 | rs429358 | N/A | diffuse plaque measurement (EFO:0010699) |
PMID:28322283 |
GWAS1138798_H | GCST90012825 | Neuritic plaque | 909 European ancestry individuals | T | 0.86 | 3E-24 | 23.523 | rs429358 | N/A | neuritic plaque measurement (EFO:0006798) |
PMID:28322283 |
GWAS1139671_H | GCST90012832 | Neuropathologic traits (pleiotropy) | 909 European ancestry individuals | T | 0.85 | 3E-33 | 32.523 | rs429358 | N/A | brain infarction (EFO:0004277) neuritic plaque measurement (EFO:0006798) Lewy body dementia (EFO:0006792) cerebral amyloid angiopathy (EFO:0006790) More... |
PMID:28322283 |
GWAS1139764_H | GCST90012828 | Cerebral amyloid angiopathy | 404 European ancestry mild cases, 209 European ancestry moderate cases, 113 European ancestry severe cases, 183 European ancestry controls | T | 0.86 | 5E-25 | 24.302 | rs429358 | N/A | cerebral amyloid angiopathy (EFO:0006790) |
PMID:28322283 |
GWAS1649242_H | GCST90475349 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | 54,914 Hispanic or Latin American individuals | T | 0.8834 | 4E-29 | 28.398 | rs429358 | 0.1034 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39024449 |
GWAS1140626_H | GCST010002 | Refractive error | 542,934 European ancestry individuals | ? | NR | 3E-17 | 16.523 | rs429358 | N/A | Abnormality of refraction (HP:0000539) |
PMID:32231278 |
GWAS1649302_H | GCST90475356 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | 404,121 European ancestry individuals | T | 0.8593 | 3E-298 | 297.523 | rs429358 | 0.1516 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39024449 |
GWAS1649384_H | GCST90475353 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | 54,914 Hispanic or Latin American individuals | T | 0.8834 | 4E-30 | 29.398 | rs429358 | 0.1051 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39024449 |
GWAS1649445_H | GCST90475348 | high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed) | 404,121 European ancestry individuals | T | 0.8593 | 2E-263 | 262.699 | rs429358 | 0.1426 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39024449 |
GWAS1143322_H | GCST009777 | C-reactive protein levels | 418,642 British ancestry individuals | T | 0.8442 | 2E-1953 | 1952.699 | rs429358 | 0.26396 | C-reactive protein measurement (EFO:0004458) |
PMID:31900758 |
GWAS1069146_H | GCST004621 | Red cell distribution width | 171,529 European ancestry individuals | C | 0.1416 | 8E-26 | 25.097 | rs429358 | 0.05202347 | Red cell distribution width (EFO:0009188) |
PMID:27863252 |
GWAS1650391_H | GCST90480043 | Macular degeneration, dry (PheCode 362.21) | 1,083 African American or Afro-Caribbean cases, 119,609 African American or Afro-Caribbean controls, 27,144 European ancestry cases, 412,580 European ancestry controls, 1,519 Hispanic or Latin American cases, 57,488 Hispanic or Latin American controls | T | 0.847 | 8E-17 | 16.097 | rs429358 | 0.1155 | macular degeneration (EFO:0009606) |
PMID:39024449 |
None Available | GCST90091033 | Nonalcoholic fatty liver disease | 8,434 European ancestry cases, 770,180 European ancestry controls | C | NR | 1E-8 | 8 | rs429358 | 0.1366 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:34841290 |
GWAS1650885_H | GCST90475162 | Blood urea nitrogen (BUN, maximum, inv-norm transformed) | 418,135 European ancestry individuals | T | 0.8593 | 2E-16 | 15.699 | rs429358 | 0.02676 | blood urea nitrogen measurement (EFO:0004741) |
PMID:39024449 |
GWAS1651449_H | GCST90475332 | Glucose (fasting status unknown, mean, inv-norm transformed) | 419,946 European ancestry individuals | T | 0.8594 | 4E-35 | 34.398 | rs429358 | 0.04582 | glucose measurement (EFO:0004468) |
PMID:39024449 |
GWAS1152954_H | GCST009496 | Alzheimer's disease (onset between ages 58 and 79) | 7,316 European ancestry cases, 7,579 European ancestry controls | C | 0.248 | 5E-286 | 285.302 | rs429358 | 3.93 | PMID:30979435 | |
GWAS1153699_H | GCST009497 | Alzheimer's disease (onset at age over 80) | 2,399 European ancestry cases, 4,160 European ancestry controls | C | 0.126 | 4E-43 | 42.398 | rs429358 | 2.39 | PMID:30979435 | |
GWAS1651760_H | GCST90475321 | Takes medication for acid reflux/GERD? | 86,135 European ancestry cases, 229,533 European ancestry controls | T | 0.8619 | 8E-13 | 12.097 | rs429358 | 0.05592 | drug use measurement (EFO:0007010) gastroesophageal reflux disease (EFO:0003948) |
PMID:39024449 |
GWAS1155273_H | GCST009858 | Waist-to-hip ratio adjusted for BMI | 457,690 European ancestry individuals | ? | NR | 3E-19 | 18.523 | rs429358 | N/A | BMI-adjusted waist-hip ratio (EFO:0007788) |
PMID:31669095 |
GWAS1652029_H | GCST90475345 | high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed) | 54,914 Hispanic or Latin American individuals | T | 0.8834 | 2E-23 | 22.699 | rs429358 | 0.09223 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39024449 |
GWAS1652243_H | GCST90475165 | Blood urea nitrogen (BUN, mean, inv-norm transformed) | 418,647 European ancestry individuals | T | 0.8593 | 2E-27 | 26.699 | rs429358 | 0.0361 | blood urea nitrogen measurement (EFO:0004741) |
PMID:39024449 |
None Available | GCST90475211 | Heart attack | 39,300 European ancestry cases, 276,368 European ancestry controls | T | 0.8619 | 2E-13 | 12.699 | rs429358 | 0.07671 | myocardial infarction (EFO:0000612) |
PMID:39024449 |
GWAS1652509_H | GCST90475168 | Blood urea nitrogen (BUN, minimum, inv-norm transformed) | 419,128 European ancestry individuals | T | 0.8593 | 9E-28 | 27.046 | rs429358 | 0.03765 | blood urea nitrogen measurement (EFO:0004741) |
PMID:39024449 |
GWAS1680377_H | GCST90475248 | Biological Father: Alzheimer's / Other Dementia | 1,591 Hispanic or Latin American cases, 27,723 Hispanic or Latin American controls | T | 0.8849 | 6E-12 | 11.222 | rs429358 | 0.3644 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1653185_H | GCST90475249 | Biological Father: Alzheimer's / Other Dementia | 19,600 European ancestry cases, 296,068 European ancestry controls | T | 0.8619 | 3E-150 | 149.523 | rs429358 | 0.3694 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1653206_H | GCST90475235 | C-reactive protein (CRP, dL, minimum, inv-norm transformed) | 20,574 European ancestry individuals | T | 0.8694 | 7E-13 | 12.155 | rs429358 | 0.1041 | C-reactive protein measurement (EFO:0004458) |
PMID:39024449 |
None Available | GCST90475237 | C-reactive protein (CRP, L, minimum, inv-norm transformed) | 26,471 European ancestry individuals | T | 0.8656 | 5E-13 | 12.302 | rs429358 | 0.09373 | C-reactive protein measurement (EFO:0004458) |
PMID:39024449 |
GWAS1653243_H | GCST90475268 | Takes medication for Diabetes/sugar? | 67,092 European ancestry cases, 248,576 European ancestry controls | T | 0.8619 | 6E-21 | 20.222 | rs429358 | 0.07593 | diabetes mellitus (EFO:0000400) Drugs used in diabetes use measurement (EFO:0009924) |
PMID:39024449 |
None Available | GCST90475265 | Diabetes / "Sugar" | 80,160 European ancestry cases, 235,508 European ancestry controls | T | 0.8619 | 3E-18 | 17.523 | rs429358 | 0.06446 | diabetes mellitus (EFO:0000400) |
PMID:39024449 |
GWAS1161924_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.905 | 2E-7 | 6.699 | rs429358 | 0.152 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS1161925_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.789 | 0.000002 | 5.699 | rs429358 | 0.151 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS1161926_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | NR | 3E-187 | 186.523 | rs429358 | 0.193 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS1163411_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.868 | 9E-34 | 33.046 | rs429358 | 0.078 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS1163412_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.905 | 0.000001 | 6 | rs429358 | 0.129 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
None Available | GCST90475386 | Macular degeneration | 17,289 European ancestry cases, 298,379 European ancestry controls | T | 0.8619 | 1E-11 | 11 | rs429358 | 0.117 | macular degeneration (EFO:0009606) |
PMID:39024449 |
GWAS1163971_H | GCST006034 | Total cholesterol levels | 128,305 Japanese ancestry individuals | ? | NR | 2E-57 | 56.699 | rs429358 | 0.1052 | total cholesterol measurement (EFO:0004574) |
PMID:29403010 |
GWAS1164968_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.868 | 1E-123 | 123 | rs429358 | 0.168 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS1164969_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.885 | 3E-14 | 13.523 | rs429358 | 0.18 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS1164970_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.905 | 3E-8 | 7.523 | rs429358 | 0.162 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS1164971_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | NR | 1E-145 | 145 | rs429358 | 0.167 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS1165339_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | NR | 1E-39 | 39 | rs429358 | 0.077 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS1655223_H | GCST90475352 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | 404,121 European ancestry individuals | T | 0.8593 | 1E-323 | 323 | rs429358 | 0.1592 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39024449 |
None Available | GCST90479501 | Hemoglobin A1c (HbA1c, mean, inv-norm transformed) | 98,735 African American or Afro-Caribbean individuals, 49,225 Hispanic or Latin American individuals, 5,475 East Asian ancestry individuals, 338,848 European ancestry individuals | T | 0.8475 | 1E-20 | 20 | rs429358 | 0.03852 | HbA1c measurement (EFO:0004541) |
PMID:39024449 |
GWAS1168025_H | GCST006005 | High density lipoprotein cholesterol levels | 70,657 Japanese ancestry individuals | ? | NR | 2E-24 | 23.699 | rs429358 | 0.08948 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29403010 |
GWAS1168085_H | GCST006004 | Low density lipoprotein cholesterol levels | 72,866 Japanese ancestry individuals | ? | NR | 4E-71 | 70.398 | rs429358 | 0.1558 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29403010 |
None Available | GCST005078 | Mortality | 138,536 British ancestry mothers, 133,545 British ancestry fathers | C | NR | 1E-20 | 20 | rs429358 | 1.107 | mortality (EFO:0004352) |
PMID:27029810 |
GWAS655841_H | GCST007988 | Insomnia | 651,923 European ancestry males, 679,087 European ancestry females | T | 0.8458 | 2E-8 | 7.699 | rs429358 | 1.047 | insomnia measurement (EFO:0007876) |
PMID:30804565 |
GWAS1168803_H | GCST006012 | C-reactive protein levels | 75,391 Japanese ancestry individuals | ? | NR | 7E-36 | 35.155 | rs429358 | 0.1086 | C-reactive protein measurement (EFO:0004458) |
PMID:29403010 |
GWAS1655842_H | GCST90479500 | Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) | 98,772 African American or Afro-Caribbean individuals, 49,229 Hispanic or Latin American individuals, 5,477 East Asian ancestry individuals, 338,857 European ancestry individuals | T | 0.8476 | 7E-20 | 19.155 | rs429358 | 0.03688 | HbA1c measurement (EFO:0004541) |
PMID:39024449 |
GWAS1169633_H | GCST005276 | Dementia with Lewy bodies | 1,216 European ancestry cases, 3,791 European ancestry controls | C | 0.14 | 3E-64 | 63.523 | rs429358 | 2.46 | Lewy body dementia (EFO:0006792) |
PMID:29263008 |
GWAS1169964_H | GCST004983 | Parental lifespan | up to 586,626 European ancestry individuals, up to 19,433 African ancestry individuals | C | 0.142 | 1E-27 | 27 | rs429358 | 0.9 | parental longevity (EFO:0007796) |
PMID:29030599 |
GWAS1656065_H | GCST90479508 | Alanine transaminase (ALT, minimum, inv-norm transformed) | 115,132 African American or Afro-Caribbean individuals, 55,858 Hispanic or Latin American individuals, 6,027 East Asian ancestry individuals, 406,784 European ancestry individuals | T | 0.847 | 2E-41 | 40.699 | rs429358 | 0.04292 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:39024449 |
None Available | GCST90479522 | Body mass index (BMI, mean, inv-normal transformed) | 118,993 African American or Afro-Caribbean individuals, 57,793 Hispanic or Latin American individuals, 6,384 East Asian ancestry individuals, 424,221 European ancestry individuals | T | 0.8472 | 3E-14 | 13.523 | rs429358 | 0.03163 | body mass index (EFO:0004340) |
PMID:39024449 |
GWAS1657680_H | GCST90479523 | Body mass index (BMI, minimum, inv-normal transformed) | 118,992 African American or Afro-Caribbean individuals, 57,794 Hispanic or Latin American individuals, 6,384 East Asian ancestry individuals, 424,217 European ancestry individuals | T | 0.8472 | 1E-25 | 25 | rs429358 | 0.04135 | body mass index (EFO:0004340) |
PMID:39024449 |
None Available | GCST90479524 | Blood urea nitrogen (BUN, maximum, inv-norm transformed) | 117,530 African American or Afro-Caribbean individuals, 57,007 Hispanic or Latin American individuals, 6,277 East Asian ancestry individuals, 418,135 European ancestry individuals | T | 0.8471 | 6E-16 | 15.222 | rs429358 | 0.02514 | blood urea nitrogen measurement (EFO:0004741) |
PMID:39024449 |
GWAS1174990_H | GCST011947 | White matter hyperintensity volume | 48,454 European ancestry individuals | C | 0.8556 | 1E-7 | 7 | rs429358 | 0.0447 | white matter hyperintensity measurement (EFO:0005665) |
PMID:33293549 |
None Available | GCST90479526 | Blood urea nitrogen (BUN, minimum, inv-norm transformed) | 118,165 African American or Afro-Caribbean individuals, 57,207 Hispanic or Latin American individuals, 6,303 East Asian ancestry individuals, 419,128 European ancestry individuals | T | 0.8471 | 4E-20 | 19.398 | rs429358 | 0.02948 | blood urea nitrogen measurement (EFO:0004741) |
PMID:39024449 |
GWAS1657970_H | GCST90479525 | Blood urea nitrogen (BUN, mean, inv-norm transformed) | 117,876 African American or Afro-Caribbean individuals, 57,109 Hispanic or Latin American individuals, 6,288 East Asian ancestry individuals, 418,647 European ancestry individuals | T | 0.8471 | 4E-22 | 21.398 | rs429358 | 0.03145 | blood urea nitrogen measurement (EFO:0004741) |
PMID:39024449 |
GWAS1175559_H | GCST011949 | White matter hyperintensity volume (adjusted for hypertension) | 46,055 European ancestry individuals, 2,469 African American individuals | C | 0.8556 | 0.000005 | 5.302 | rs429358 | 0.0399 | white matter hyperintensity measurement (EFO:0005665) |
PMID:33293549 |
GWAS1175714_H | GCST011583 | Serum C-reactive protein concentration | 10,798 European ancestry women | ? | NR | 8E-10 | 9.097 | rs429358 | 0.76 | C-reactive protein measurement (EFO:0004458) |
PMID:32928877 |
GWAS1659031_H | GCST90479543 | Coronary artery / coronary heart disease (including heart attack, angina) | 5,298 African American or Afro-Caribbean cases, 50,207 African American or Afro-Caribbean controls, 3,107 Hispanic or Latin American cases, 26,207 Hispanic or Latin American controls, 381 East Asian ancestry cases, 3,166 East Asian ancestry controls, 52,789 European ancestry cases, 262,879 European ancestry controls | T | 0.8537 | 3E-12 | 11.523 | rs429358 | 0.07025 | coronary artery disease (EFO:0001645) |
PMID:39024449 |
GWAS1180906_H | GCST90002396 | Mean reticulocyte volume | 408,112 British individuals | C | 0.154459 | 4E-21 | 20.398 | rs429358 | 0.029556824 | mean reticulocyte volume (EFO:0010701) |
PMID:32888494 |
GWAS1181661_H | GCST010557 | Type 2 diabetes | 148,726 European ancestry cases, 24,646 African American cases, 8,616 Hispanic cases, 46,511 Asian ancestry cases, 965,732 European ancestry controls, 31,446 African American controls, 11,829 Hispanic controls, 169,776 Asian ancestry controls | C | 0.1469 | 2E-26 | 25.699 | rs429358 | 0.0585 | PMID:32541925 | |
GWAS1659710_H | GCST90475494 | Biological Mother: Alzheimer's / Other Dementia | 2,720 Hispanic or Latin American cases, 26,594 Hispanic or Latin American controls | T | 0.8849 | 4E-32 | 31.398 | rs429358 | 0.4923 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1659711_H | GCST90475495 | Biological Mother: Alzheimer's / Other Dementia | 4,657 African American or Afro-Caribbean cases, 50,848 African American or Afro-Caribbean controls | T | 0.7868 | 7E-51 | 50.155 | rs429358 | 0.3853 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
None Available | GCST90475496 | Biological Mother: Alzheimer's / Other Dementia | 37,456 European ancestry cases, 278,212 European ancestry controls | T | 0.8619 | 1E-323 | 323 | rs429358 | 0.4395 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1183317_H | GCST009859 | Adult onset asthma or type 2 diabetes | 33,418 European ancestry asthma cases, 393,186 European ancestry asthma controls, 159,208 European ancestry diabetes cases and controls | ? | NR | 2E-10 | 9.699 | rs429358 | N/A | adult onset asthma (EFO:1002011) |
PMID:31669095 |
None Available | GCST011946 | White matter hyperintensity volume | 2,516 African American individuals, 48,454 European ancestry individuals | C | 0.8556 | 2E-7 | 6.699 | rs429358 | 0.0445 | white matter hyperintensity measurement (EFO:0005665) |
PMID:33293549 |
GWAS1186949_H | GCST010555 | Type 2 diabetes | 148,726 European ancestry cases, 965,732 European ancestry controls | C | 0.1454 | 4E-28 | 27.398 | rs429358 | 0.073 | PMID:32541925 | |
GWAS1662557_H | GCST90476491 | Delirium dementia and amnestic and other cognitive disorders (PheCode 290) | 3,319 Hispanic or Latin American cases, 54,404 Hispanic or Latin American controls | T | 0.8836 | 5E-18 | 17.302 | rs429358 | 0.3357 | PMID:39024449 | |
None Available | GCST90476492 | Delirium dementia and amnestic and other cognitive disorders (PheCode 290) | 8,216 African American or Afro-Caribbean cases, 108,456 African American or Afro-Caribbean controls | T | 0.783 | 2E-28 | 27.699 | rs429358 | 0.2224 | PMID:39024449 | |
GWAS1662558_H | GCST90476493 | Delirium dementia and amnestic and other cognitive disorders (PheCode 290) | 33,956 European ancestry cases, 397,556 European ancestry controls | T | 0.8602 | 5E-306 | 305.302 | rs429358 | 0.4127 | PMID:39024449 | |
GWAS1662559_H | GCST90476494 | Dementias (PheCode 290.1) | 1,955 Hispanic or Latin American cases, 57,086 Hispanic or Latin American controls | T | 0.8837 | 2E-21 | 20.699 | rs429358 | 0.4706 | PMID:39024449 | |
GWAS1662560_H | GCST90476495 | Dementias (PheCode 290.1) | 4,671 African American or Afro-Caribbean cases, 115,178 African American or Afro-Caribbean controls | T | 0.7834 | 4E-56 | 55.398 | rs429358 | 0.4112 | PMID:39024449 | |
None Available | GCST90476497 | Alzheimer's disease (PheCode 290.11) | 441 Hispanic or Latin American cases, 59,228 Hispanic or Latin American controls | T | 0.8834 | 3E-20 | 19.523 | rs429358 | 0.8728 | PMID:39024449 | |
GWAS1662564_H | GCST90476498 | Alzheimer's disease (PheCode 290.11) | 801 African American or Afro-Caribbean cases, 120,641 African American or Afro-Caribbean controls | T | 0.7836 | 2E-46 | 45.699 | rs429358 | 0.8431 | PMID:39024449 | |
GWAS1662565_H | GCST90476499 | Alzheimer's disease (PheCode 290.11) | 4,713 European ancestry cases, 444,093 European ancestry controls | T | 0.8603 | 3E-267 | 266.523 | rs429358 | 0.9424 | PMID:39024449 | |
GWAS1662566_H | GCST90476500 | Dementia with cerebral degenerations (PheCode 290.12) | 1,830 European ancestry cases, 448,078 European ancestry controls | T | 0.86 | 1E-30 | 30 | rs429358 | 0.5086 | PMID:39024449 | |
None Available | GCST90476501 | Vascular dementia (PheCode 290.16) | 1,530 African American or Afro-Caribbean cases, 119,510 African American or Afro-Caribbean controls | T | 0.7836 | 6E-20 | 19.222 | rs429358 | 0.3963 | PMID:39024449 | |
None Available | GCST90476502 | Vascular dementia (PheCode 290.16) | 4,533 European ancestry cases, 443,622 European ancestry controls | T | 0.8602 | 4E-87 | 86.398 | rs429358 | 0.5601 | PMID:39024449 | |
GWAS1662647_H | GCST90476503 | Delirium due to conditions classified elsewhere (PheCode 290.2) | 5,690 European ancestry cases, 438,267 European ancestry controls | T | 0.8601 | 2E-22 | 21.699 | rs429358 | 0.2506 | delirium (EFO:0009267) |
PMID:39024449 |
None Available | GCST90476504 | Other persistent mental disorders due to conditions classified elsewhere (PheCode 290.3) | 18,183 European ancestry cases, 422,062 European ancestry controls | T | 0.8603 | 2E-56 | 55.699 | rs429358 | 0.231 | mental or behavioural disorder (EFO:0000677) |
PMID:39024449 |
GWAS1662648_H | GCST90476505 | Neurological disorders (PheCode 292) | 15,108 African American or Afro-Caribbean cases, 97,035 African American or Afro-Caribbean controls | T | 0.7841 | 3E-15 | 14.523 | rs429358 | 0.1182 | nervous system disease (EFO:0000618) |
PMID:39024449 |
GWAS1662649_H | GCST90476506 | Neurological disorders (PheCode 292) | 58,508 European ancestry cases, 357,691 European ancestry controls | T | 0.8605 | 8E-166 | 165.097 | rs429358 | 0.2349 | nervous system disease (EFO:0000618) |
PMID:39024449 |
GWAS1662650_H | GCST90476507 | Mild cognitive impairment (PheCode 292.2) | 18,233 European ancestry cases, 420,369 European ancestry controls | T | 0.8606 | 8E-130 | 129.097 | rs429358 | 0.3517 | Cognitive impairment (HP:0100543) |
PMID:39024449 |
GWAS1662651_H | GCST90476508 | Memory loss (PheCode 292.3) | 14,942 European ancestry cases, 420,923 European ancestry controls | T | 0.8607 | 2E-67 | 66.699 | rs429358 | 0.2787 | amnesia (EFO:1001454) |
PMID:39024449 |
None Available | GCST90476509 | Altered mental status (PheCode 292.4) | 14,396 European ancestry cases, 419,075 European ancestry controls | T | 0.8605 | 3E-33 | 32.523 | rs429358 | 0.1976 | mental or behavioural disorder (EFO:0000677) |
PMID:39024449 |
GWAS1662939_H | GCST90475097 | Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) | 338,640 European ancestry individuals | T | 0.86 | 4E-47 | 46.398 | rs429358 | 0.05885 | HbA1c measurement (EFO:0004541) |
PMID:39024449 |
GWAS1187563_H | GCST003219 | Advanced age-related macular degeneration | 16,144 European ancestry cases, 17,832 European ancestry controls | ? | NR | 2E-42 | 41.699 | rs429358 | 1.4285715 | atrophic macular degeneration (EFO:1001492) age-related macular degeneration (EFO:0001365) wet macular degeneration (EFO:0004683) |
PMID:26691988 |
None Available | GCST90475094 | Hemoglobin A1c (HbA1c, mean, inv-norm transformed) | 338,848 European ancestry individuals | T | 0.8599 | 1E-51 | 51 | rs429358 | 0.06229 | HbA1c measurement (EFO:0004541) |
PMID:39024449 |
GWAS1663347_H | GCST90475091 | Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) | 338,857 European ancestry individuals | T | 0.86 | 5E-47 | 46.302 | rs429358 | 0.05822 | HbA1c measurement (EFO:0004541) |
PMID:39024449 |
GWAS1663365_H | GCST90475115 | Alanine transaminase (ALT, minimum, inv-norm transformed) | 406,784 European ancestry individuals | T | 0.8593 | 7E-68 | 67.155 | rs429358 | 0.06032 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:39024449 |
GWAS1663395_H | GCST90475112 | Alanine transaminase (ALT, mean, inv-norm transformed) | 406,803 European ancestry individuals | T | 0.8593 | 3E-67 | 66.523 | rs429358 | 0.05985 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:39024449 |
GWAS1663840_H | GCST90476422 | total cholesterol (mean, inv-norm transformed) | 6,014 East Asian ancestry individuals | T | 0.9021 | 4E-11 | 10.398 | rs429358 | 0.2065 | total cholesterol measurement (EFO:0004574) |
PMID:39024449 |
None Available | GCST90476424 | total cholesterol (mean, inv-norm transformed) | 397,615 European ancestry individuals | T | 0.8596 | 1E-323 | 323 | rs429358 | 0.1372 | total cholesterol measurement (EFO:0004574) |
PMID:39024449 |
None Available | GCST90476420 | total cholesterol (maximum, inv-norm transformed) | 397,478 European ancestry individuals | T | 0.8596 | 1E-323 | 323 | rs429358 | 0.1385 | total cholesterol measurement (EFO:0004574) |
PMID:39024449 |
None Available | GCST90476386 | Waking up during the night and not easily going back to sleep | 105,771 European ancestry cases, 138,105 European ancestry controls | T | 0.8631 | 4E-11 | 10.398 | rs429358 | 0.05513 | Sleep Disorder (EFO:0008568) |
PMID:39024449 |
None Available | GCST003077 | Cerebral amyloid deposition positivity (PET imaging) | up to 350 European and other ancestry positive individuals, up to 296 European and other ancestry negative individuals | C | 0.85 | 5E-20 | 19.302 | rs429358 | 4.72 | cerebral amyloid deposition measurement (EFO:0007707) |
PMID:26252872 |
None Available | GCST002591 | Lewy body disease | up to 3,526 individuals | C | 0.7347 | 5E-12 | 11.302 | rs429358 | 0.508 | Lewy body dementia (EFO:0006792) Lewy body dementia measurement (EFO:0006799) |
PMID:25188341 |
None Available | GCST002591 | Lewy body disease | up to 3,526 individuals | C | 0.7344 | 3E-11 | 10.523 | rs429358 | 0.4905 | Lewy body dementia (EFO:0006792) Lewy body dementia measurement (EFO:0006799) |
PMID:25188341 |
GWAS1189325_H | GCST002591 | Lewy body disease | up to 3,526 individuals | C | 0.732 | 1E-12 | 12 | rs429358 | 0.4997 | Lewy body dementia (EFO:0006792) Lewy body dementia measurement (EFO:0006799) |
PMID:25188341 |
GWAS1189429_H | GCST003073 | Cerebral amyloid deposition (PET imaging) | up to 883 European and other ancestry individuals | T | 0.02 | 8E-32 | 31.097 | rs429358 | 0.13 | cerebral amyloid deposition measurement (EFO:0007707) |
PMID:26252872 |
GWAS1664466_H | GCST90476375 | Biological Sibling: Alzheimer's / Other Dementia | 6,960 European ancestry cases, 308,708 European ancestry controls | T | 0.8619 | 4E-108 | 107.398 | rs429358 | 0.5168 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
None Available | GCST90476418 | total cholesterol (maximum, inv-norm transformed) | 6,013 East Asian ancestry individuals | T | 0.9021 | 3E-11 | 10.523 | rs429358 | 0.2098 | total cholesterol measurement (EFO:0004574) |
PMID:39024449 |
GWAS1664666_H | GCST90476469 | What is your weight? (pounds, inv-normal transformed) | 288,216 European ancestry individuals | T | 0.8615 | 2E-29 | 28.699 | rs429358 | 0.05074 | body weight (EFO:0004338) |
PMID:39024449 |
GWAS1190819_H | GCST002899 | HDL cholesterol | up to 62,166 European ancestry individuals | T | 0.84 | 1E-14 | 14 | rs429358 | 0.066 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:25961943 |
GWAS1192547_H | GCST011348 | High density lipoprotein cholesterol levels | 76,081 European ancestry individuals, 127,395 Japanese ancestry individuals | ? | NR | 2E-58 | 57.699 | rs429358 | 0.1026 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:33339817 |
GWAS1194324_H | GCST012140 | High-sensitivity C-reactive protein levels in HIV infection | 4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals | C | 0.154 | 2E-22 | 21.699 | rs429358 | 0.282 | C-reactive protein measurement (EFO:0004458) |
PMID:33095540 |
None Available | GCST90476084 | Other chronic nonalcoholic liver disease (PheCode 571.5) | 29,342 European ancestry cases, 403,367 European ancestry controls | T | 0.8595 | 2E-27 | 26.699 | rs429358 | 0.137 | liver disease (EFO:0001421) |
PMID:39024449 |
GWAS1665831_H | GCST90475938 | Other chronic ischemic heart disease, unspecified (PheCode 411.8) | 71,808 European ancestry cases, 357,986 European ancestry controls | T | 0.8597 | 1E-26 | 26 | rs429358 | 0.07884 | heart disease (EFO:0003777) |
PMID:39024449 |
GWAS1665896_H | GCST90479689 | Biological Grandparent (maternal): Alzheimer's / Other Dementia | 3,009 African American or Afro-Caribbean cases, 52,496 African American or Afro-Caribbean controls, 20,408 European ancestry cases, 295,260 European ancestry controls, 1,680 Hispanic or Latin American cases, 27,634 Hispanic or Latin American controls | T | 0.8532 | 1E-70 | 70 | rs429358 | 0.2255 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1665939_H | GCST90476081 | Chronic liver disease and cirrhosis (PheCode 571) | 30,744 European ancestry cases, 401,215 European ancestry controls | T | 0.8594 | 9E-27 | 26.046 | rs429358 | 0.1316 | liver disease (EFO:0001421) |
PMID:39024449 |
GWAS1195829_H | GCST011350 | C-reactive protein levels | 76,081 European ancestry individuals, 127,395 Japanese ancestry individuals | ? | NR | 2E-140 | 139.699 | rs429358 | 0.1672 | C-reactive protein measurement (EFO:0004458) |
PMID:33339817 |
GWAS1666122_H | GCST90479926 | Mixed hyperlipidemia (PheCode 272.13) | 21,139 African American or Afro-Caribbean cases, 91,230 African American or Afro-Caribbean controls, 11,971 Hispanic or Latin American cases, 43,005 Hispanic or Latin American controls, 1,030 East Asian ancestry cases, 5,367 East Asian ancestry controls, 98,406 European ancestry cases, 315,322 European ancestry controls | T | 0.8484 | 1E-69 | 69 | rs429358 | 0.1167 | Hyperlipidemia (HP:0003077) |
PMID:39024449 |
None Available | GCST90479696 | Biological Mother: Diabetes / "Sugar" | 13,594 African American or Afro-Caribbean cases, 41,911 African American or Afro-Caribbean controls, 7,144 Hispanic or Latin American cases, 22,170 Hispanic or Latin American controls, 717 East Asian ancestry cases, 2,830 East Asian ancestry controls, 46,816 European ancestry cases, 268,852 European ancestry controls | T | 0.8537 | 3E-17 | 16.523 | rs429358 | 0.07651 | diabetes mellitus (EFO:0000400) family history (EFO:0000493) |
PMID:39024449 |
None Available | GCST90479700 | Biological Mother: Alzheimer's / Other Dementia | 4,657 African American or Afro-Caribbean cases, 50,848 African American or Afro-Caribbean controls, 2,720 Hispanic or Latin American cases, 26,594 Hispanic or Latin American controls, 263 East Asian ancestry cases, 3,284 East Asian ancestry controls, 37,456 European ancestry cases, 278,212 European ancestry controls | T | 0.8537 | 1E-323 | 323 | rs429358 | 0.4344 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1666466_H | GCST90479717 | Takes medication for Dementia (includes Alzheimer's, Vascular, etc.)? | 465 African American or Afro-Caribbean cases, 55,040 African American or Afro-Caribbean controls, 2,486 European ancestry cases, 313,182 European ancestry controls, 207 Hispanic or Latin American cases, 29,107 Hispanic or Latin American controls | T | 0.8532 | 5E-72 | 71.302 | rs429358 | 0.5671 | drug use measurement (EFO:0007010) |
PMID:39024449 |
GWAS1666467_H | GCST90479718 | Dementia (includes Alzheimer's, Vascular, etc.) | 635 African American or Afro-Caribbean cases, 54,870 African American or Afro-Caribbean controls, 4,040 European ancestry cases, 311,628 European ancestry controls, 325 Hispanic or Latin American cases, 28,989 Hispanic or Latin American controls | T | 0.8532 | 1E-113 | 113 | rs429358 | 0.5755 | PMID:39024449 | |
GWAS1666470_H | GCST90479720 | Takes medication for memory loss or impairment? | 1,229 African American or Afro-Caribbean cases, 54,276 African American or Afro-Caribbean controls, 5,175 European ancestry cases, 310,493 European ancestry controls, 615 Hispanic or Latin American cases, 28,699 Hispanic or Latin American controls | T | 0.8532 | 1E-34 | 34 | rs429358 | 0.2797 | drug use measurement (EFO:0007010) memory impairment (EFO:0001072) |
PMID:39024449 |
GWAS1666471_H | GCST90479721 | Memory loss or impairment | 5,639 African American or Afro-Caribbean cases, 49,866 African American or Afro-Caribbean controls, 3,648 Hispanic or Latin American cases, 25,666 Hispanic or Latin American controls, 286 East Asian ancestry cases, 3,261 East Asian ancestry controls, 31,336 European ancestry cases, 284,332 European ancestry controls | T | 0.8537 | 2E-48 | 47.699 | rs429358 | 0.1548 | memory impairment (EFO:0001072) |
PMID:39024449 |
GWAS1198728_H | GCST011365 | Myocardial infarction | 14,825 European ancestry cases, 44,000 European and unknown ancestry cases, 2,680 cases, 380,970 European ancestry controls, 123,504 European and unknown ancestry controls, 73,242 controls | C | 0.139064 | 4E-22 | 21.398 | rs429358 | 1.11 | myocardial infarction (EFO:0000612) |
PMID:33532862 |
GWAS1199343_H | GCST90011898 | Alanine aminotransferase levels | 390,812 European ancestry individuals | T | 0.84 | 5E-35 | 34.302 | rs429358 | 12.4 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:33547301 |
GWAS1199374_H | GCST90013665 | Alzheimer's disease | 212 European ancestry cases, 333 European ancestry controls | C | 0.2968 | 3E-7 | 6.523 | rs429358 | 2.256 | PMID:33223526 | |
GWAS1199375_H | GCST90013667 | Amyloid status (abnormal vs normal) | 455 European ancestry cases, 416 European ancestry controls | C | 0.2968 | 2E-25 | 24.699 | rs429358 | 5.664 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
GWAS1199621_H | GCST90002400 | Plateletcrit | 408,112 British individuals | C | 0.154526 | 6E-31 | 30.222 | rs429358 | 0.03638729 | platelet crit (EFO:0007985) |
PMID:32888494 |
GWAS1199841_H | GCST90013668 | Central cerebrospinal fluid amyloid beta 42 to 40 ratio (abnormal vs normal) | 418 European ancestry cases, 259 European ancestry controls | C | 0.2968 | 5E-24 | 23.302 | rs429358 | 7.027 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
GWAS1199842_H | GCST90013670 | Amyloid pathology | 890 European ancestry individuals | T | 0.7032 | 4E-33 | 32.398 | rs429358 | 0.573 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
GWAS1199843_H | GCST90013671 | Central cerebrospinal fluid amyloid beta 42 levels | 677 European ancestry individuals | T | 0.7032 | 5E-17 | 16.302 | rs429358 | 0.11 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
GWAS1202303_H | GCST90128558 | Amygdala volume change rate x age interaction (1df) | 15,100 European ancestry individuals | T | 0.839 | 6E-8 | 7.222 | rs429358 | N/A | amygdala volume change measurement (EFO:0021490) age at assessment (EFO:0008007) |
PMID:35383335 |
None Available | GCST90128587 | Total brain volume change rate x age interaction (2df) | 15,100 European ancestry individuals | T | 0.839 | 0.000001 | 6 | rs429358 | N/A | total brain volume change measurement (EFO:0021504) age at assessment (EFO:0008007) |
PMID:35383335 |
GWAS1202849_H | GCST90128573 | Amygdala volume change rate x age interaction (2df) | 15,100 European ancestry individuals | T | 0.839 | 8E-8 | 7.097 | rs429358 | N/A | amygdala volume change measurement (EFO:0021490) age at assessment (EFO:0008007) |
PMID:35383335 |
None Available | GCST90128580 | Hippocampus volume change rate x age interaction (2df) | 15,100 European ancestry individuals | T | 0.8401 | 2E-8 | 7.699 | rs429358 | N/A | hippocampus volume change measurement (EFO:0021492) age at assessment (EFO:0008007) |
PMID:35383335 |
None Available | GCST90128592 | Hippocampus volume change rate x age interaction (2df) | 15,100 European ancestry individuals, 490 Mixed ancestry individuals, 50 South African ancestry individuals | T | 0.8401 | 1E-8 | 8 | rs429358 | N/A | hippocampus volume change measurement (EFO:0021492) age at assessment (EFO:0008007) |
PMID:35383335 |
GWAS1207865_H | GCST90002404 | Red cell distribution width | 408,112 British individuals | C | 0.154472 | 2E-59 | 58.699 | rs429358 | 0.050305303 | Red cell distribution width (EFO:0009188) |
PMID:32888494 |
GWAS1208069_H | GCST90012877 | Alzheimer's disease or family history of Alzheimer's disease | 472,868 European ancestry individuals | ? | NR | 1E-300 | 300 | rs429358 | 1.17924 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:33589840 |
None Available | GCST90002402 | Platelet count | 408,112 British individuals | C | 0.154533 | 4E-21 | 20.398 | rs429358 | 0.029496036 | platelet count (EFO:0004309) |
PMID:32888494 |
GWAS1209586_H | GCST90013674 | Central cerebrospinal fluid amyloid beta 42 to 40 ratio | 677 European ancestry individuals | T | 0.7032 | 6E-32 | 31.222 | rs429358 | 0.105 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
None Available | GCST90012792 | Acceptance of an invitation to participate in a mental health questionnaire | 146,074 European ancestry cases, 148,713 European ancestry controls | T | 0.85 | 1E-20 | 20 | rs429358 | 1.06 | health study participation (EFO:0010130) |
PMID:33563987 |
GWAS731563_H | GCST009441 | Age-related cognitive decline (memory) (slope of z-scores) | 1,145 European ancestry individuals | C | 0.1 | 0.000007 | 5.155 | rs429358 | 0.29 | cognitive decline measurement (EFO:0007710) |
PMID:30954325 |
None Available | GCST006135 | Cortical amyloid beta load | 936 European ancestry individuals | ? | NR | 3E-50 | 49.523 | rs429358 | N/A | cerebral amyloid deposition measurement (EFO:0007707) |
PMID:29860282 |
None Available | GCST006136 | Alzheimer's disease progression score | 944 European ancestry individuals | ? | NR | 4E-33 | 32.398 | rs429358 | N/A | Alzheimer's disease biomarker measurement (EFO:0006514) |
PMID:29860282 |
GWAS1211647_H | GCST007615 | C-reactive protein levels | 148,164 European ancestry individuals | T | 0.85 | 6E-363 | 362.222 | rs429358 | 0.24 | C-reactive protein measurement (EFO:0004458) |
PMID:30388399 |
GWAS1211743_H | GCST006904 | Cerebral amyloid deposition (PET imaging) | 983 European ancestry individuals | C | 0.21 | 9E-30 | 29.046 | rs429358 | 0.18 | cerebral amyloid deposition measurement (EFO:0007707) |
PMID:30361487 |
GWAS732620_H | GCST008740 | Hyperopia | 361 European ancestry cases, 1,700 European ancestry controls | C | NR | 1E-7 | 7 | rs429358 | 1.77 | PMID:30098192 | |
GWAS1212056_H | GCST007615 | C-reactive protein levels | 148,164 European ancestry individuals | T | 0.85 | 4E-328 | 327.398 | rs429358 | 0.247 | C-reactive protein measurement (EFO:0004458) |
PMID:30388399 |
GWAS733778_H | GCST009449 | Parental longevity (mother's age at death or mother's attained age) | up to 699,000 individuals | T | NR | 4E-57 | 56.398 | rs429358 | N/A | parental longevity (EFO:0007796) |
PMID:31484785 |
GWAS1670407_H | GCST90480687 | Biological Sibling: Alzheimer's / Other Dementia | 803 African American or Afro-Caribbean cases, 54,702 African American or Afro-Caribbean controls, 6,960 European ancestry cases, 308,708 European ancestry controls, 461 Hispanic or Latin American cases, 28,853 Hispanic or Latin American controls | T | 0.8532 | 6E-119 | 118.222 | rs429358 | 0.479 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1214120_H | GCST006134 | Hippocampal volume | 926 European ancestry individuals | ? | NR | 1E-10 | 10 | rs429358 | N/A | hippocampal volume (EFO:0005035) |
PMID:29860282 |
GWAS1214212_H | GCST90054782 | Nonalcoholic fatty liver disease | 4,761 European ancestry cases, 373,227 European ancestry controls | C | 0.156 | 3E-13 | 12.523 | rs429358 | 0.82 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:34535985 |
GWAS1214873_H | GCST90087645 | Serum levels of protein CTF1 | 5,329 Icelandic ancestry individuals | C | 0.1528 | 3E-159 | 158.523 | rs429358 | 0.566759 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1671033_H | GCST90475484 | Biological Grandparent (maternal): Alzheimer's / Other Dementia | 20,408 European ancestry cases, 295,260 European ancestry controls | T | 0.8619 | 3E-62 | 61.523 | rs429358 | 0.2366 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:39024449 |
GWAS1215635_H | GCST90089065 | Serum levels of protein SNRPF | 5,356 Icelandic ancestry individuals | C | 0.1528 | 2E-76 | 75.699 | rs429358 | 0.453913 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90475492 | Biological Mother: Diabetes / "Sugar" | 46,816 European ancestry cases, 268,852 European ancestry controls | T | 0.8619 | 2E-19 | 18.699 | rs429358 | 0.09297 | diabetes mellitus (EFO:0000400) family history (EFO:0000493) |
PMID:39024449 |
GWAS1216209_H | GCST90088668 | Serum levels of protein CRP | 5,368 Icelandic ancestry individuals | C | 0.1528 | 2E-23 | 22.699 | rs429358 | 0.268878 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90089007 | Serum levels of protein CPE | 5,339 Icelandic ancestry individuals | C | 0.1528 | 2E-19 | 18.699 | rs429358 | 0.212236 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1217682_H | GCST90088867 | Serum levels of protein MSN | 5,364 Icelandic ancestry individuals | C | 0.1528 | 2E-127 | 126.699 | rs429358 | 0.600298 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90088872 | Serum levels of protein PLA2G7 | 5,366 Icelandic ancestry individuals | C | 0.1528 | 2E-13 | 12.699 | rs429358 | 0.192497 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1680543_H | GCST90089380 | Serum levels of protein C5orf38 | 5,357 Icelandic ancestry individuals | C | 0.1528 | 1E-61 | 61 | rs429358 | 0.432082 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1219083_H | GCST90090174 | Serum levels of protein YWHAE | 5,363 Icelandic ancestry individuals | C | 0.1528 | 5E-57 | 56.302 | rs429358 | 0.419172 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS743791_H | GCST007067 | Waist-hip ratio | approximately 458,000 European ancestry individuals | ? | NR | 4E-18 | 17.398 | rs429358 | N/A | waist-hip ratio (EFO:0004343) |
PMID:30595370 |
GWAS1219895_H | GCST90087352 | Serum levels of protein PSD | 5,348 Icelandic ancestry individuals | C | 0.1528 | 4E-52 | 51.398 | rs429358 | 0.371641 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1220001_H | GCST90086204 | Serum levels of protein BIRC2 | 5,366 Icelandic ancestry individuals | C | 0.1528 | 3E-111 | 110.523 | rs429358 | 0.579285 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1220070_H | GCST90090956 | Serum levels of protein IRF6 | 5,367 Icelandic ancestry individuals | C | 0.1528 | 2E-186 | 185.699 | rs429358 | 0.716266 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1220232_H | GCST90089008 | Serum levels of protein CKAP2 | 5,351 Icelandic ancestry individuals | C | 0.1528 | 4E-24 | 23.398 | rs429358 | 0.254682 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1222871_H | GCST90026487 | Alzheimer's disease | 622 cases, 366 controls | ? | NR | 5E-36 | 35.302 | rs429358 | 4.348 | PMID:34336000 | |
None Available | GCST90044699 | Late-onset Alzheimer's disease | 43,725 European ancestry cases, 46,613 European ancestry proxy cases, 1,036,225 European ancestry controls | ? | NR | 1E-300 | 300 | rs429358 | N/A | late-onset Alzheimers disease (EFO:1001870) |
PMID:34493870 |
GWAS1223957_H | GCST90319532 | High-sensitivity C-reactive protein levels | 9,947 Han Chinese ancestry individuals, 294 individuals | C | NR | 3E-22 | 21.523 | rs429358 | 0.25 | C-reactive protein measurement (EFO:0004458) |
PMID:37479695 |
GWAS1225748_H | GCST012482 | Cerebral amyloid angiopathy in APOEe4 carrier Alzheimer’s disease | 534 European ancestry individuals | C | 0.39 | 9E-16 | 15.046 | rs429358 | 0.32 | cerebral amyloid angiopathy (EFO:0006790) |
PMID:34020725 |
None Available | GCST90480714 | total cholesterol (maximum, inv-norm transformed) | 112,221 African American or Afro-Caribbean individuals, 54,837 Hispanic or Latin American individuals, 6,013 East Asian ancestry individuals, 397,478 European ancestry individuals | T | 0.8472 | 1E-323 | 323 | rs429358 | 0.1427 | total cholesterol measurement (EFO:0004574) |
PMID:39024449 |
None Available | GCST90448447 | Memory decline in normal cognition | 4,950 European ancestry males, 391 African ancestry males | ? | NR | 9E-13 | 12.046 | rs429358 | 0.013374 | memory performance (EFO:0004874) |
PMID:37984853 |
GWAS1226489_H | GCST90095658 | Hippocampal volume | 2,643 Korean ancestry individuals | C | 0.11 | 1E-15 | 15 | rs429358 | 0.3 | hippocampal volume (EFO:0005035) |
PMID:34785643 |
None Available | GCST90095659 | Entorhinal cortical thickness | 2,643 Korean ancestry individuals | C | 0.11 | 1E-9 | 9 | rs429358 | 0.25 | cortical thickness (EFO:0004840) |
PMID:34785643 |
None Available | GCST90095660 | Superior frontal cortical thickness | 2,643 Korean ancestry individuals | C | 0.11 | 1E-8 | 8 | rs429358 | 0.24 | cortical thickness (EFO:0004840) |
PMID:34785643 |
None Available | GCST90480341 | Chronic liver disease and cirrhosis (PheCode 571) | 8,971 African American or Afro-Caribbean cases, 107,387 African American or Afro-Caribbean controls, 6,334 Hispanic or Latin American cases, 50,421 Hispanic or Latin American controls, 515 East Asian ancestry cases, 6,057 East Asian ancestry controls, 30,744 European ancestry cases, 401,215 European ancestry controls | T | 0.8475 | 2E-25 | 24.699 | rs429358 | 0.1085 | liver disease (EFO:0001421) |
PMID:39024449 |
GWAS1227961_H | GCST90448452 | Memory decline in impaired cognition | 4,478 European ancestry males | ? | NR | 1E-17 | 17 | rs429358 | 0.048454 | memory performance (EFO:0004874) |
PMID:37984853 |
GWAS1228035_H | GCST90448456 | Memory decline in normal cognition | 7,839 European ancestry females, 1,384 African ancestry females | ? | NR | 6E-21 | 20.222 | rs429358 | 0.015197 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448451 | Memory decline | 11,062 European ancestry males | ? | NR | 1E-27 | 27 | rs429358 | 0.019976 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448445 | Memory decline | 11,062 European ancestry males, 880 African ancestry males | ? | NR | 2E-26 | 25.699 | rs429358 | 0.018969 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448453 | Memory decline in normal cognition | 4,950 European ancestry males | ? | NR | 2E-13 | 12.699 | rs429358 | 0.01405 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448454 | Memory decline | 13,154 European ancestry females, 2,487 African ancestry females | ? | NR | 6E-35 | 34.222 | rs429358 | 0.019133 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90480202 | Abdominal aortic aneurysm (PheCode 442.11) | 1,773 African American or Afro-Caribbean cases, 118,830 African American or Afro-Caribbean controls, 16,289 European ancestry cases, 427,111 European ancestry controls, 729 Hispanic or Latin American cases, 58,657 Hispanic or Latin American controls | T | 0.8473 | 2E-21 | 20.699 | rs429358 | 0.1494 | Abdominal Aortic Aneurysm (EFO:0004214) |
PMID:39024449 |
GWAS1232059_H | GCST90161240 | Hip fracture | 11,516 European ancestry cases, 723,838 European ancestry controls | C | 0.17 | 4E-11 | 10.398 | rs429358 | 1.14 | hip fracture (EFO:0003964) |
PMID:36260985 |
GWAS1232943_H | GCST90244976 | 1-stearoyl-GPE (18:0) levels | 14,296 European ancestry individuals | T | 0.8452 | 8E-19 | 18.097 | rs429358 | 0.12185323 | 1-stearoyl-GPE (18:0) measurement (EFO:0800227) |
PMID:36357675 |
None Available | GCST90239729 | Brain morphology (MOSTest) | 33,735 white British ancestry individuals | ? | NR | 1E-9 | 9 | rs429358 | N/A | neuroimaging measurement (EFO:0004346) |
PMID:35164939 |
None Available | GCST90244950 | 1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels | 14,296 European ancestry individuals | T | 0.845 | 7E-19 | 18.155 | rs429358 | 0.12448824 | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement (EFO:0800396) |
PMID:36357675 |
None Available | GCST90480195 | Cerebrovascular disease (PheCode 433) | 16,858 African American or Afro-Caribbean cases, 97,523 African American or Afro-Caribbean controls, 6,375 Hispanic or Latin American cases, 50,360 Hispanic or Latin American controls, 488 East Asian ancestry cases, 6,144 East Asian ancestry controls, 69,894 European ancestry cases, 349,486 European ancestry controls | T | 0.8481 | 1E-11 | 11 | rs429358 | 0.05338 | cerebrovascular disorder (EFO:0003763) |
PMID:39024449 |
GWAS1234384_H | GCST90244654 | High density lipoprotein cholesterol levels | 29,502 European ancestry individuals, 16,983 Black individuals, 13,943 Hispanic individuals, 4,719 Asian ancestry individuals, 1,182 Samoan ancestry individuals | ? | NR | 8E-40 | 39.097 | rs429358 | 1.6491529 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:36220816 |
GWAS1676702_H | GCST90480732 | Dementia with cerebral degenerations (PheCode 290.12) | 241 African American or Afro-Caribbean cases, 121,442 African American or Afro-Caribbean controls, 1,830 European ancestry cases, 448,078 European ancestry controls | T | 0.8437 | 8E-37 | 36.097 | rs429358 | 0.4998 | PMID:39024449 | |
None Available | GCST90480733 | Vascular dementia (PheCode 290.16) | 1,530 African American or Afro-Caribbean cases, 119,510 African American or Afro-Caribbean controls, 4,533 European ancestry cases, 443,622 European ancestry controls, 536 Hispanic or Latin American cases, 59,026 Hispanic or Latin American controls | T | 0.8477 | 8E-118 | 117.097 | rs429358 | 0.5135 | PMID:39024449 | |
GWAS1676722_H | GCST90480735 | Delirium due to conditions classified elsewhere (PheCode 290.2) | 1,406 African American or Afro-Caribbean cases, 118,362 African American or Afro-Caribbean controls, 5,690 European ancestry cases, 438,267 European ancestry controls, 609 Hispanic or Latin American cases, 58,407 Hispanic or Latin American controls | T | 0.8476 | 8E-24 | 23.097 | rs429358 | 0.2199 | delirium (EFO:0009267) |
PMID:39024449 |
None Available | GCST90480736 | Other persistent mental disorders due to conditions classified elsewhere (PheCode 290.3) | 4,638 African American or Afro-Caribbean cases, 114,329 African American or Afro-Caribbean controls, 2,652 Hispanic or Latin American cases, 55,675 Hispanic or Latin American controls, 213 East Asian ancestry cases, 6,474 East Asian ancestry controls, 18,183 European ancestry cases, 422,062 European ancestry controls | T | 0.8482 | 4E-56 | 55.398 | rs429358 | 0.1952 | mental or behavioural disorder (EFO:0000677) |
PMID:39024449 |
None Available | GCST90480737 | Delirium dementia and amnestic and other cognitive disorders (PheCode 290) | 8,216 African American or Afro-Caribbean cases, 108,456 African American or Afro-Caribbean controls, 3,319 Hispanic or Latin American cases, 54,404 Hispanic or Latin American controls, 202 East Asian ancestry cases, 6,530 East Asian ancestry controls, 33,956 European ancestry cases, 397,556 European ancestry controls | T | 0.8482 | 1E-300 | 300 | rs429358 | 0.3632 | PMID:39024449 | |
None Available | GCST90480729 | What is your weight? (pounds, inv-normal transformed) | 52,481 African American or Afro-Caribbean individuals, 27,471 Hispanic or Latin American individuals, 3,165 East Asian ancestry individuals, 288,216 European ancestry individuals | T | 0.8531 | 4E-12 | 11.398 | rs429358 | 0.03345 | body weight (EFO:0004338) |
PMID:39024449 |
GWAS1235947_H | GCST90270129 | Parkinson’s disease progression to dementia | 3,923 European ancestry individuals | C | NR | 2E-15 | 14.699 | rs429358 | 2.41 | disease progression measurement (EFO:0008336) |
PMID:36348503 |
GWAS1676948_H | GCST90480742 | Mild cognitive impairment (PheCode 292.2) | 4,130 African American or Afro-Caribbean cases, 114,830 African American or Afro-Caribbean controls, 2,289 Hispanic or Latin American cases, 55,878 Hispanic or Latin American controls, 221 East Asian ancestry cases, 6,476 East Asian ancestry controls, 18,233 European ancestry cases, 420,369 European ancestry controls | T | 0.8486 | 2E-131 | 130.699 | rs429358 | 0.2993 | Cognitive impairment (HP:0100543) |
PMID:39024449 |
GWAS1676949_H | GCST90480743 | Memory loss (PheCode 292.3) | 2,939 African American or Afro-Caribbean cases, 115,581 African American or Afro-Caribbean controls, 14,942 European ancestry cases, 420,923 European ancestry controls, 1,973 Hispanic or Latin American cases, 55,873 Hispanic or Latin American controls | T | 0.848 | 4E-73 | 72.398 | rs429358 | 0.2502 | amnesia (EFO:1001454) |
PMID:39024449 |
GWAS1676950_H | GCST90480744 | Altered mental status (PheCode 292.4) | 4,047 African American or Afro-Caribbean cases, 112,927 African American or Afro-Caribbean controls, 14,396 European ancestry cases, 419,075 European ancestry controls, 1,622 Hispanic or Latin American cases, 56,281 Hispanic or Latin American controls | T | 0.8479 | 3E-37 | 36.523 | rs429358 | 0.1783 | mental or behavioural disorder (EFO:0000677) |
PMID:39024449 |
GWAS1677044_H | GCST90480747 | Neurological disorders (PheCode 292) | 15,108 African American or Afro-Caribbean cases, 97,035 African American or Afro-Caribbean controls, 7,866 Hispanic or Latin American cases, 47,201 Hispanic or Latin American controls, 618 East Asian ancestry cases, 5,831 East Asian ancestry controls, 58,508 European ancestry cases, 357,691 European ancestry controls | T | 0.8486 | 3E-148 | 147.523 | rs429358 | 0.1947 | nervous system disease (EFO:0000618) |
PMID:39024449 |
None Available | GCST90102753 | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels | 8,809 European ancestry individuals | C | NR | 4E-11 | 10.398 | rs429358 | 0.137 | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement (EFO:0800402) |
PMID:35050183 |
GWAS1237072_H | GCST90085710 | Apo E plasma levels | 400 French ancestry individuals | T | NR | 4E-9 | 8.398 | rs429358 | 0.233 | apolipoprotein E measurement (EFO:0008029) |
PMID:35264221 |
None Available | GCST90244565 | Body mass index (aged 64-69 years) | 85,009 European ancestry individuals | ? | NR | 2E-14 | 13.699 | rs429358 | 0.2246 | body mass index (EFO:0004340) |
PMID:36276968 |
None Available | GCST90244566 | Body fat percentage (aged 64-69 years) | 83,345 European ancestry individuals | C | NR | 1E-15 | 15 | rs429358 | 0.325 | body fat percentage (EFO:0007800) |
PMID:36276968 |
GWAS1237475_H | GCST90244567 | Waist-hip ratio (aged 64-69 years) | 85,152 European ancestry individuals | C | NR | 4E-15 | 14.398 | rs429358 | 0.0035 | waist-hip ratio (EFO:0004343) |
PMID:36276968 |
None Available | GCST90480731 | Alzheimer's disease (PheCode 290.11) | 801 African American or Afro-Caribbean cases, 120,641 African American or Afro-Caribbean controls, 4,713 European ancestry cases, 444,093 European ancestry controls, 441 Hispanic or Latin American cases, 59,228 Hispanic or Latin American controls | T | 0.8477 | 1E-323 | 323 | rs429358 | 0.9221 | PMID:39024449 | |
GWAS1680668_H | GCST90480728 | Weight (minimum, inv-normal transformed) | 119,286 African American or Afro-Caribbean individuals, 57,954 Hispanic or Latin American individuals, 6,419 East Asian ancestry individuals, 425,537 European ancestry individuals | T | 0.8472 | 1E-19 | 19 | rs429358 | 0.03656 | body weight (EFO:0004338) |
PMID:39024449 |
GWAS1074293_H | GCST002531 | Cerebrospinal AB1-42 levels in Alzheimer's disease dementia | 363 European ancestry individuals | ? | 0.442 | 4E-17 | 16.398 | rs429358 | 0.4 | beta-amyloid 1-42 measurement (EFO:0004670) |
PMID:25027320 |
GWAS1238476_H | GCST90134519 | HDL cholesterol levels | 58,701 Korean ancestry individuals | C | NR | 1E-46 | 46 | rs429358 | 1.78 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:35884923 |
GWAS1239618_H | GCST90267352 | Liver proton density fat fraction | 33,235 European ancestry individuals | C | 0.16 | 2E-29 | 28.699 | rs429358 | 11.26 | liver fat measurement (EFO:0010821) |
PMID:36402844 |
GWAS1240694_H | GCST90179150 | Body mass index (MTAG) | 694,649 European ancestry individuals | T | NR | 3E-36 | 35.523 | rs429358 | 0.035985 | body mass index (EFO:0004340) |
PMID:36376304 |
None Available | GCST90179147 | High-density lipoprotein levels (MTAG) | 361,194 European ancestry individuals | T | NR | 2E-19 | 18.699 | rs429358 | 0.03274 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:36376304 |
GWAS1074472_H | GCST000900 | Alzheimer's disease biomarkers | 96 European ancestry Alzheimer disease cases, 176 European ancestry individuals with mild cognitive impairment, 102 European ancestry controls | ? | NR | 0.000001 | 6 | rs429358 | N/A | p-tau measurement (EFO:0004763) beta-amyloid 1-42 measurement (EFO:0004670) t-tau measurement (EFO:0004760) |
PMID:21123754 |
None Available | GCST90480206 | Other aneurysm (PheCode 442) | 3,536 African American or Afro-Caribbean cases, 116,104 African American or Afro-Caribbean controls, 24,982 European ancestry cases, 414,741 European ancestry controls, 1,386 Hispanic or Latin American cases, 57,666 Hispanic or Latin American controls | T | 0.8474 | 9E-16 | 15.046 | rs429358 | 0.1022 | aneurysm (EFO:0009659) |
PMID:39024449 |
GWAS1243676_H | GCST90267367 | Body composition (MOSTest) | 33,588 European ancestry individuals | ? | NR | 7E-31 | 30.155 | rs429358 | 11.56 | body composition measurement (EFO:0005106) |
PMID:36402844 |
GWAS1244074_H | GCST90250902 | Medication use for hyperlipidemia (number of purchases) | 567,671 European ancestry individuals | ? | NR | 1E-308 | 308 | rs429358 | 0.070676 | antihyperlipidemic drug use measurement (EFO:0803367) |
PMID:36653479 |
GWAS1245088_H | GCST90092865 | Phospholipids to total lipids ratio in large LDL | 115,082 European ancestry individuals | T | 0.845176 | 5E-54 | 53.302 | rs429358 | 0.0883229 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipids:total lipids ratio (EFO:0020946) |
PMID:35213538 |
None Available | GCST000573 | Brain imaging | 175 European ancestry Alzheimer cases, 354 European ancestry amnestic mild cognitive impairment cases, 204 European ancestry controls | ? | NR | 1E-7 | 7 | rs429358 | N/A | neuroimaging measurement (EFO:0004346) |
PMID:20100581 |
None Available | GCST000573 | Brain imaging | 175 European ancestry Alzheimer cases, 354 European ancestry amnestic mild cognitive impairment cases, 204 European ancestry controls | ? | NR | 1E-9 | 9 | rs429358 | N/A | neuroimaging measurement (EFO:0004346) |
PMID:20100581 |
GWAS1246072_H | GCST90092866 | Triglyceride levels in large LDL | 115,082 European ancestry individuals | T | 0.845176 | 3E-58 | 57.523 | rs429358 | 0.09009 | triglyceride measurement (EFO:0004530) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:35213538 |
GWAS1248179_H | GCST90308733 | Cognitive domain scores for memory | 60,296 European ancestry individuals | ? | NR | 3E-374 | 373.523 | rs429358 | N/A | memory performance (EFO:0004874) |
PMID:37349795 |
GWAS1248181_H | GCST90308734 | Cognitive domain scores for memory | 43,500 European ancestry individuals | ? | NR | 4E-51 | 50.398 | rs429358 | N/A | memory performance (EFO:0004874) |
PMID:37349795 |
GWAS1248618_H | GCST90308740 | Cognitive domain scores for executive function | 43,500 European ancestry individuals | ? | NR | 7E-20 | 19.155 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:37349795 |
GWAS1248650_H | GCST90308736 | Cognitive domain scores for language | 60,296 European ancestry individuals | ? | NR | 4E-206 | 205.398 | rs429358 | N/A | language measurement (EFO:0007797) |
PMID:37349795 |
GWAS1248652_H | GCST90308732 | Cognitive domain scores for memory | 103,796 European ancestry individuals | ? | NR | 8E-321 | 320.097 | rs429358 | N/A | memory performance (EFO:0004874) |
PMID:37349795 |
GWAS1248659_H | GCST90308737 | Cognitive domain scores for language | 43,500 European ancestry individuals | ? | NR | 3E-16 | 15.523 | rs429358 | N/A | language measurement (EFO:0007797) |
PMID:37349795 |
GWAS1248662_H | GCST90308738 | Cognitive domain scores for executive function | 103,796 European ancestry individuals | ? | NR | 9E-145 | 144.046 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:37349795 |
GWAS1248663_H | GCST90308739 | Cognitive domain scores for executive function | 60,296 European ancestry individuals | ? | NR | 2E-170 | 169.699 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:37349795 |
GWAS1248664_H | GCST90308735 | Cognitive domain scores for language | 103,796 European ancestry individuals | ? | NR | 3E-158 | 157.523 | rs429358 | N/A | language measurement (EFO:0007797) |
PMID:37349795 |
GWAS1248744_H | GCST90092890 | Triglyceride levels in LDL | 115,082 European ancestry individuals | T | 0.845176 | 1E-57 | 57 | rs429358 | 0.0894871 | triglyceride measurement (EFO:0004530) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:35213538 |
GWAS1249936_H | GCST90092894 | Cholesteryl ester levels in medium HDL | 115,082 European ancestry individuals | T | 0.845176 | 2E-50 | 49.699 | rs429358 | 0.0789013 | cholesteryl ester measurement (EFO:0010351) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:35213538 |
None Available | GCST009367 | HDL cholesterol levels x short total sleep time interaction (2df test) | 3,007 African American short sleepers, 369 Chinese ancestry short sleepers, 114 Asian ancestry short sleepers, at least 8,474 European ancestry short sleepers, 1,082 Hispanic/Latino short sleepers, up to 11,901 African American controls, 1,444 Chinese ancestry controls, 452 Asian ancestry controls, at least 31,567 European ancestry controls, 4,047 Hispanic/Latino controls | ? | NR | 4E-37 | 36.398 | rs429358 | 0.0204 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:31719535 |
GWAS1250921_H | GCST90276157 | Alzheimer's disease and Lewy body co-pathology | 1,072 European ancestry postmortem cases, 1,263 European ancestry postmortem controls | C | 0.271 | 1E-52 | 52 | rs429358 | 4.24 | Lewy body dementia (EFO:0006792) |
PMID:37700353 |
GWAS1250923_H | GCST90276158 | Alzheimer's disease pathology | 2,492 European ancestry postmortem cases, 1,263 European ancestry postmortem controls | C | 0.271 | 1E-69 | 69 | rs429358 | 4.22 | PMID:37700353 | |
None Available | GCST90092914 | Triglyceride levels in medium LDL | 115,082 European ancestry individuals | T | 0.845176 | 1E-64 | 64 | rs429358 | 0.0946684 | triglyceride measurement (EFO:0004530) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:35213538 |
None Available | GCST90092811 | 3-Hydroxybutyrate levels | 113,594 European ancestry individuals | T | 0.845115 | 2E-23 | 22.699 | rs429358 | 0.0564519 | 3-hydroxybutyrate measurement (EFO:0010982) |
PMID:35213538 |
GWAS1258191_H | GCST90093287 | Alzheimer's disease (age of onset) | 10,216 European ancestry individuals | ? | NR | 4E-497 | 496.398 | rs429358 | 3.32 | age at onset (EFO:0004847) |
PMID:33637690 |
GWAS809391_H | GCST001868 | Alzheimer's disease biomarkers | 555 European ancestry individuals | C | 0.28 | 5E-14 | 13.302 | rs429358 | N/A | amyloid-beta measurement (EFO:0005194) |
PMID:23419831 |
None Available | GCST90018793 | Angina pectoris | 30,025 European ancestry cases, 440,906 European ancestry controls, 14,007 East Asian ancestry cases, 145,158 East Asian ancestry controls | C | NR | 1E-16 | 16 | rs429358 | 0.0937 | angina pectoris (EFO:0003913) |
PMID:34594039 |
None Available | GCST90451696 | Alzheimer's disease | 345 Puerto Rican cases, 303 Puerto Rican controls | C | 0.13 | 1E-7 | 7 | rs429358 | 2.19 | PMID:39295643 | |
GWAS1262746_H | GCST90018943 | Alanine aminotransferase levels | 344,136 European ancestry individuals, 150,545 East Asian ancestry individuals | C | NR | 4E-40 | 39.398 | rs429358 | 0.0359 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:34594039 |
GWAS1263102_H | GCST90092892 | Cholesterol levels in medium HDL | 115,082 European ancestry individuals | T | 0.845176 | 2E-45 | 44.699 | rs429358 | 0.0744857 | total cholesterol measurement (EFO:0004574) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:35213538 |
GWAS1263871_H | GCST90302108 | Free cholesterol in small VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 3E-95 | 94.523 | rs429358 | 0.1129 | free cholesterol in small VLDL measurement (EFO:0022272) |
PMID:38448586 |
GWAS1264267_H | GCST90302110 | Total lipids in small VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 4E-96 | 95.398 | rs429358 | 0.1139 | total lipids in small VLDL (EFO:0022148) |
PMID:38448586 |
GWAS1264313_H | GCST90018730 | C-reactive protein | 83,025 East Asian ancestry individuals | C | 0.10215 | 2E-53 | 52.699 | rs429358 | 0.120771 | C-reactive protein measurement (EFO:0004458) |
PMID:34594039 |
GWAS1682953_H | GCST011100 | Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis) | at least 837,415 European ancestry individuals | T | 0.8533 | 1E-126 | 126 | rs429358 | N/A | healthspan (EFO:0009762) parental longevity (EFO:0007796) |
PMID:32678081 |
None Available | GCST90020027 | Waist-hip index | 219,872 British ancestry women | C | NR | 4E-11 | 10.398 | rs429358 | 0.0257463 | BMI-adjusted waist-hip ratio (EFO:0007788) |
PMID:34021172 |
GWAS1265315_H | GCST90018736 | HDL cholesterol | 74,970 East Asian ancestry individuals | C | 0.102979 | 3E-30 | 29.523 | rs429358 | 0.0899756 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34594039 |
GWAS1683257_H | GCST90302122 | Valine levels | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 9E-10 | 9.046 | rs429358 | 0.0349 | valine measurement (EFO:0009792) |
PMID:38448586 |
GWAS1266251_H | GCST90247157 | Cysteine-rich protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 4E-26 | 25.398 | rs429358 | 0.198 | protein measurement (EFO:0004747) |
PMID:34648354 |
None Available | GCST90302120 | Tyrosine levels | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 2E-11 | 10.699 | rs429358 | 0.038 | tyrosine measurement (EFO:0005058) |
PMID:38448586 |
GWAS1267291_H | GCST90302118 | Total fatty acids | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 2E-123 | 122.699 | rs429358 | 0.1307 | fatty acid measurement (EFO:0005110) |
PMID:38448586 |
None Available | GCST90246878 | Carboxypeptidase E levels | 10,708 European ancestry individuals | T | 0.85 | 9E-25 | 24.046 | rs429358 | 0.199 | carboxypeptidase e measurement (EFO:0020234) |
PMID:34648354 |
GWAS1267499_H | GCST90179151 | Cigarettes smoked per day (MTAG) | 337,334 European ancestry individuals | T | NR | 1E-18 | 18 | rs429358 | 0.031518 | cigarettes per day measurement (EFO:0006525) |
PMID:36376304 |
GWAS1267614_H | GCST90250187 | Vacuolar protein sorting-associated protein 29 levels | 10,708 European ancestry individuals | T | 0.85 | 7E-176 | 175.155 | rs429358 | 0.517 | vacuolar protein sorting-associated protein 29 measurement (EFO:0802207) |
PMID:34648354 |
None Available | GCST90247196 | CUB and zona pellucida-like domain-containing protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 6E-35 | 34.222 | rs429358 | 0.238 | CUB and zona pellucida-like domain-containing protein 1 measurement (EFO:0803309) |
PMID:34648354 |
GWAS1268189_H | GCST90248753 | Nucleosome-remodeling factor subunit BPTF levels | 10,708 European ancestry individuals | T | 0.85 | 6E-49 | 48.222 | rs429358 | 0.281 | protein measurement (EFO:0004747) |
PMID:34648354 |
GWAS1268318_H | GCST90247243 | DCN1-like protein 5 levels | 10,708 European ancestry individuals | T | 0.85 | 2E-441 | 440.699 | rs429358 | 0.787 | DCN1-like protein 5 measurement (EFO:0801520) |
PMID:34648354 |
GWAS1268405_H | GCST90247951 | Heparan sulfate glucosamine 3-O-sulfotransferase 5 levels | 10,708 European ancestry individuals | T | 0.85 | 2E-12 | 11.699 | rs429358 | 0.128 | protein measurement (EFO:0004747) |
PMID:34648354 |
GWAS1268682_H | GCST90248334 | Leucine-rich repeat neuronal protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 8E-1394 | 1393.097 | rs429358 | 1.217 | leucine-rich repeat neuronal protein 1 measurement (EFO:0801760) |
PMID:34648354 |
GWAS1268767_H | GCST90249308 | Regulator of G-protein signaling 7 levels | 10,708 European ancestry individuals | T | 0.85 | 2E-16 | 15.699 | rs429358 | 0.158 | protein measurement (EFO:0004747) |
PMID:34648354 |
None Available | GCST90002397 | Mean spheric corpuscular volume | 408,112 British individuals | C | 0.154528 | 2E-46 | 45.699 | rs429358 | 0.044340204 | PMID:32888494 | |
GWAS1268944_H | GCST90275066 | C-reactive protein levels | 47,258 Korean ancestry individuals | C | 0.096 | 4E-125 | 124.398 | rs429358 | 0.321 | C-reactive protein measurement (EFO:0004458) |
PMID:36996866 |
GWAS1269063_H | GCST90247165 | C-reactive protein levels | 10,708 European ancestry individuals | T | 0.85 | 4E-32 | 31.398 | rs429358 | 0.225 | C-reactive protein measurement (EFO:0004458) |
PMID:34648354 |
None Available | GCST90264174 | Intelligence | 223,731 British ancestry individuals | ? | NR | 4E-18 | 17.398 | rs429358 | N/A | intelligence (EFO:0004337) |
PMID:36378351 |
GWAS1271415_H | GCST90269506 | Triglycerides in LDL (UKB data field 23409) | 88,329 European ancestry individuals | C | 0.155555 | 9E-51 | 50.046 | rs429358 | 0.096245 | triglycerides in LDL measurement (EFO:0022320) |
PMID:36764567 |
None Available | GCST90301972 | Mean diameter of HDL particles | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 7E-31 | 30.155 | rs429358 | 0.0645 | PMID:38448586 | |
GWAS1272049_H | GCST90267627 | Alzheimer's disease, proxy Alzheimer's disease or related dementias | 6,796 African American cases, 4,385 African American maternal cases, 2,256 African American paternal cases, 69,627 African American controls | T | NR | 6E-150 | 149.222 | rs429358 | N/A | family history of Alzheimer’s disease (EFO:0009268) |
PMID:36543923 |
None Available | GCST90302030 | Triglycerides to total lipids ratio in large VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8423 | 2E-21 | 20.699 | rs429358 | 0.0559 | triglycerides:total lipids ratio (EFO:0020947) |
PMID:38448586 |
GWAS1272756_H | GCST90246545 | Apolipoprotein B levels | 10,708 European ancestry individuals | T | 0.85 | 2E-78 | 77.699 | rs429358 | 0.351 | apolipoprotein B measurement (EFO:0004615) |
PMID:34648354 |
None Available | GCST90246572 | ADP-ribosylation factor-like protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 4E-17 | 16.398 | rs429358 | 0.151 | ADP-ribosylation factor-like protein 1 measurement (EFO:0801354) |
PMID:34648354 |
GWAS1273828_H | GCST90249978 | tRNA (guanine-N(7)-)-methyltransferase levels | 10,708 European ancestry individuals | T | 0.85 | 3E-75 | 74.523 | rs429358 | 0.342 | tRNA (guanine-N(7)-)-methyltransferase measurement (EFO:0802162) |
PMID:34648354 |
GWAS1274108_H | GCST90249920 | Transmembrane and coiled-coil domains protein 3 levels | 10,708 European ancestry individuals | T | 0.85 | 1E-181 | 181 | rs429358 | 0.527 | protein measurement (EFO:0004747) |
PMID:34648354 |
None Available | GCST010988 | Adult body size | 453,169 European ancestry individuals | T | 0.845733 | 3E-17 | 16.523 | rs429358 | 0.0160691 | PMID:32376654 | |
GWAS1274520_H | GCST90250009 | Tumor protein p53-inducible protein 11 levels | 10,708 European ancestry individuals | T | 0.85 | 2E-228 | 227.699 | rs429358 | 0.582 | tumor protein p53-inducible protein 11 measurement (EFO:0802169) |
PMID:34648354 |
GWAS1274607_H | GCST90248138 | Integral membrane protein 2B levels | 10,708 European ancestry individuals | T | 0.85 | 8E-16 | 15.097 | rs429358 | 0.151 | integral membrane protein 2B measurement (EFO:0802634) |
PMID:34648354 |
None Available | GCST90248651 | Neutrophil collagenase levels | 10,708 European ancestry individuals | T | 0.85 | 1E-62 | 62 | rs429358 | 0.319 | neutrophil collagenase measurement (EFO:0008248) |
PMID:34648354 |
GWAS1275283_H | GCST90248017 | Inactive gamma-glutamyltranspeptidase 2 levels | 10,708 European ancestry individuals | T | 0.85 | 4E-225 | 224.398 | rs429358 | 0.577 | inactive gamma-glutamyltranspeptidase 2 measurement (EFO:0801692) |
PMID:34648354 |
None Available | GCST90100220 | Estimated glomerular filtration rate (creatinine) | 1,205,871 European ancestry individuals, 168,300 East Asian ancestry individuals, 63,553 African ancestry individuals, 23,509 Hispanic or Latin American individuals, 22,103 African American individuals, 21,791 Central Asian or South Asian ancestry individuals, 1,502 Middle Eastern ancestry individuals, 939 other admixed ancestry individuals, 602 Native American ancestry individuals, 150 Asian ancestry individuals, 339 individuals | C | 0.152 | 2E-18 | 17.699 | rs429358 | 8.776 | PMID:35710981 | |
GWAS1276480_H | GCST90274865 | Obstructive sleep apnea | 23,651 black cases, 84,817 black controls, 1,720 Asian ancestry cases, 6,361 Asian ancestry controls, 117,496 European ancestry cases, 635,463 European ancestry controls, 11,056 Hispanic or Latin American cases, 34,840 Hispanic or Latin American controls, 130 cases, 1,162 controls | ? | 0.192886 | 5E-11 | 10.302 | rs429358 | 0.959817 | obstructive sleep apnea (EFO:0003918) |
PMID:36989840 |
GWAS1276719_H | GCST90249769 | Tubulin-specific chaperone A levels | 10,708 European ancestry individuals | T | 0.85 | 2E-1609 | 1608.699 | rs429358 | 1.256 | tubulin-specific chaperone A measurement (EFO:0802166) |
PMID:34648354 |
None Available | GCST90249737 | Surfeit locus protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 1E-18 | 18 | rs429358 | 0.169 | surfeit locus protein 1 measurement (EFO:0802105) |
PMID:34648354 |
None Available | GCST90248843 | Platelet-activating factor acetylhydrolase levels | 10,708 European ancestry individuals | T | 0.85 | 1E-64 | 64 | rs429358 | 0.319 | protein measurement (EFO:0004747) |
PMID:34648354 |
GWAS1277539_H | GCST90248673 | Neurofilament light polypeptide levels | 10,708 European ancestry individuals | T | 0.85 | 2E-1534 | 1533.699 | rs429358 | 1.251 | protein measurement (EFO:0004747) |
PMID:34648354 |
GWAS1278313_H | GCST90249151 | Pregnancy-specific beta-1-glycoprotein 5 levels | 10,708 European ancestry individuals | T | 0.85 | 1E-112 | 112 | rs429358 | 0.422 | pregnancy-specific beta-1-glycoprotein 5 measurement (EFO:0801908) |
PMID:34648354 |
GWAS1278442_H | GCST90269571 | 3-hydroxybutyrate levels (UKB data field 23474) | 87,151 European ancestry individuals | C | 0.155644 | 4E-19 | 18.398 | rs429358 | 0.0584598 | 3-hydroxybutyrate measurement (EFO:0010982) |
PMID:36764567 |
GWAS1278544_H | GCST90249141 | PH and SEC7 domain-containing protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 6E-20 | 19.222 | rs429358 | 0.173 | PH and SEC7 domain-containing protein 1 measurement (EFO:0803302) |
PMID:34648354 |
None Available | GCST90269711 | Phospholipids to total lipids in large LDL percentage (UKB data field 23614) | 88,329 European ancestry individuals | C | 0.155555 | 2E-42 | 41.699 | rs429358 | 0.0888502 | phospholipids:total lipids ratio (EFO:0020946) |
PMID:36764567 |
None Available | GCST90018979 | Serum creatinine levels | 344,104 European ancestry individuals, 150,266 East Asian ancestry individuals | C | NR | 5E-28 | 27.302 | rs429358 | 0.0256 | PMID:34594039 | |
GWAS1280224_H | GCST90269689 | Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592) | 88,321 European ancestry individuals | C | 0.155563 | 1E-59 | 59 | rs429358 | 0.105862 | free cholesterol to total lipids in large VLDL percentage (EFO:0022281) |
PMID:36764567 |
GWAS1280632_H | GCST90269690 | Triglycerides to total lipids in large VLDL percentage (UKB data field 23593) | 88,321 European ancestry individuals | C | 0.155563 | 2E-33 | 32.699 | rs429358 | 0.0784912 | triglycerides to total lipids in large VLDL percentage (EFO:0022332) |
PMID:36764567 |
None Available | GCST90269640 | Triglycerides in medium LDL (UKB data field 23543) | 88,329 European ancestry individuals | C | 0.155555 | 5E-57 | 56.302 | rs429358 | 0.10196 | triglycerides in medium LDL measurement (EFO:0022322) |
PMID:36764567 |
None Available | GCST90269633 | Triglycerides in large LDL (UKB data field 23536) | 88,329 European ancestry individuals | C | 0.155555 | 2E-50 | 49.699 | rs429358 | 0.0960259 | triglycerides in large LDL measurement (EFO:0022319) |
PMID:36764567 |
None Available | GCST90269666 | Cholesteryl esters in medium HDL (UKB data field 23569) | 88,329 European ancestry individuals | C | 0.155555 | 4E-43 | 42.398 | rs429358 | 0.0835073 | cholesteryl ester measurement (EFO:0010351) |
PMID:36764567 |
GWAS1282729_H | GCST90269681 | Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584) | 87,620 European ancestry individuals | C | 0.155872 | 7E-66 | 65.155 | rs429358 | 0.111748 | phospholipids:total lipids ratio (EFO:0020946) |
PMID:36764567 |
GWAS1284571_H | GCST90269665 | Cholesterol in medium HDL (UKB data field 23568) | 88,329 European ancestry individuals | C | 0.155555 | 9E-39 | 38.046 | rs429358 | 0.0787552 | cholesterol in medium HDL measurement (EFO:0021903) |
PMID:36764567 |
GWAS1683865_H | GCST90271622 | Nonalcoholic fatty liver disease | 691,479 European ancestry, African American or Afro-Caribbean, East Asian ancestry, Hispanic or Latin American, South Asian ancestry individuals | T | 0.85 | 4E-34 | 33.398 | rs429358 | 12.18 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:37709864 |
None Available | GCST90267908 | Left hippocampal volume | 65,791 European ancestry, East Asian ancestry individuals | C | 0.092637 | 1E-10 | 10 | rs429358 | 0.0507656 | hippocampal volume (EFO:0005035) |
PMID:37337106 |
None Available | GCST90244370 | Sterol ester (27:1/14:0) levels | 4,642 European ancestry women | C | NR | 1E-9 | 9 | rs429358 | 0.1696 | level of Sterol ester (27:1/14:0) in blood serum (OBA:2045188) |
PMID:36193934 |
None Available | GCST90244376 | Sterol ester (27:1/18:0) levels | 4,642 European ancestry women | C | NR | 2E-8 | 7.699 | rs429358 | 0.1578 | level of Sterol ester (27:1/18:0) in blood serum (OBA:2045196) |
PMID:36193934 |
GWAS1287961_H | GCST90267930 | Right hippocampal volume | 65,791 European ancestry, East Asian ancestry individuals | C | 0.092637 | 6E-9 | 8.222 | rs429358 | 0.0461954 | hippocampal volume (EFO:0005035) |
PMID:37337106 |
GWAS1288298_H | GCST90271929 | Nonalcoholic fatty liver disease | 2,757 European ancestry cases, 460,161 European ancestry controls | ? | NR | 5E-8 | 7.302 | rs429358 | N/A | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:36986172 |
GWAS1288751_H | GCST90448434 | Baseline memory in impaired cognition | 3,987 European ancestry females | ? | NR | 1E-19 | 19 | rs429358 | 0.325115 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90270902 | Cognitive performance (memory) (longitudinal) | 3,042 European ancestry individuals aged 65 years or older | C | 0.1073 | 6E-9 | 8.222 | rs429358 | 0.2252 | memory performance (EFO:0004874) |
PMID:37089073 |
None Available | GCST90271817 | Serum Tau-C levels | 4,968 Danish ancestry individuals | ? | NR | 2E-11 | 10.699 | rs429358 | 0.12 | p-tau measurement (EFO:0004763) |
PMID:37357295 |
GWAS1290641_H | GCST90275041 | Nonalcoholic fatty liver disease | 6,623 European ancestry cases, 26,318 European ancestry controls | C | NR | 6E-16 | 15.222 | rs429358 | 0.88 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:37235137 |
None Available | GCST90448433 | Baseline memory | 13,154 European ancestry females | ? | NR | 7E-20 | 19.155 | rs429358 | 0.134697 | memory performance (EFO:0004874) |
PMID:37984853 |
GWAS1290786_H | GCST90275047 | Nonalcoholic fatty liver disease in overweight individuals (25<=BMI<=30) | 3,069 European ancestry cases, 10,641 European ancestry controls | C | NR | 1E-11 | 11 | rs429358 | 0.76 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:37235137 |
None Available | GCST90103635 | Estimated glomerular filtration rate (cystatin c) | 460,826 European or unknown ancestry individuals | T | 0.8456 | 3E-18 | 17.523 | rs429358 | 0.0056 | PMID:34272381 | |
None Available | GCST90270905 | Cognitive performance (global cognitive function) (longitudinal) | 3,013 European ancestry individuals aged 65 years or older | C | 0.1074 | 2E-8 | 7.699 | rs429358 | 0.2189 | cognitive function measurement (EFO:0008354) |
PMID:37089073 |
GWAS1292347_H | GCST90278635 | High density lipoprotein cholesterol levels | 92,615 Taiwanese ancestry individuals | ? | NR | 6E-56 | 55.222 | rs429358 | N/A | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38116116 |
None Available | GCST90448425 | Baseline memory in impaired cognition | 4,478 European ancestry males | ? | NR | 5E-11 | 10.302 | rs429358 | 0.206475 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448424 | Baseline memory | 11,062 European ancestry males | ? | NR | 6E-14 | 13.222 | rs429358 | 0.131 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90103633 | Estimated glomerular filtration rate (creatinine) | 1,004,040 European ancestry individuals, 165,726 East Asian ancestry individuals, 13,842 African American individuals, 13,359 South Asian ancestry individuals, 4,961 Hispanic individuals, 2 individuals | T | 0.845375880615863 | 7E-26 | 25.155 | rs429358 | 0.0029 | PMID:34272381 | |
None Available | GCST90448418 | Baseline memory | 11,062 European ancestry males, 880 African ancestry males | ? | NR | 2E-14 | 13.699 | rs429358 | 0.129137 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448427 | Baseline memory | 13,154 European ancestry females, 2,487 African ancestry females | ? | NR | 4E-20 | 19.398 | rs429358 | 0.123151 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST012419 | Longevity (100 years and older) | 1,320 European ancestry cases, 2,899 European ancestry controls | C | 0.138 | 3E-28 | 27.523 | rs429358 | 11.02543 | PMID:33948810 | |
GWAS1296690_H | GCST90428121 | Whole body fat mass (UKB data field 23100) | 337,196 European ancestry individuals | C | NR | 5E-10 | 9.302 | rs429358 | 0.0203752 | obsolete_fat body mass (EFO:0005409) |
PMID:38538606 |
GWAS1297513_H | GCST90448462 | Memory decline in normal cognition | 7,839 European ancestry females | ? | NR | 3E-20 | 19.523 | rs429358 | 0.015817 | memory performance (EFO:0004874) |
PMID:37984853 |
GWAS1298024_H | GCST90448460 | Memory decline | 13,154 European ancestry females | ? | NR | 6E-33 | 32.222 | rs429358 | 0.019882 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90000618 | Serum 25-Hydroxyvitamin D levels | 496,946 European ancestry individuals | ? | NR | 1E-15 | 15 | rs429358 | 0.0232636 | vitamin D measurement (EFO:0004631) |
PMID:32242144 |
None Available | GCST011622 | Serum type 1 collagen metabolite levels | 4,891 Danish ancestry individuals | C | 0.16 | 1E-17 | 17 | rs429358 | 0.1619 | PMID:33134509 | |
GWAS1308129_H | GCST007881 | Dementia with Lewy bodies | 720 European ancestry cases, 6,490 European ancestry controls | ? | NR | 6E-17 | 16.222 | rs429358 | 2.28 | Lewy body dementia (EFO:0006792) |
PMID:31065058 |
GWAS1309603_H | GCST006611 | HDL cholesterol | 215,551 European ancestry individuals, 57,332 African American individuals, 24,743 Hispanic individuals | T | 0.8416 | 1E-142 | 142 | rs429358 | 0.093 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:30275531 |
None Available | GCST90011296 | Executive function (trail making test B) | 78,547 British ancestry individuals | ? | NR | 2E-13 | 12.699 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:32895543 |
None Available | GCST90011297 | Information processing speed (symbol digit substitution) | 87,741 British ancestry individuals | ? | NR | 2E-18 | 17.699 | rs429358 | N/A | information processing speed (EFO:0004363) |
PMID:32895543 |
GWAS1310957_H | GCST007600 | Alzheimer's disease | 952 European ancestry male cases, 1,789 European ancestry female cases, 6,337 European ancestry male controls, 8,402 European ancestry female controls | ? | NR | 2E-91 | 90.699 | rs429358 | 3.9972339 | PMID:30636644 | |
None Available | GCST007600 | Alzheimer's disease | 952 European ancestry male cases, 1,789 European ancestry female cases, 6,337 European ancestry male controls, 8,402 European ancestry female controls | ? | NR | 3E-31 | 30.523 | rs429358 | 3.8628085 | PMID:30636644 | |
None Available | GCST90165317 | Node-level brain connectivity (multivariate analysis) | 30,810 British ancestry individuals | T | 0.847988 | 9E-10 | 9.046 | rs429358 | 6.1278005 | PMID:36800424 | |
GWAS1314132_H | GCST007600 | Alzheimer's disease | 952 European ancestry male cases, 1,789 European ancestry female cases, 6,337 European ancestry male controls, 8,402 European ancestry female controls | ? | NR | 1E-53 | 53 | rs429358 | 3.921738 | PMID:30636644 | |
GWAS1314466_H | GCST90091671 | Postprandial IDL particle concentration | null | C | 0.162286109 | 3E-23 | 22.523 | rs429358 | 0.285903 | intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091655 | Postprandial esterified cholesterol | null | C | 0.16245049 | 5E-19 | 18.302 | rs429358 | 0.258516 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091589 | Fasting saturated fatty acids | null | C | 0.161711477 | 1E-12 | 12 | rs429358 | 0.197394 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
None Available | GCST90091595 | Fasting phospholipid levels in small HDL | null | C | 0.161366928 | 2E-13 | 12.699 | rs429358 | 0.203946 | phospholipid measurement (EFO:0004639) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091568 | Fasting total cholesterol in medium LDL | null | C | 0.161622913 | 2E-26 | 25.699 | rs429358 | 0.29323 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091569 | Fasting cholesterol esters in medium LDL | null | C | 0.161622913 | 4E-26 | 25.398 | rs429358 | 0.291486 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091573 | Fasting phospholipid levels in medium LDL | null | C | 0.161622913 | 2E-28 | 27.699 | rs429358 | 0.305241 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091574 | Fasting triglycerides levels in medium LDL | null | C | 0.161622913 | 1E-11 | 11 | rs429358 | 0.18747 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
GWAS1315965_H | GCST90091767 | Postprandial triglycerides levels in very large HDL | null | C | 0.161841572 | 6E-12 | 11.222 | rs429358 | 0.203111 | triglyceride measurement (EFO:0004530) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091575 | Fasting monounsaturated fatty acids (16:1, 18:1) | null | C | 0.161676923 | 5E-13 | 12.302 | rs429358 | 0.201189 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
GWAS1316184_H | GCST90091570 | Fasting free cholesterol in medium LDL | null | C | 0.161622913 | 4E-27 | 26.398 | rs429358 | 0.297518 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
GWAS1316186_H | GCST90091571 | Fasting total lipids in medium LDL | null | C | 0.161622913 | 9E-27 | 26.046 | rs429358 | 0.295396 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
GWAS1316191_H | GCST90091658 | Postprandial omega-6 fatty acids | null | C | 0.162416939 | 5E-18 | 17.302 | rs429358 | 0.250807 | omega-6 polyunsaturated fatty acid measurement (EFO:0005680) |
PMID:34610981 |
None Available | GCST90091572 | Fasting medium LDL particle concentration | null | C | 0.161622913 | 9E-27 | 26.046 | rs429358 | 0.295573 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091585 | Fasting polyunsaturated fatty acids | null | C | 0.161647532 | 3E-20 | 19.523 | rs429358 | 0.255085 | polyunsaturated fatty acid measurement (EFO:0010733) |
PMID:34610981 |
None Available | GCST90091586 | Fasting remnant cholesterol | null | C | 0.161731728 | 2E-24 | 23.699 | rs429358 | 0.281063 | remnant cholesterol measurement (EFO:0010815) |
PMID:34610981 |
None Available | GCST90091587 | Fasting serum total cholesterol | null | C | 0.161731728 | 4E-21 | 20.398 | rs429358 | 0.260759 | total cholesterol measurement (EFO:0004574) |
PMID:34610981 |
None Available | GCST90091672 | Postprandial phospholipid levels in IDL | null | C | 0.162360792 | 2E-19 | 18.699 | rs429358 | 0.259683 | phospholipid measurement (EFO:0004639) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091673 | Postprandial triglycerides levels in IDL | null | C | 0.162360792 | 2E-12 | 11.699 | rs429358 | 0.203331 | triglyceride measurement (EFO:0004530) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091675 | Postprandial linoleic acid (18:2) | null | C | 0.162416939 | 2E-18 | 17.699 | rs429358 | 0.254613 | linoleic acid measurement (EFO:0006807) |
PMID:34610981 |
None Available | GCST90091676 | Postprandial total cholesterol in LDL | null | C | 0.162286109 | 3E-24 | 23.523 | rs429358 | 0.291885 | total cholesterol measurement (EFO:0004574) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091678 | Postprandial triglycerides in LDL | null | C | 0.162286109 | 4E-11 | 10.398 | rs429358 | 0.19086 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
GWAS1317310_H | GCST90091668 | Postprandial cholesterol esters in IDL | null | C | 0.162360792 | 1E-25 | 25 | rs429358 | 0.300889 | esterified cholesterol measurement (EFO:0008589) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
GWAS1317312_H | GCST90091659 | Postprandial free cholesterol | null | C | 0.162419911 | 5E-16 | 15.302 | rs429358 | 0.23526 | free cholesterol measurement (EFO:0008591) |
PMID:34610981 |
None Available | GCST90091667 | Postprandial total cholesterol in IDL | null | C | 0.162360792 | 2E-23 | 22.699 | rs429358 | 0.287255 | intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
GWAS1317765_H | GCST90091687 | Postprandial total cholesterol in large LDL | null | C | 0.162286109 | 6E-24 | 23.222 | rs429358 | 0.290593 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091669 | Postprandial free cholesterol in IDL | null | C | 0.162360792 | 4E-17 | 16.398 | rs429358 | 0.242738 | free cholesterol measurement (EFO:0008591) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
GWAS1317770_H | GCST90091670 | Postprandial total lipids in IDL | null | C | 0.162286109 | 6E-23 | 22.222 | rs429358 | 0.283672 | lipid measurement (EFO:0004529) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
GWAS1318399_H | GCST90091600 | Fasting total lipids in small LDL | null | C | 0.161585113 | 7E-27 | 26.155 | rs429358 | 0.296182 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
GWAS1318401_H | GCST90091601 | Fasting small LDL particle concentration | null | C | 0.161585113 | 5E-27 | 26.302 | rs429358 | 0.296908 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091602 | Fasting phospholipid levels in small LDL | null | C | 0.161585113 | 4E-26 | 25.398 | rs429358 | 0.291909 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091613 | Fasting total fatty acids | null | C | 0.161537304 | 4E-17 | 16.398 | rs429358 | 0.23343 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
None Available | GCST90091552 | Fasting phospholipid levels in large LDL | null | C | 0.161731728 | 4E-24 | 23.398 | rs429358 | 0.279787 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091553 | Fasting triglycerides levels in large LDL | null | C | 0.161731728 | 1E-12 | 12 | rs429358 | 0.195889 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091547 | Fasting total cholesterol in large LDL | null | C | 0.161731728 | 5E-25 | 24.302 | rs429358 | 0.285202 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091735 | Postprandial phospholipid levels in small HDL | null | C | 0.162158672 | 6E-17 | 16.222 | rs429358 | 0.241174 | phospholipid measurement (EFO:0004639) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
GWAS1319220_H | GCST90091597 | Fasting total cholesterol in small LDL | null | C | 0.161585113 | 5E-26 | 25.302 | rs429358 | 0.291323 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091598 | Fasting cholesterol esters in small LDL | null | C | 0.161585113 | 1E-25 | 25 | rs429358 | 0.289353 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091599 | Fasting free cholesterol in small LDL | null | C | 0.161585113 | 9E-27 | 26.046 | rs429358 | 0.295596 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
GWAS1319276_H | GCST90091548 | Fasting cholesterol esters in large LDL | null | C | 0.161731728 | 3E-26 | 25.523 | rs429358 | 0.29202 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
GWAS1684883_H | GCST90091549 | Fasting free cholesterol in large LDL | null | C | 0.161731728 | 1E-21 | 21 | rs429358 | 0.264058 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091550 | Fasting total lipids in large LDL | null | C | 0.161731728 | 9E-25 | 24.046 | rs429358 | 0.283473 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
GWAS1319279_H | GCST90091551 | Fasting large LDL particle concentration | null | C | 0.161731728 | 6E-25 | 24.222 | rs429358 | 0.284538 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
GWAS1319283_H | GCST90091737 | Postprandial total cholesterol in small LDL | null | C | 0.162323441 | 1E-23 | 23 | rs429358 | 0.288119 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
GWAS1319285_H | GCST90091725 | Postprandial polyunsaturated fatty acids | null | C | 0.162416939 | 9E-18 | 17.046 | rs429358 | 0.249076 | polyunsaturated fatty acid measurement (EFO:0010733) |
PMID:34610981 |
None Available | GCST90091741 | Postprandial small LDL particle concentration | null | C | 0.162323441 | 3E-24 | 23.523 | rs429358 | 0.29204 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
GWAS1319452_H | GCST90091742 | Postprandial phospholipid levels in small LDL | null | C | 0.162323441 | 1E-22 | 22 | rs429358 | 0.281664 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091743 | Postprandial triglycerides levels in small LDL | null | C | 0.162323441 | 4E-11 | 10.398 | rs429358 | 0.190428 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091738 | Postprandial cholesterol esters in small LDL | null | C | 0.162323441 | 3E-23 | 22.523 | rs429358 | 0.285996 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091739 | Postprandial free cholesterol in small LDL | null | C | 0.162323441 | 4E-24 | 23.398 | rs429358 | 0.291267 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091740 | Postprandial total lipids in small LDL | null | C | 0.162323441 | 3E-24 | 23.523 | rs429358 | 0.292 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091726 | Postprandial remnant cholesterol | null | C | 0.162286109 | 3E-23 | 22.523 | rs429358 | 0.285465 | remnant cholesterol measurement (EFO:0010815) |
PMID:34610981 |
None Available | GCST90091727 | Postprandial serum total cholesterol | null | C | 0.162286109 | 5E-19 | 18.302 | rs429358 | 0.256825 | total cholesterol measurement (EFO:0004574) |
PMID:34610981 |
GWAS1684887_H | GCST90091729 | Postprandial saturated fatty acids | null | C | 0.162437075 | 7E-10 | 9.155 | rs429358 | 0.179498 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
GWAS1320074_H | GCST90091753 | Postprandial total fatty acids | null | C | 0.162371642 | 4E-13 | 12.398 | rs429358 | 0.210999 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
GWAS1320200_H | GCST90091603 | Fasting triglycerides levels in small LDL | null | C | 0.161585113 | 4E-14 | 13.398 | rs429358 | 0.20887 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
GWAS1320409_H | GCST90091508 | Fasting apolipoprotein B | null | C | 0.161731728 | 6E-26 | 25.222 | rs429358 | 0.290338 | apolipoprotein B measurement (EFO:0004615) |
PMID:34610981 |
GWAS1320475_H | GCST90091650 | Postprandial apolipoprotein B | null | C | 0.162286109 | 9E-23 | 22.046 | rs429358 | 0.28278 | apolipoprotein B measurement (EFO:0004615) |
PMID:34610981 |
None Available | GCST90091512 | Fasting esterified cholesterol | null | C | 0.161711832 | 2E-22 | 21.699 | rs429358 | 0.26976 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091627 | Fasting triglycerides levels in very large HDL | null | C | 0.160012675 | 9E-13 | 12.046 | rs429358 | 0.201575 | triglyceride measurement (EFO:0004530) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091703 | Postprandial free cholesterol in medium HDL | null | C | 0.162323441 | 1E-8 | 8 | rs429358 | 0.165019 | free cholesterol measurement (EFO:0008591) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091704 | Postprandial total lipids in medium HDL | null | C | 0.162323441 | 1E-9 | 9 | rs429358 | 0.176055 | lipid measurement (EFO:0004529) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091705 | Postprandial medium HDL particle concentration | null | C | 0.162323441 | 1E-9 | 9 | rs429358 | 0.1758 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
GWAS1321685_H | GCST90091688 | Postprandial cholesterol esters in large LDL | null | C | 0.162286109 | 3E-25 | 24.523 | rs429358 | 0.298956 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091689 | Postprandial free cholesterol in large LDL | null | C | 0.162286109 | 2E-19 | 18.699 | rs429358 | 0.259943 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091690 | Postprandial total lipids in large LDL | null | C | 0.162286109 | 2E-23 | 22.699 | rs429358 | 0.287575 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091708 | Postprandial total cholesterol in medium LDL | null | C | 0.162323441 | 2E-24 | 23.699 | rs429358 | 0.293495 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091709 | Postprandial cholesterol esters in medium LDL | null | C | 0.162323441 | 3E-24 | 23.523 | rs429358 | 0.292372 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
GWAS1321872_H | GCST90091710 | Postprandial free cholesterol in medium LDL | null | C | 0.162323441 | 7E-25 | 24.155 | rs429358 | 0.296131 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST011496 | Abdominal aortic aneurysm | 7,642 European ancestry cases, 172,172 European ancestry controls | C | 0.1401 | 1E-15 | 15 | rs429358 | 1.17 | Abdominal Aortic Aneurysm (EFO:0004214) |
PMID:32981348 |
GWAS1322076_H | GCST90091711 | Postprandial total lipids in medium LDL | null | C | 0.162323441 | 1E-24 | 24 | rs429358 | 0.295134 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091712 | Postprandial medium LDL particle concentration | null | C | 0.162323441 | 2E-24 | 23.699 | rs429358 | 0.294126 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091713 | Postprandial phospholipid levels in medium LDL | null | C | 0.162323441 | 1E-25 | 25 | rs429358 | 0.301564 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
GWAS1322081_H | GCST90091714 | Postprandial triglycerides levels in medium LDL | null | C | 0.162323441 | 5E-9 | 8.302 | rs429358 | 0.169359 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091715 | Postprandial monounsaturated fatty acids (16:1, 18:1) | null | C | 0.162399016 | 6E-9 | 8.222 | rs429358 | 0.16938 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
None Available | GCST007780 | Parkinson's disease (age of onset) | 17,996 cases | ? | NR | 6E-8 | 7.222 | rs429358 | 0.707 | age at onset (EFO:0004847) |
PMID:30957308 |
None Available | GCST90091526 | Fasting total cholesterol in IDL | null | C | 0.161479805 | 2E-24 | 23.699 | rs429358 | 0.281504 | intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
GWAS1685699_H | GCST90092873 | Free cholesterol to total lipids ratio in large VLDL | 115,071 European ancestry individuals | T | 0.84517 | 3E-76 | 75.523 | rs429358 | 0.104559 | free cholesterol:total lipids ratio (EFO:0020945) |
PMID:35213538 |
None Available | GCST90091691 | Postprandial large LDL particle concentration | null | C | 0.162286109 | 1E-23 | 23 | rs429358 | 0.288742 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
GWAS1324356_H | GCST90091692 | Postprandial phospholipid levels in large LDL | null | C | 0.162286109 | 8E-23 | 22.097 | rs429358 | 0.282984 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091693 | Postprandial triglycerides levels in large LDL | null | C | 0.162286109 | 5E-11 | 10.302 | rs429358 | 0.189325 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091701 | Postprandial total cholesterol in medium HDL | null | C | 0.162323441 | 5E-10 | 9.302 | rs429358 | 0.179913 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091702 | Postprandial cholesterol esters in medium HDL | null | C | 0.162323441 | 2E-10 | 9.699 | rs429358 | 0.183513 | esterified cholesterol measurement (EFO:0008589) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90318118 | Cerebrospinal fluid 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) levels | 2,602 European ancestry individuals | T | NR | 3E-11 | 10.523 | rs429358 | 0.0296 | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement (EFO:0800396) |
PMID:39528826 |
None Available | GCST90318123 | Cerebrospinal fluid 1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)* levels | 2,602 European ancestry individuals | T | NR | 4E-11 | 10.398 | rs429358 | 0.0226 | 1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1) measurement (EFO:0022084) |
PMID:39528826 |
GWAS1687246_H | GCST90092879 | Triglycerides to total lipids ratio in large VLDL | 115,071 European ancestry individuals | T | 0.84517 | 1E-43 | 43 | rs429358 | 0.07883 | triglycerides:total lipids ratio (EFO:0020947) |
PMID:35213538 |
None Available | GCST90317929 | Cerebrospinal fluid 1,2-dipalmitoyl-GPC (16:0/16:0) levels | 2,602 European ancestry individuals | T | NR | 3E-11 | 10.523 | rs429358 | 0.024 | 1,2-dipalmitoyl-GPC (16:0/16:0) measurement (EFO:0800189) |
PMID:39528826 |
None Available | GCST90317930 | Cerebrospinal fluid 1-myristoyl-2-palmitoyl-GPC (14:0/16:0) levels | 2,602 European ancestry individuals | T | NR | 1E-13 | 13 | rs429358 | 0.0283 | 1-myristoyl-2-palmitoyl-GPC (14:0/16:0) measurement (EFO:0800191) |
PMID:39528826 |
None Available | GCST90131904 | Whole brain restricted isotropic diffusion (multivariate analysis) | 23,543 European ancestry individuals | ? | NR | 4E-15 | 14.398 | rs429358 | N/A | PMID:35505052 | |
GWAS1330342_H | GCST90089238 | Serum levels of protein PSME1 | 5,352 Icelandic ancestry individuals | C | 0.1528 | 7E-32 | 31.155 | rs429358 | 0.301643 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90131905 | Whole brain restricted directional diffusion (multivariate analysis) | 23,543 European ancestry individuals | ? | NR | 9E-13 | 12.046 | rs429358 | N/A | PMID:35505052 | |
None Available | GCST90090811 | Serum levels of protein NDE1 | 5,363 Icelandic ancestry individuals | C | 0.1528 | 2E-91 | 90.699 | rs429358 | 0.51394 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90131906 | Whole brain free water diffusion (multivariate analysis) | 23,543 European ancestry individuals | ? | NR | 8E-15 | 14.097 | rs429358 | N/A | PMID:35505052 | |
GWAS1331890_H | GCST90087869 | Serum levels of protein RALA | 5,366 Icelandic ancestry individuals | C | 0.1528 | 8E-13 | 12.097 | rs429358 | 0.188585 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90093025 | Phospholipids to total lipids ratio in very large VLDL | 114,160 European ancestry individuals | T | 0.844871 | 1E-76 | 76 | rs429358 | 0.105943 | phospholipids:total lipids ratio (EFO:0020946) |
PMID:35213538 |
None Available | GCST90091061 | Cortical thickness | 35,657 White British ancestry individuals | C | 0.1526 | 5E-10 | 9.302 | rs429358 | N/A | cortical thickness (EFO:0004840) |
PMID:34560273 |
GWAS1333752_H | GCST90088031 | Serum levels of protein AIMP1 | 5,349 Icelandic ancestry individuals | C | 0.1528 | 3E-53 | 52.523 | rs429358 | 0.372704 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90088077 | Serum levels of protein APOB | 5,366 Icelandic ancestry individuals | C | 0.1528 | 3E-24 | 23.523 | rs429358 | 0.271148 | apolipoprotein B measurement (EFO:0004615) |
PMID:35078996 |
GWAS1690205_H | GCST90302164 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 2E-84 | 83.699 | rs429358 | 0.1074 | cholesteryl ester measurement (EFO:0010351) |
PMID:38448586 |
None Available | GCST90020025 | Waist-to-hip ratio adjusted for BMI | 219,872 British ancestry women | C | NR | 2E-11 | 10.699 | rs429358 | 0.0262381 | BMI-adjusted waist-hip ratio (EFO:0007788) |
PMID:34021172 |
GWAS1690749_H | GCST90302123 | Total cholesterol levels in VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 7E-138 | 137.155 | rs429358 | 0.1367 | total cholesterol measurement (EFO:0004574) |
PMID:38448586 |
None Available | GCST90302111 | Concentration of small VLDL particles | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 9E-87 | 86.046 | rs429358 | 0.1083 | PMID:38448586 | |
None Available | GCST90103982 | Low high density lipoprotein cholesterol levels | 20,763 Taiwanese ancestry males | ? | NR | 8E-13 | 12.097 | rs429358 | N/A | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:35238325 |
None Available | GCST90091527 | Fasting cholesterol esters in IDL | null | C | 0.161479805 | 8E-26 | 25.097 | rs429358 | 0.290188 | esterified cholesterol measurement (EFO:0008589) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091528 | Fasting free cholesterol in IDL | null | C | 0.161479805 | 5E-20 | 19.302 | rs429358 | 0.253317 | free cholesterol measurement (EFO:0008591) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091529 | Fasting total lipids in IDL | null | C | 0.161731728 | 6E-23 | 22.222 | rs429358 | 0.272217 | lipid measurement (EFO:0004529) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091530 | Fasting IDL particle concentration | null | C | 0.161731728 | 3E-23 | 22.523 | rs429358 | 0.273934 | intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091536 | Fasting total cholesterol in LDL | null | C | 0.161731728 | 1E-25 | 25 | rs429358 | 0.288192 | total cholesterol measurement (EFO:0004574) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091538 | Fasting triglycerides in LDL | null | C | 0.161731728 | 4E-13 | 12.398 | rs429358 | 0.200855 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091515 | Fasting omega-6 fatty acids | null | C | 0.16165072 | 1E-20 | 20 | rs429358 | 0.257377 | omega-6 polyunsaturated fatty acid measurement (EFO:0005680) |
PMID:34610981 |
None Available | GCST90091516 | Fasting free cholesterol | null | C | 0.161722328 | 9E-18 | 17.046 | rs429358 | 0.237671 | free cholesterol measurement (EFO:0008591) |
PMID:34610981 |
None Available | GCST90091531 | Fasting phospholipid levels in IDL | null | C | 0.161479805 | 4E-21 | 20.398 | rs429358 | 0.260746 | phospholipid measurement (EFO:0004639) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091532 | Fasting triglycerides levels in IDL | null | C | 0.161479805 | 1E-12 | 12 | rs429358 | 0.196548 | triglyceride measurement (EFO:0004530) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091534 | Fasting linoleic acid (18:2) | null | C | 0.161647532 | 3E-22 | 21.523 | rs429358 | 0.268282 | linoleic acid measurement (EFO:0006807) |
PMID:34610981 |
GWAS921858_H | GCST009890 | Parental lifespan | at least 500,193 European ancestry offspring | T | 0.85 | 3E-83 | 82.523 | rs429358 | 1.0561 | parental longevity (EFO:0007796) |
PMID:30642433 |
None Available | GCST90134472 | Alanine aminotransferase levels | 5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals | ? | NR | 2E-24 | 23.699 | rs429358 | N/A | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:35810165 |
None Available | GCST90091605 | Fasting total cholesterol in small VLDL | null | C | 0.161548128 | 4E-18 | 17.398 | rs429358 | 0.240037 | PMID:34610981 | |
GWAS924565_H | GCST011950 | White matter hyperintensity volume (adjusted for hypertension) | 46,055 European ancestry individuals | C | 0.8556 | 0.000003 | 5.523 | rs429358 | 0.0401 | white matter hyperintensity measurement (EFO:0005665) |
PMID:33293549 |
None Available | GCST90091606 | Fasting cholesterol esters in small VLDL | null | C | 0.161548128 | 7E-19 | 18.155 | rs429358 | 0.245388 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091607 | Fasting free cholesterol in small VLDL | null | C | 0.161548128 | 3E-14 | 13.523 | rs429358 | 0.20992 | free cholesterol measurement (EFO:0008591) |
PMID:34610981 |
GWAS1691581_H | GCST90091783 | Postprandial cholesterol esters in chylomicrons and extremely large VLDL | null | C | 0.165453761 | 7E-9 | 8.155 | rs429358 | 0.169466 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091608 | Fasting total lipids in small VLDL | null | C | 0.161548128 | 3E-13 | 12.523 | rs429358 | 0.202751 | lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091609 | Fasting small VLDL particle concentration | null | C | 0.161548128 | 1E-12 | 12 | rs429358 | 0.196494 | PMID:34610981 | |
GWAS1691618_H | GCST90091610 | Fasting phospholipid levels in small VLDL | null | C | 0.161548128 | 9E-12 | 11.046 | rs429358 | 0.189076 | phospholipid measurement (EFO:0004639) |
PMID:34610981 |
GWAS1343049_H | GCST90104611 | Amyloid beta positivity in normal cognition | 175 Korean ancestry individuals | T | NR | 7E-8 | 7.155 | rs429358 | 0.8055 | amyloid-beta measurement (EFO:0005194) |
PMID:35366586 |
GWAS1343050_H | GCST90104612 | Amyloid beta positivity in normal cognition | 196 European ancestry individuals | ? | NR | 4E-7 | 6.398 | rs429358 | N/A | amyloid-beta measurement (EFO:0005194) |
PMID:35366586 |
None Available | GCST90091778 | Postprandial total lipids in very small VLDL | null | C | 0.162323441 | 2E-21 | 20.699 | rs429358 | 0.273218 | lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091639 | Fasting very small VLDL particle concentration | null | C | 0.161800085 | 3E-19 | 18.523 | rs429358 | 0.247981 | PMID:34610981 | |
None Available | GCST90091779 | Postprandial very small VLDL particle concentration | null | C | 0.162323441 | 7E-21 | 20.155 | rs429358 | 0.270037 | PMID:34610981 | |
None Available | GCST90091780 | Postprandial phospholipid levels in very small VLDL | null | C | 0.162323441 | 1E-19 | 19 | rs429358 | 0.26193 | phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091640 | Fasting phospholipid levels in very small VLDL | null | C | 0.161800085 | 2E-18 | 17.699 | rs429358 | 0.241817 | phospholipid measurement (EFO:0004639) |
PMID:34610981 |
GWAS1691723_H | GCST90091618 | Fasting total cholesterol in VLDL | null | C | 0.161731728 | 7E-17 | 16.155 | rs429358 | 0.230802 | total cholesterol measurement (EFO:0004574) |
PMID:34610981 |
None Available | GCST90091576 | Fasting total cholesterol in medium VLDL | null | C | 0.161657082 | 1E-12 | 12 | rs429358 | 0.196782 | PMID:34610981 | |
GWAS1691749_H | GCST90091577 | Fasting cholesterol esters in medium VLDL | null | C | 0.161657082 | 9E-15 | 14.046 | rs429358 | 0.21437 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091716 | Postprandial total cholesterol in medium VLDL | null | C | 0.162286109 | 2E-10 | 9.699 | rs429358 | 0.184361 | PMID:34610981 | |
None Available | GCST90091717 | Postprandial cholesterol esters in medium VLDL | null | C | 0.162286109 | 3E-13 | 12.523 | rs429358 | 0.210906 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091776 | Postprandial cholesterol esters in very small VLDL | null | C | 0.162323441 | 1E-21 | 21 | rs429358 | 0.275209 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091635 | Fasting total cholesterol in very small VLDL | null | C | 0.161800085 | 6E-18 | 17.222 | rs429358 | 0.23843 | PMID:34610981 | |
None Available | GCST90091745 | Postprandial total cholesterol in small VLDL | null | C | 0.162286109 | 1E-16 | 16 | rs429358 | 0.238085 | PMID:34610981 | |
None Available | GCST90091721 | Postprandial phospholipid levels in medium VLDL | null | C | 0.162286109 | 2E-8 | 7.699 | rs429358 | 0.161577 | phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091746 | Postprandial cholesterol esters in small VLDL | null | C | 0.162286109 | 4E-19 | 18.398 | rs429358 | 0.257337 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091777 | Postprandial free cholesterol in very small VLDL | null | C | 0.162323441 | 2E-18 | 17.699 | rs429358 | 0.25234 | free cholesterol measurement (EFO:0008591) |
PMID:34610981 |
GWAS1691818_H | GCST90091636 | Fasting cholesterol esters in very small VLDL | null | C | 0.161800085 | 2E-17 | 16.699 | rs429358 | 0.234638 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091637 | Fasting free cholesterol in very small VLDL | null | C | 0.161800085 | 2E-17 | 16.699 | rs429358 | 0.235239 | free cholesterol measurement (EFO:0008591) |
PMID:34610981 |
GWAS1691825_H | GCST90091747 | Postprandial free cholesterol in small VLDL | null | C | 0.162286109 | 6E-11 | 10.222 | rs429358 | 0.188943 | free cholesterol measurement (EFO:0008591) |
PMID:34610981 |
None Available | GCST90091748 | Postprandial total lipids in small VLDL | null | C | 0.162286109 | 1E-10 | 10 | rs429358 | 0.185288 | lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091749 | Postprandial small VLDL particle concentration | null | C | 0.162286109 | 7E-10 | 9.155 | rs429358 | 0.17839 | PMID:34610981 | |
None Available | GCST90091750 | Postprandial phospholipid levels in small VLDL | null | C | 0.162286109 | 3E-9 | 8.523 | rs429358 | 0.171262 | phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091638 | Fasting total lipids in very small VLDL | null | C | 0.161800085 | 2E-19 | 18.699 | rs429358 | 0.248816 | lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091775 | Postprandial total cholesterol in very small VLDL | null | C | 0.162323441 | 3E-21 | 20.523 | rs429358 | 0.272445 | PMID:34610981 | |
GWAS1691865_H | GCST90091578 | Fasting free cholesterol in medium VLDL | null | C | 0.161657082 | 4E-10 | 9.398 | rs429358 | 0.173567 | free cholesterol measurement (EFO:0008591) |
PMID:34610981 |
GWAS1078272_H | GCST011037 | Parkinson's disease progression (cognitive) | 2,788 individuals | C | 0.14 | 3E-13 | 12.523 | rs429358 | 0.38 | disease progression measurement (EFO:0008336) |
PMID:33111402 |
None Available | GCST011039 | Parkinson's disease progression (composite) | 2,755 individuals | C | 0.14 | 1E-8 | 8 | rs429358 | 0.35 | disease progression measurement (EFO:0008336) |
PMID:33111402 |
None Available | GCST90091579 | Fasting total lipids in medium VLDL | null | C | 0.161657082 | 5E-10 | 9.302 | rs429358 | 0.172049 | lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091580 | Fasting medium VLDL particle concentration | null | C | 0.161657082 | 9E-10 | 9.046 | rs429358 | 0.169589 | PMID:34610981 | |
None Available | GCST90091758 | Postprandial total cholesterol in VLDL | null | C | 0.162286109 | 4E-15 | 14.398 | rs429358 | 0.226902 | total cholesterol measurement (EFO:0004574) |
PMID:34610981 |
None Available | GCST90027237 | Plasma p-tau181 levels | 1,153 European ancestry individuals | ? | NR | 3E-25 | 24.523 | rs429358 | 0.281 | p-tau measurement (EFO:0004763) |
PMID:34119372 |
None Available | GCST90432154 | Basal ganglia structure | 34,794 British ancestry individuals | C | NR | 8E-11 | 10.097 | rs429358 | N/A | PMID:39353893 | |
GWAS1691911_H | GCST90091581 | Fasting phospholipid levels in medium VLDL | null | C | 0.161657082 | 8E-11 | 10.097 | rs429358 | 0.179834 | phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST011941 | Plasma amyloid beta peptide concentrations (ABx-42) | 12,369 European ancestry non-demented individuals | C | 0.134 | 9E-13 | 12.046 | rs429358 | 0.167 | plasma beta-amyloid 1-42 measurement (EFO:0005660) |
PMID:34002480 |
None Available | GCST011943 | Plasma amyloid beta peptide concentration (ABx-40/ABx-42 ratio) | 12,369 European ancestry non-demented individuals | C | 0.134 | 6E-20 | 19.222 | rs429358 | 0.212 | plasma beta-amyloid 1-40:1-42 ratio measurement (EFO:0600016) |
PMID:34002480 |
None Available | GCST90448667 | Lipoprotein-associated phospholipase A2 activity | 511 Asian ancestry individuals, 1,546 Black individuals, 836 Hispanic or Latin American individuals, 7,317 European ancestry individuals | C | 0.1367 | 4E-37 | 36.398 | rs429358 | 0.064 | lipoprotein-associated phospholipase A(2) measurement (EFO:0004746) |
PMID:38747556 |
GWAS1346588_H | GCST90104006 | Familial combined hyperlipidemia defined by Consensus criteria | 39,961 British ancestry cases, 309,261 British ancestry controls | T | 0.844393 | 3E-226 | 225.523 | rs429358 | 0.321864 | PMID:34906840 | |
GWAS1346857_H | GCST90448658 | C-reactive protein levels | 592 Asian ancestry individuals, 8,819 Black individuals, 8,721 Hispanic or Latin American individuals, 20,333 European ancestry individuals | C | 0.1481 | 6E-109 | 108.222 | rs429358 | 0.25 | C-reactive protein measurement (EFO:0004458) |
PMID:38747556 |
GWAS1692054_H | GCST90013405 | Liver enzyme levels (alanine transaminase) | 437,267 European ancestry individuals | T | 0.845488 | 1E-56 | 56 | rs429358 | 0.0085211 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:33972514 |
None Available | GCST90013406 | Liver enzyme levels (alkaline phosphatase) | 437,438 European ancestry individuals | T | 0.845457 | 8E-40 | 39.097 | rs429358 | 0.00415406 | alkaline phosphatase measurement (EFO:0004533) |
PMID:33972514 |
GWAS1350967_H | GCST90038451 | Alzheimer's disease | 4,010 European ancestry cases, 4,672 European ancestry controls | C | 0.226 | 5E-122 | 121.302 | rs429358 | 3.245 | PMID:34122051 | |
GWAS1350976_H | GCST90038452 | Alzheimer's disease | 5,705 European ancestry cases, 7,067 European ancestry controls | C | 0.216 | 2E-215 | 214.699 | rs429358 | 3.655 | PMID:34122051 | |
None Available | GCST90131412 | Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node42) | 34,691 British ancestry individuals | ? | NR | 4E-13 | 12.398 | rs429358 | 0.0721823 | PMID:35393594 | |
None Available | GCST90301368 | Age of onset of ischemic stroke | 10,857 European ancestry individuals | C | 0.16 | 0.000001 | 6 | rs429358 | 0.88 | age of onset of stroke disorder (OBA:2040155) |
PMID:39286457 |
None Available | GCST90301370 | Age of onset of ischemic stroke | 4,679 European ancestry females | C | 0.14 | 2E-11 | 10.699 | rs429358 | 1.29 | age of onset of stroke disorder (OBA:2040155) |
PMID:39286457 |
None Available | GCST90131354 | Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node5) | 34,691 British ancestry individuals | ? | NR | 6E-12 | 11.222 | rs429358 | 0.072033 | PMID:35393594 | |
None Available | GCST90131409 | Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node39) | 34,691 British ancestry individuals | ? | NR | 2E-15 | 14.699 | rs429358 | 0.0794547 | PMID:35393594 | |
GWAS1354021_H | GCST90016673 | Percent liver fat | 32,858 European ancestry individuals | ? | NR | 1E-30 | 30 | rs429358 | 0.123 | liver fat measurement (EFO:0010821) |
PMID:34128465 |
GWAS1357026_H | GCST90449024 | Dementia | 44,009 European ancestry cases, 466,606 European ancestry controls | C | 0.1515 | 7E-305 | 304.155 | rs429358 | 1.1728 | PMID:39046104 | |
None Available | GCST90449025 | Vascular dementia | 3,892 European ancestry cases, 466,606 European ancestry controls | C | 0.1549 | 3E-196 | 195.523 | rs429358 | 0.8794 | PMID:39046104 | |
GWAS1358422_H | GCST90129599 | Cerebrospinal fluid amyloid beta 42 levels | 8,074 European ancestry individuals | C | 0.29 | 1E-379 | 379 | rs429358 | 41.68 | amyloid-beta measurement (EFO:0005194) |
PMID:36066633 |
GWAS1358545_H | GCST90129600 | Cerebrospinal fluid p-tau levels | 7,798 European ancestry individuals | C | 0.28 | 1E-94 | 94 | rs429358 | 20.65 | p-tau measurement (EFO:0004763) |
PMID:36066633 |
GWAS1358547_H | GCST90134628 | Cerebrospinal fluid amyloid beta 42 levels in APOE e4 carriers | 3,240 European ancestry individuals | C | 0.61 | 9E-72 | 71.046 | rs429358 | 17.918 | amyloid-beta measurement (EFO:0005194) |
PMID:36066633 |
GWAS1358548_H | GCST90134629 | Cerebrospinal fluid amyloid beta 42 levels in normal amyloid levels | 3,182 European ancestry individuals | C | 0.17 | 1E-47 | 47 | rs429358 | 14.49 | amyloid-beta measurement (EFO:0005194) |
PMID:36066633 |
None Available | GCST90134633 | Cerebrospinal fluid p-tau levels in normal amyloid levels | 3,174 European ancestry individuals | C | 0.17 | 2E-17 | 16.699 | rs429358 | 8.528 | p-tau measurement (EFO:0004763) |
PMID:36066633 |
None Available | GCST90133316 | Age of onset of parkinson disease | 7,847 European ancestry individuals, 688 East Asian ancestry individuals, 17,415 individuals | T | 0.866 | 0.000001 | 6 | rs429358 | 0.695 | age of onset of Parkinson disease (OBA:2001009) |
PMID:35970579 |
None Available | GCST90094751 | F-dairy liking (derived food-liking factor) | 159,365 European ancestry individuals | C | 0.1487 | 3E-11 | 10.523 | rs429358 | 0.05312 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90277244 | Sterol ester (27:1/18:0) levels | 7,157 Finnish ancestry individuals | C | 0.189202 | 5E-10 | 9.302 | rs429358 | 0.133624 | level of Sterol ester (27:1/18:0) in blood serum (OBA:2045196) |
PMID:37907536 |
None Available | GCST90277238 | Sterol ester (27:1/14:0) levels | 7,174 Finnish ancestry individuals | C | 0.189202 | 4E-11 | 10.398 | rs429358 | 0.141695 | level of Sterol ester (27:1/14:0) in blood serum (OBA:2045188) |
PMID:37907536 |
None Available | GCST90277242 | Sterol ester (27:1/17:0) levels | 7,047 Finnish ancestry individuals | C | 0.189202 | 2E-8 | 7.699 | rs429358 | 0.121765 | level of Sterol ester (27:1/17:0) in blood serum (OBA:2045192) |
PMID:37907536 |
None Available | GCST90277248 | Sterol ester (27:1/20:2) levels | 5,848 Finnish ancestry individuals | C | 0.189202 | 9E-12 | 11.046 | rs429358 | 0.162093 | level of Sterol ester (27:1/20:2) in blood serum (OBA:2045200) |
PMID:37907536 |
None Available | GCST90137939 | Neutrophil collagenase levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 5E-35 | 34.302 | rs429358 | 0.45 | matrix metalloproteinase 8 measurement (EFO:0008466) |
PMID:34814699 |
GWAS1361249_H | GCST90094725 | F-carbohydrate liking (derived food-liking factor) | 159,523 European ancestry individuals | C | 0.1486 | 6E-15 | 14.222 | rs429358 | 0.15209 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90137536 | Apolipoprotein E levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 1E-39 | 39 | rs429358 | 0.45 | apolipoprotein E measurement (EFO:0008029) |
PMID:34814699 |
GWAS1362931_H | GCST90137537 | Apolipoprotein E (isoform E2) levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 5E-43 | 42.302 | rs429358 | 0.47 | apolipoprotein E isoform E2 measurement (EFO:0008028) |
PMID:34814699 |
GWAS1363147_H | GCST90137693 | Apolipoprotein E (isoform E3) levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 1E-34 | 34 | rs429358 | 0.42 | apolipoprotein E (isoform E3) measurement (EFO:0020157) |
PMID:34814699 |
GWAS1363148_H | GCST90137694 | Apolipoprotein E (isoform E4) levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 8E-29 | 28.097 | rs429358 | 0.38 | apolipoprotein E (isoform E4) measurement (EFO:0020158) |
PMID:34814699 |
GWAS1363318_H | GCST90094761 | F-fatty food liking (derived food-liking factor) | 159,481 European ancestry individuals | C | 0.1486 | 8E-9 | 8.097 | rs429358 | 0.02885 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094732 | Chicken liking | 158,559 European ancestry individuals | C | 0.1486 | 4E-8 | 7.398 | rs429358 | 0.02748 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90239651 | High density lipoprotein cholesterol levels | 146,492 East Asian ancestry individuals | C | 0.0933232 | 1E-47 | 47 | rs429358 | 0.114308 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34887591 |
None Available | GCST90094790 | Lamb liking | 158,453 European ancestry individuals | C | 0.1487 | 2E-12 | 11.699 | rs429358 | 0.03535 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094835 | F-savour/caloric food liking (derived food-liking factor) | 158,684 European ancestry individuals | C | 0.1486 | 1E-23 | 23 | rs429358 | 0.16206 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094794 | Liver liking | 158,306 European ancestry individuals | C | 0.1486 | 5E-13 | 12.302 | rs429358 | 0.10338 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
GWAS1365331_H | GCST90094821 | Roast chicken liking | 158,556 European ancestry individuals | C | 0.1486 | 2E-9 | 8.699 | rs429358 | 0.05908 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094819 | Red meat liking | 158,624 European ancestry individuals | C | 0.1486 | 1E-16 | 16 | rs429358 | 0.0415 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094700 | Beef/steak liking | 158,442 European ancestry individuals | C | 0.1486 | 5E-16 | 15.302 | rs429358 | 0.04074 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094836 | F-seafood liking (derived food-liking factor) | 156,740 European ancestry individuals | C | 0.1486 | 6E-9 | 8.222 | rs429358 | 0.08124 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
GWAS1366146_H | GCST90132183 | Type 2 diabetes | 251,740 European ancestry individuals, 139,705 East Asian ancestry individuals, 40,737 South Asian ancestry individuals, 27,417 Hispanic individuals, 30,167 African American individuals, 2,426 Zulu ancestry individuals | T | NR | 7E-14 | 13.155 | rs429358 | 1.06 | PMID:35551307 | |
GWAS1366259_H | GCST90094799 | F-meat liking (derived food-liking factor) | 158,509 European ancestry individuals | C | 0.1486 | 4E-23 | 22.398 | rs429358 | 0.16691 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
GWAS1366327_H | GCST90132184 | Type 2 diabetes | 251,740 European ancestry individuals | T | 0.847 | 3E-15 | 14.523 | rs429358 | 0.072 | PMID:35551307 | |
None Available | GCST90094698 | BBQ/grilled meat liking | 158,387 European ancestry individuals | C | 0.1486 | 5E-19 | 18.302 | rs429358 | 0.04474 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90161481 | Stromelysin-1 levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 1E-15 | 15 | rs429358 | 0.394747 | stromelysin‐1 measurement (EFO:0010608) |
PMID:36168886 |
None Available | GCST90162367 | Apolipoprotein E (isoform E2) levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 1E-30 | 30 | rs429358 | 0.566227 | apolipoprotein E isoform E2 measurement (EFO:0008028) |
PMID:36168886 |
None Available | GCST90161353 | Apolipoprotein E levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 1E-18 | 18 | rs429358 | 0.43479 | apolipoprotein E measurement (EFO:0008029) |
PMID:36168886 |
GWAS1370663_H | GCST90161542 | Apolipoprotein E (isoform E3) levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 8E-20 | 19.097 | rs429358 | 0.448356 | apolipoprotein E (isoform E3) measurement (EFO:0020157) |
PMID:36168886 |
None Available | GCST90161543 | Apolipoprotein E (isoform E4) levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 2E-19 | 18.699 | rs429358 | 0.444119 | apolipoprotein E (isoform E4) measurement (EFO:0020158) |
PMID:36168886 |
None Available | GCST90131903 | Insomnia | 390,751 European ancestry female cases, 1,018,386 European ancestry female controls | T | NR | 6E-9 | 8.222 | rs429358 | 0.01 | insomnia (EFO:0004698) |
PMID:35835914 |
None Available | GCST90032648 | Relative carbohydrate intake | 282,271 European ancestry individuals | T | 0.848 | 2E-8 | 7.699 | rs429358 | 0.1863 | carbohydrate intake measurement (EFO:0010811) |
PMID:34426670 |
GWAS1373430_H | GCST90250832 | Age-related macular degeneration or COVID-19 critical illness (MTAG) | 16,144 European ancestry AMD cases, 5,101 European ancestry COVID-19 critical illness cases, 1,401,064 European ancestry controls | ? | NR | 1E-44 | 44 | rs429358 | 0.17 | age-related macular degeneration (EFO:0001365) |
PMID:36614910 |
GWAS1373859_H | GCST90250833 | Age-related macular degeneration or COVID-19 hospitalization (MTAG) | 16,144 European ancestry AMD cases, 9,986 European ancestry COVID-19 hospitalization cases, 1,895,495 European ancestry controls | ? | NR | 2E-44 | 43.699 | rs429358 | 0.17 | age-related macular degeneration (EFO:0001365) |
PMID:36614910 |
GWAS1079749_H | GCST010417 | Liver fat content (MRI proton density fat fraction measure) | 14,440 European ancestry individuals | T | 0.848199 | 6E-11 | 10.222 | rs429358 | 0.073 | liver fat measurement (EFO:0010821) liver disease biomarker (EFO:0006845) |
PMID:32247823 |
None Available | GCST90250834 | Age-related macular degeneration or COVID-19 infection (MTAG) | 16,144 European ancestry AMD cases, 38,984 European ancestry COVID-19 infection cases, 1,662,607 European ancestry controls | ? | NR | 2E-44 | 43.699 | rs429358 | 0.17 | age-related macular degeneration (EFO:0001365) |
PMID:36614910 |
GWAS1375917_H | GCST90179211 | Phospholipids to total lipids ratio in small LDL | 7,142 European ancestry individuals | T | 0.15 | 5E-33 | 32.302 | rs429358 | 0.27 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipids:total lipids ratio (EFO:0020946) |
PMID:32150548 |
None Available | GCST90301999 | Free cholesterol in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-57 | 56.699 | rs429358 | 0.0892 | free cholesterol in large HDL measurement (EFO:0022157) |
PMID:38448586 |
GWAS1376937_H | GCST90302002 | Concentration of large HDL particles | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-68 | 67.699 | rs429358 | 0.0976 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1376974_H | GCST90301969 | Total cholesterol in HDL2 | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 1E-40 | 40 | rs429358 | 0.0744 | total cholesterol measurement (EFO:0004574) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
None Available | GCST90475229 | creatinine (mean, inv-norm transformed) | 421,411 European ancestry individuals | T | 0.8594 | 2E-20 | 19.699 | rs429358 | 0.03275 | PMID:39024449 | |
None Available | GCST90302001 | Total lipids in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-68 | 67.699 | rs429358 | 0.0975 | total lipids in large HDL (EFO:0022189) |
PMID:38448586 |
None Available | GCST90302003 | Phospholipids in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 3E-64 | 63.523 | rs429358 | 0.0945 | phospholipids in large HDL measurement (EFO:0022190) |
PMID:38448586 |
None Available | GCST90301971 | Total cholesterol levels in HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-28 | 27.699 | rs429358 | 0.0617 | total cholesterol measurement (EFO:0004574) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1378536_H | GCST90302033 | Cholesterol esters in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8434 | 4E-89 | 88.398 | rs429358 | 0.1133 | esterified cholesterol measurement (EFO:0008589) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1378693_H | GCST90448094 | Age-related macular degeneration | 2,123 European ancestry cases, 2,704 European ancestry controls | ? | NR | 9E-26 | 25.046 | rs429358 | 0.513 | age-related macular degeneration (EFO:0001365) |
PMID:37975850 |
None Available | GCST90475232 | creatinine (minimum, inv-norm transformed) | 421,910 European ancestry individuals | T | 0.8594 | 1E-19 | 19 | rs429358 | 0.03245 | PMID:39024449 | |
GWAS1694181_H | GCST90302006 | Triglycerides to total lipids ratio in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8435 | 3E-28 | 27.523 | rs429358 | 0.0613 | triglycerides:total lipids ratio (EFO:0020947) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1379124_H | GCST90302034 | Cholesteryl esters to total lipids ratio in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8434 | 1E-54 | 54 | rs429358 | 0.0866 | cholesteryl esters:total lipids ratio (EFO:0020944) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1379282_H | GCST90302038 | Concentration of medium HDL particles | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-69 | 68.699 | rs429358 | 0.0993 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1379337_H | GCST90018950 | C-reactive protein | 353,466 European ancestry individuals, 83,025 East Asian ancestry individuals | C | NR | 1E-1420 | 1420 | rs429358 | 0.2447 | C-reactive protein measurement (EFO:0004458) |
PMID:34594039 |
GWAS1379449_H | GCST90302039 | Phospholipids in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 3E-63 | 62.523 | rs429358 | 0.0949 | phospholipids in medium HDL measurement (EFO:0022295) |
PMID:38448586 |
GWAS1379619_H | GCST90302012 | Free cholesterol to total lipids ratio in large LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 5E-92 | 91.302 | rs429358 | 0.1139 | low density lipoprotein cholesterol measurement (EFO:0004611) free cholesterol:total lipids ratio (EFO:0020945) |
PMID:38448586 |
GWAS1379816_H | GCST90301985 | Triglycerides in IDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 1E-100 | 100 | rs429358 | 0.1169 | triglycerides in IDL measurement (EFO:0022149) |
PMID:38448586 |
None Available | GCST90302037 | Total lipids in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8433 | 9E-72 | 71.046 | rs429358 | 0.1013 | total lipids in medium HDL measurement (EFO:0022310) |
PMID:38448586 |
GWAS1380110_H | GCST90302031 | Total cholesterol levels in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8434 | 4E-82 | 81.398 | rs429358 | 0.1085 | total cholesterol measurement (EFO:0004574) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1380145_H | GCST90302017 | Triglycerides in large LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 1E-115 | 115 | rs429358 | 0.1256 | triglycerides in large LDL measurement (EFO:0022319) |
PMID:38448586 |
GWAS1380300_H | GCST90018956 | HDL cholesterol | 315,133 European ancestry individuals, 74,970 East Asian ancestry individuals | C | NR | 2E-155 | 154.699 | rs429358 | 0.0773 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34594039 |
GWAS1380476_H | GCST90302032 | Total cholesterol to total lipids ratio in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8434 | 5E-52 | 51.302 | rs429358 | 0.0841 | esterified cholesterol measurement (EFO:0008589) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
None Available | GCST90301993 | Triglyceride levels in LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 2E-123 | 122.699 | rs429358 | 0.13 | triglyceride measurement (EFO:0004530) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:38448586 |
None Available | GCST90475226 | creatinine (maximum, inv-norm transformed) | 420,576 European ancestry individuals | T | 0.8593 | 1E-14 | 14 | rs429358 | 0.02716 | PMID:39024449 | |
GWAS1381065_H | GCST90301995 | Total cholesterol in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 9E-73 | 72.046 | rs429358 | 0.1006 | total cholesterol change measurement (EFO:0007806) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1381186_H | GCST90302035 | Free cholesterol in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 9E-54 | 53.046 | rs429358 | 0.087 | free cholesterol in medium HDL measurement (EFO:0022267) |
PMID:38448586 |
None Available | GCST90302129 | Cholesteryl esters to total lipids ratio in very large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 4E-82 | 81.398 | rs429358 | 0.1068 | cholesteryl esters:total lipids ratio (EFO:0020944) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1381803_H | GCST90302059 | Cholesterol esters in medium VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 1E-105 | 105 | rs429358 | 0.1203 | cholesterol esters in medium VLDL measurement (EFO:0022182) |
PMID:38448586 |
GWAS1381839_H | GCST90302040 | Phospholipids to total lipids ratio in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 3E-52 | 51.523 | rs429358 | 0.0832 | phospholipids:total lipids ratio (EFO:0020946) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1382984_H | GCST90301948 | 3-Hydroxybutyrate levels | 11,340 South Asian ancestry individuals, 72,076 European ancestry individuals | T | 0.8425 | 9E-20 | 19.046 | rs429358 | 0.0652 | 3-hydroxybutyrate measurement (EFO:0010982) |
PMID:38448586 |
GWAS1383259_H | GCST90302053 | Triglycerides in medium LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 3E-124 | 123.523 | rs429358 | 0.1305 | triglycerides in medium LDL measurement (EFO:0022322) |
PMID:38448586 |
GWAS1383901_H | GCST90302077 | Saturated fatty acids | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 5E-87 | 86.302 | rs429358 | 0.1096 | saturated fatty acids measurement (EFO:0022304) |
PMID:38448586 |
GWAS1383962_H | GCST90301997 | Cholesterol esters in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-77 | 76.699 | rs429358 | 0.1039 | cholesterol esters in large HDL measurement (EFO:0022159) |
PMID:38448586 |
GWAS1384087_H | GCST90302135 | Phospholipids to total lipids ratio in very large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-97 | 96.699 | rs429358 | 0.1168 | phospholipids:total lipids ratio (EFO:0020946) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
None Available | GCST90446655 | Fall | 20,789 European ancestry cases, 180,658 European ancestry controls | C | NR | 4E-9 | 8.398 | rs429358 | 0.085 | fall (EFO:0009631) |
PMID:37945700 |
None Available | GCST90302101 | Triglycerides in small LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 2E-127 | 126.699 | rs429358 | 0.1325 | triglycerides in small LDL measurement (EFO:0022323) |
PMID:38448586 |
GWAS1384642_H | GCST90302055 | Monounsaturated fatty acids (16:1, 18:1) levels | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 2E-73 | 72.699 | rs429358 | 0.1004 | fatty acid measurement (EFO:0005110) |
PMID:38448586 |
GWAS1384728_H | GCST90302104 | Total cholesterol in small VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 2E-148 | 147.699 | rs429358 | 0.1412 | total cholesterol in small VLDL (EFO:0022171) |
PMID:38448586 |
None Available | GCST90444489 | Metabolic syndrome | 10,684 Korean ancestry cases, 51,630 Korean ancestry controls | ? | NR | 1E-14 | 14 | rs429358 | 0.190901 | metabolic syndrome (EFO:0000195) |
PMID:39349817 |
None Available | GCST90446533 | Angina | 25,257 European ancestry cases, 433,881 European ancestry controls | ? | NR | 2E-16 | 15.699 | rs429358 | N/A | angina pectoris (EFO:0003913) |
PMID:37947095 |
None Available | GCST90446535 | Cardiovascular disease | 44,238 European ancestry cases, 414,900 European ancestry controls | ? | NR | 3E-19 | 18.523 | rs429358 | N/A | cardiovascular disease (EFO:0000319) |
PMID:37947095 |
GWAS1385326_H | GCST90302078 | Ratio of saturated fatty acids to total fatty acids | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 8E-30 | 29.097 | rs429358 | 0.0636 | fatty acid measurement (EFO:0005110) |
PMID:38448586 |
GWAS1385523_H | GCST90302127 | Total cholesterol to total lipids ratio in very large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8433 | 1E-97 | 97 | rs429358 | 0.1169 | cholesterol:total lipids ratio (EFO:0020943) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1385778_H | GCST90302136 | Triglycerides in very large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 3E-41 | 40.523 | rs429358 | 0.0739 | triglycerides in very large HDL measurement (EFO:0022324) |
PMID:38448586 |
None Available | GCST90297542 | Plasma neurofilament light levels | 2,380 European ancestry individuals | ? | NR | 8E-10 | 9.097 | rs429358 | 0.184 | PMID:37208024 | |
None Available | GCST90448615 | HDL cholesterol levels | 38,000 South Asian ancestry individuals | C | NR | 2E-50 | 49.699 | rs429358 | 0.169 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39414775 |
None Available | GCST90448604 | C-reactive protein levels | 38,000 South Asian ancestry individuals | C | NR | 1E-39 | 39 | rs429358 | 0.187 | C-reactive protein measurement (EFO:0004458) |
PMID:39414775 |
None Available | GCST90309350 | Coronary artery disease (confirmatory factor analysis Factor 16) | 360,021 European ancestry individuals | ? | NR | 4E-43 | 42.398 | rs429358 | N/A | coronary artery disease (EFO:0001645) |
PMID:38965376 |
None Available | GCST90309364 | Inflammatory markers and poor diet (confirmatory factor analysis Factor 30) | 337,045 European ancestry individuals | ? | NR | 2E-18 | 17.699 | rs429358 | N/A | inflammatory biomarker measurement (EFO:0004872) diet measurement (EFO:0008111) |
PMID:38965376 |
None Available | GCST90309357 | Physical activity (confirmatory factor analysis Factor 23) | 354,112 European ancestry individuals | ? | NR | 4E-9 | 8.398 | rs429358 | N/A | physical activity measurement (EFO:0008002) |
PMID:38965376 |
GWAS1390718_H | GCST90451698 | Type 2 diabetes mellitus or coronary artery disease (pleiotropy) | 74,124 European ancestry type 2 diabetes cases, 181,522 European ancestry coronary artery disease cases, 1,808,174 European ancestry controls | ? | NR | 6E-65 | 64.222 | rs429358 | N/A | coronary artery disease (EFO:0001645) |
PMID:38062574 |
None Available | GCST90100667 | Apolipoprotein E (isoform E2) levels | 997 European ancestry individuals | ? | NR | 2E-12 | 11.699 | rs429358 | N/A | apolipoprotein E isoform E2 measurement (EFO:0008028) |
PMID:28240269 |
GWAS1694587_H | GCST90503209 | High-sensitivity C-reactive protein levels | 71,019 Korean ancestry individuals | C | 0.0955 | 7E-194 | 193.155 | rs429358 | 0.224 | C-reactive protein measurement (EFO:0004458) |
PMID:39747571 |
None Available | GCST90244568 | Waist circumference (aged 64-69 years) | 85,157 European ancestry individuals | ? | NR | 1E-16 | 16 | rs429358 | 0.635 | PMID:36276968 | |
None Available | GCST90244569 | Hip circumference (aged 64-69 years) | 85,156 European ancestry individuals | ? | NR | 4E-8 | 7.398 | rs429358 | 0.3191 | PMID:36276968 | |
None Available | GCST90448696 | Breakthrough COVID-19 severity after at least one dose of a COVID-19 vaccine | 3,860 European ancestry cases, 70,802 European ancestry controls | C | 0.15 | 1E-8 | 8 | rs429358 | 1.21 | response to COVID-19 vaccine (EFO:0803362) |
PMID:39384777 |
GWAS1392229_H | GCST90024164 | Lysophosphatidylcholine (20:0) [sn2] levels | 4,492 European ancestry individuals | C | NR | 0.000008 | 5.097 | rs429358 | 0.14 | lysophosphatidylcholine 20:0 measurement (EFO:0021456) |
PMID:35668104 |
GWAS1392231_H | GCST90024165 | Lysophosphatidylcholine (20:1) [sn1] levels | 4,492 European ancestry individuals | C | NR | 0.000006 | 5.222 | rs429358 | 0.143 | lysophosphatidylcholine 20:1 measurement (EFO:0021457) |
PMID:35668104 |
GWAS1392504_H | GCST90024526 | Sulfatide (d18:1/24:0(OH) levels) levels | 4,492 European ancestry individuals | C | NR | 9E-7 | 6.046 | rs429358 | 0.151 | ceramide measurement (EFO:0010222) |
PMID:35668104 |
GWAS1393633_H | GCST90025404 | Lysophosphatidylcholine (20:1) [sn1] levels | 4,492 European ancestry individuals | C | NR | 9E-9 | 8.046 | rs429358 | 0.182 | lysophosphatidylcholine 20:1 measurement (EFO:0021457) |
PMID:35668104 |
GWAS1393916_H | GCST90241762 | Leucine-rich repeat neuronal protein 1 levels (LRRN1.11293.14.3) | 3,301 European ancestry individuals | C | 0.153 | 3E-418 | 417.523 | rs429358 | 1.18 | leucine-rich repeat neuronal protein 1 measurement (EFO:0801760) |
PMID:29875488 |
None Available | GCST90025292 | Ceramide (d18:2/20:0) levels | 4,492 European ancestry individuals | C | NR | 9E-9 | 8.046 | rs429358 | 0.182 | ceramide measurement (EFO:0010222) |
PMID:35668104 |
GWAS1394569_H | GCST90240603 | Cardiotrophin-1 levels (CTF1.13732.79.3) | 3,301 European ancestry individuals | C | 0.153 | 4E-148 | 147.398 | rs429358 | 0.8 | cardiotrophin-1 measurement (EFO:0020235) |
PMID:29875488 |
None Available | GCST90249595 | Small nuclear ribonucleoprotein F levels | 10,708 European ancestry individuals | T | 0.85 | 9E-109 | 108.046 | rs429358 | 0.416 | PMID:34648354 | |
None Available | GCST90025200 | Total Lysophosphatidylethanolamine levels | 6,057 European ancestry individuals | C | NR | 2E-14 | 13.699 | rs429358 | N/A | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS1694827_H | GCST90240886 | Deoxycytidine kinase levels (DCK.9836.20.3) | 3,301 European ancestry individuals | C | 0.153 | 7E-21 | 20.155 | rs429358 | 0.31 | deoxycytidine kinase measurement (EFO:0801523) |
PMID:29875488 |
None Available | GCST90242741 | Selenoprotein S levels (VIMP.11286.78.3) | 3,301 European ancestry individuals | C | 0.153 | 6E-35 | 34.222 | rs429358 | 0.41 | selenoprotein S measurement (EFO:0802046) |
PMID:29875488 |
None Available | GCST90240441 | Beta-soluble NSF attachment protein levels (NAPB.12655.30.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-25 | 25 | rs429358 | 0.35 | beta-soluble NSF attachment protein measurement (EFO:0801423) |
PMID:29875488 |
GWAS1396856_H | GCST90242240 | PH and SEC7 domain-containing protein 1 levels (PSD.13055.53.3) | 3,301 European ancestry individuals | C | 0.153 | 2E-96 | 95.699 | rs429358 | 0.66 | PH and SEC7 domain-containing protein 1 measurement (EFO:0803302) |
PMID:29875488 |
None Available | GCST90241699 | Killer cell immunoglobulin-like receptor 2DL5A levels (KIR2DL5A.8000.17.3) | 3,301 European ancestry individuals | C | 0.153 | 8E-26 | 25.097 | rs429358 | 0.35 | killer cell immunoglobulin-like receptor 2DL5A measurement (EFO:0801745) |
PMID:29875488 |
GWAS1396940_H | GCST90243133 | Tubulin-specific chaperone A levels (TBCA.12501.10.3) | 3,301 European ancestry individuals | C | 0.153 | 5E-646 | 645.302 | rs429358 | 1.34 | tubulin-specific chaperone A measurement (EFO:0802166) |
PMID:29875488 |
GWAS1396945_H | GCST90242425 | Protein CEI levels (C5orf38.6378.2.3) | 3,301 European ancestry individuals | C | 0.153 | 4E-159 | 158.398 | rs429358 | 0.82 | protein CEI measurement (EFO:0801936) |
PMID:29875488 |
GWAS1397366_H | GCST90240197 | Adhesion G-protein coupled receptor F1 levels (ADGRF1.11243.90.3) | 3,301 European ancestry individuals | C | 0.153 | 7E-30 | 29.155 | rs429358 | 0.38 | adhesion G-protein coupled receptor F1 measurement (EFO:0801347) |
PMID:29875488 |
None Available | GCST90241094 | Epididymal-specific lipocalin-10 levels (LCN10.13007.66.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-20 | 20 | rs429358 | 0.31 | epididymal-specific lipocalin-10 measurement (EFO:0801576) |
PMID:29875488 |
GWAS1397369_H | GCST90241096 | Epididymis-specific alpha-mannosidase levels (MAN2B2.9251.28.3) | 3,301 European ancestry individuals | C | 0.153 | 8E-12 | 11.097 | rs429358 | 0.23 | epididymis-specific alpha-mannosidase measurement (EFO:0801577) |
PMID:29875488 |
GWAS1397375_H | GCST90241113 | Estrogen sulfotransferase levels (SULT1E1.9878.3.3) | 3,301 European ancestry individuals | C | 0.153 | 3E-34 | 33.523 | rs429358 | 0.4 | estrogen sulfotransferase measurement (EFO:0801586) |
PMID:29875488 |
None Available | GCST90129602 | Chronic elevation of alanine aminotransferase (cALT) levels | 95,472 European ancestry cases, 68,725 European ancestry controls | C | 0.139 | 5E-19 | 18.302 | rs429358 | 0.094 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:35654975 |
None Available | GCST90242208 | PDZK1-interacting protein 1 levels (PDZK1IP1.8260.13.3) | 3,301 European ancestry individuals | C | 0.153 | 3E-26 | 25.523 | rs429358 | 0.35 | PDZK1-interacting protein 1 measurement (EFO:0801869) |
PMID:29875488 |
None Available | GCST90242903 | Stromal interaction molecule 1 levels (STIM1.9271.101.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-14 | 14 | rs429358 | 0.26 | stromal interaction molecule 1 measurement (EFO:0802093) |
PMID:29875488 |
None Available | GCST90240210 | ADP-ribosylation factor-like protein 1 levels (ARL1.12392.30.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-19 | 19 | rs429358 | 0.3 | ADP-ribosylation factor-like protein 1 measurement (EFO:0801354) |
PMID:29875488 |
GWAS1398184_H | GCST90233503 | Tubulin-specific chaperone A level in Chronic kidney disease with hypertension and no diabetes (12501_10) | 466 African American individuals | C | 0.21 | 1E-86 | 86 | rs429358 | 1.19 | level of tubulin-specific chaperone A in blood serum (OBA:2043789) |
PMID:35870639 |
None Available | GCST90234964 | Cytidine deaminase level in Chronic kidney disease with hypertension and no diabetes (18336_31) | 466 African American individuals | C | 0.21 | 6E-13 | 12.222 | rs429358 | 0.56 | cytidine measurement (EFO:0800645) |
PMID:35870639 |
None Available | GCST90239096 | Transmembrane and coiled-coil domains protein 3 level in Chronic kidney disease with hypertension and no diabetes (8922_4) | 466 African American individuals | C | 0.21 | 1E-14 | 14 | rs429358 | 0.59 | protein measurement (EFO:0004747) |
PMID:35870639 |
GWAS1399311_H | GCST90233559 | ADP-ribosylation factor-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (12587_65) | 466 African American individuals | C | 0.21 | 8E-21 | 20.097 | rs429358 | 0.7 | level of ADP-ribosylation factor-like protein 2 in blood serum (OBA:2040666) |
PMID:35870639 |
None Available | GCST90235743 | Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase level in Chronic kidney disease with hypertension and no diabetes (21508_7) | 466 African American individuals | C | 0.21 | 6E-43 | 42.222 | rs429358 | 0.95 | level of alpha-N-acetylneuraminide alpha-2,8-sialyltransferase in blood serum (OBA:2043681) |
PMID:35870639 |
GWAS1399707_H | GCST90235979 | Forkhead box protein O1A level in Chronic kidney disease with hypertension and no diabetes (22055_31) | 466 African American individuals | C | 0.21 | 5E-29 | 28.302 | rs429358 | 0.81 | level of forkhead box protein O1 in blood serum (OBA:2041610) |
PMID:35870639 |
None Available | GCST90242148 | Nuclear receptor-binding protein levels (NRBP1.12616.45.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-24 | 24 | rs429358 | 0.34 | nuclear receptor-binding protein measurement (EFO:0801854) |
PMID:29875488 |
None Available | GCST90233177 | Leucine-rich repeat neuronal protein 1 level in Chronic kidney disease with hypertension and no diabetes (11293_14) | 466 African American individuals | C | 0.21 | 1E-68 | 68 | rs429358 | 1.11 | protein measurement (EFO:0004747) |
PMID:35870639 |
None Available | GCST90235902 | Proteasome subunit beta type-10 level in Chronic kidney disease with hypertension and no diabetes (21861_8) | 466 African American individuals | C | 0.21 | 2E-13 | 12.699 | rs429358 | 0.57 | level of proteasome subunit beta type-10 in blood serum (OBA:2043068) |
PMID:35870639 |
None Available | GCST90236845 | Arginyl-tRNA--protein transferase 1 level in Chronic kidney disease with hypertension and no diabetes (25108_6) | 466 African American individuals | C | 0.21 | 9E-20 | 19.046 | rs429358 | 0.68 | level of arginyl-tRNA--protein transferase 1 in blood serum (OBA:2040711) |
PMID:35870639 |
GWAS1400154_H | GCST90233784 | Tumor protein p53-inducible protein 11 level in Chronic kidney disease with hypertension and no diabetes (13022_20) | 466 African American individuals | C | 0.21 | 6E-51 | 50.222 | rs429358 | 1.01 | level of tumor protein p53-inducible protein 11 in blood serum (OBA:2043904) |
PMID:35870639 |
GWAS1400255_H | GCST90235567 | Pre-miRNA 5'-monophosphate methyltransferase level in Chronic kidney disease with hypertension and no diabetes (21115_48) | 466 African American individuals | C | 0.21 | 6E-46 | 45.222 | rs429358 | 0.97 | level of methyltransferase BCDIN3D in blood serum (OBA:2044601) |
PMID:35870639 |
GWAS1400373_H | GCST90236150 | Kinetochore protein Spc25 level in Chronic kidney disease with hypertension and no diabetes (22782_80) | 466 African American individuals | C | 0.21 | 4E-112 | 111.398 | rs429358 | 1.27 | level of kinetochore protein Spc25 in blood serum (OBA:2043621) |
PMID:35870639 |
GWAS1402108_H | GCST90132314 | Coronary artery disease | 181,522 European ancestry, unknown cases, 984,168 European ancestry, unknown controls | T | 0.848 | 4E-38 | 37.398 | rs429358 | 0.913 | coronary artery disease (EFO:0001645) |
PMID:36474045 |
GWAS1404789_H | GCST90238739 | Hemoglobin subunit theta-1 level in Chronic kidney disease with hypertension and no diabetes (7965_25) | 466 African American individuals | C | 0.21 | 9E-56 | 55.046 | rs429358 | 1.04 | level of hemoglobin subunit theta-1 in blood serum (OBA:2041842) |
PMID:35870639 |
None Available | GCST90103632 | Blood urea nitrogen levels | 679,531 European ancestry individuals, 173,149 individuals | T | 0.8506 | 9E-10 | 9.046 | rs429358 | 0.0043 | blood urea nitrogen measurement (EFO:0004741) |
PMID:34272381 |
None Available | GCST90428447 | Estimated glomerular filtration rate (creatinine) | 406,504 European ancestry individuals | C | NR | 8E-41 | 40.097 | rs429358 | 0.0383775 | PMID:39256582 | |
None Available | GCST90428446 | Estimated glomerular filtration rate (creatinine, cystatin c) | 406,504 European ancestry individuals | C | NR | 4E-51 | 50.398 | rs429358 | 0.042415 | PMID:39256582 | |
None Available | GCST90435413 | Body mass index | 403,610 European ancestry individuals | ? | NR | 4E-21 | 20.398 | rs429358 | 0.0269316 | body mass index (EFO:0004340) |
PMID:39134668 |
None Available | GCST90428448 | Estimated glomerular filtration rate (cystatin c) | 406,504 European ancestry individuals | C | NR | 8E-37 | 36.097 | rs429358 | 0.035446 | PMID:39256582 | |
None Available | GCST90479600 | estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed) | 110,854 African American or Afro-Caribbean individuals, 55,243 Hispanic or Latin American individuals, 6,247 East Asian ancestry individuals, 398,886 European ancestry individuals | T | 0.8473 | 3E-11 | 10.523 | rs429358 | 0.02248 | PMID:39024449 | |
None Available | GCST90018977 | Serum uric acid levels | 343,836 European ancestry individuals, 129,405 East Asian ancestry individuals | C | NR | 6E-13 | 12.222 | rs429358 | 0.0182 | uric acid measurement (EFO:0004761) |
PMID:34594039 |
None Available | GCST90104598 | Nonalcoholic fatty liver disease | 3,711 European ancestry cases, 426,252 European ancestry controls | T | NR | 5E-8 | 7.302 | rs429358 | 0.2 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:35124268 |
None Available | GCST90095131 | Vertex-wise cortical thickness | 33,748 European ancestry individuals | C | 0.16 | 5E-12 | 11.302 | rs429358 | 6.91 | cortical thickness (EFO:0004840) |
PMID:34910505 |
None Available | GCST90479562 | creatinine (mean, inv-norm transformed) | 116,707 African American or Afro-Caribbean individuals, 57,141 Hispanic or Latin American individuals, 6,285 East Asian ancestry individuals, 421,411 European ancestry individuals | T | 0.8473 | 2E-15 | 14.699 | rs429358 | 0.02602 | PMID:39024449 | |
None Available | GCST90244924 | 1-nonadecanoyl-GPC (19:0) levels | 14,296 European ancestry individuals | T | 0.8445 | 1E-13 | 13 | rs429358 | 0.10511124 | 1-nonadecanoyl-GPC (19:0) measurement (EFO:0800357) |
PMID:36357675 |
None Available | GCST90479599 | estimated glomerular filtration rate (eGFR, mean, inv-norm transformed) | 110,856 African American or Afro-Caribbean individuals, 55,244 Hispanic or Latin American individuals, 6,248 East Asian ancestry individuals, 398,886 European ancestry individuals | T | 0.8472 | 1E-13 | 13 | rs429358 | 0.02606 | PMID:39024449 | |
None Available | GCST90245425 | Sphingomyelin (d18:2/14:0, d18:1/14:1) levels | 14,296 European ancestry individuals | T | 0.8453 | 1E-10 | 10 | rs429358 | 0.08893802 | Sphingomyelin (d18:2/14:0, d18:1/14:1) measurement (EFO:0022114) |
PMID:36357675 |
None Available | GCST90162547 | Common executive function | 427,037 European ancestry individuals | ? | NR | 1E-19 | 19 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:36150907 |
GWAS1414674_H | GCST90244793 | Dyslipidemia | 15,054 Korean ancestry cases, 37,395 Korean ancestry controls | C | 0.09561 | 2E-31 | 30.699 | rs429358 | 1.298 | PMID:36419087 | |
GWAS1414715_H | GCST90245341 | N-palmitoyl-sphingosine (d18:1/16:0) levels | 14,296 European ancestry individuals | T | 0.8452 | 1E-26 | 26 | rs429358 | 0.1474476 | N-palmitoyl-sphingosine (d18:1/16:0) measurement (EFO:0800607) |
PMID:36357675 |
None Available | GCST90479598 | estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed) | 110,850 African American or Afro-Caribbean individuals, 55,242 Hispanic or Latin American individuals, 6,249 East Asian ancestry individuals, 398,886 European ancestry individuals | T | 0.8473 | 2E-13 | 12.699 | rs429358 | 0.02565 | PMID:39024449 | |
None Available | GCST90479563 | creatinine (minimum, inv-norm transformed) | 117,108 African American or Afro-Caribbean individuals, 57,292 Hispanic or Latin American individuals, 6,305 East Asian ancestry individuals, 421,910 European ancestry individuals | T | 0.8473 | 6E-15 | 14.222 | rs429358 | 0.02611 | PMID:39024449 | |
None Available | GCST90479561 | creatinine (maximum, inv-norm transformed) | 116,285 African American or Afro-Caribbean individuals, 57,003 Hispanic or Latin American individuals, 6,275 East Asian ancestry individuals, 420,576 European ancestry individuals | T | 0.8473 | 6E-12 | 11.222 | rs429358 | 0.02186 | PMID:39024449 | |
None Available | GCST90245426 | Sphingomyelin (d18:2/16:0, d18:1/16:1) levels | 14,296 European ancestry individuals | T | 0.8452 | 4E-9 | 8.398 | rs429358 | 0.081198804 | Sphingomyelin (d18:2/16:0, d18:1/16:1) measurement (EFO:0022115) |
PMID:36357675 |
GWAS1417853_H | GCST90239649 | High density lipoprotein cholesterol levels | 40,963 South Asian ancestry individuals, 48,057 Hispanic individuals, 99,432 Admixed African or African ancestry individuals, 146,492 East Asian ancestry individuals, 1,320,016 European ancestry individuals | ? | NR | 1E-497 | 497 | rs429358 | N/A | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34887591 |
None Available | GCST90131901 | Insomnia | 593,724 European ancestry cases, 1,771,286 European ancestry controls | T | NR | 2E-12 | 11.699 | rs429358 | 0.009 | insomnia (EFO:0004698) |
PMID:35835914 |
None Available | GCST90435415 | Systolic blood pressure | 404,507 European ancestry individuals | ? | NR | 8E-11 | 10.097 | rs429358 | 0.0172603 | systolic blood pressure (EFO:0006335) |
PMID:39134668 |
GWAS1420505_H | GCST90239652 | High density lipoprotein cholesterol levels | 1,320,016 European ancestry individuals | C | 0.151897 | 6E-256 | 255.222 | rs429358 | 0.0861765 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34887591 |
GWAS1696127_H | GCST90297541 | Plasma amyloid beta 42 to 40 ratio | 1,991 European ancestry individuals | ? | NR | 6E-18 | 17.222 | rs429358 | 0.363 | amyloid-beta measurement (EFO:0005194) |
PMID:37208024 |
GWAS1430364_H | GCST90244026 | Alzheimer's disease | 386 European ancestry cases, 2,206 European ancestry controls | C | 0.1099 | 9E-14 | 13.046 | rs429358 | 2.217 | PMID:35694926 | |
None Available | GCST90244027 | Alzheimer's disease | 182 European ancestry female cases, 978 European ancestry female controls | ? | NR | 2E-10 | 9.699 | rs429358 | 2.722 | PMID:35694926 | |
None Available | GCST90244029 | Dementia | 424 European ancestry cases, 2,206 European ancestry controls | C | 0.1099 | 2E-12 | 11.699 | rs429358 | 2.086 | PMID:35694926 | |
GWAS1430373_H | GCST90244030 | Dementia | 203 European ancestry female cases, 978 European ancestry female controls | ? | NR | 3E-10 | 9.523 | rs429358 | 2.582 | PMID:35694926 | |
None Available | GCST90104755 | COVID-19 (severe vs population) | 1,120 European ancestry cases, 458,130 European ancestry controls, 124 cases, 27,946 controls | C | 0.15406817 | 1E-7 | 7 | rs429358 | 0.30173 | PMID:35224516 | |
None Available | GCST90104761 | COVID-19 (severe vs tested, not severe) | 1,120 European ancestry cases, 79,439 European ancestry controls, 124 cases, 5,303 controls | C | 0.15463564 | 4E-7 | 6.398 | rs429358 | 0.29009 | PMID:35224516 | |
None Available | GCST90270074 | Personality traits or cognitive traits (multivariate analysis) | 337,125 British ancestry individuals | ? | NR | 1E-36 | 36 | rs429358 | N/A | neuroticism measurement (EFO:0007660) cognitive function measurement (EFO:0008354) |
PMID:37365406 |
GWAS1437116_H | GCST90428729 | Alanine aminotransferase levels | 1,010,710 European ancestry individuals | C | NR | 2E-61 | 60.699 | rs429358 | 0.0088 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:38632349 |
None Available | GCST90428730 | Gamma glutamyl transferase levels | 875,069 European ancestry individuals | C | NR | 2E-14 | 13.699 | rs429358 | 0.0054 | serum gamma-glutamyl transferase measurement (EFO:0004532) |
PMID:38632349 |
GWAS1438065_H | GCST90428732 | Gall stone disease or coronary artery disease | 43,639 European ancestry gall stone disease cases, 181,522 European ancestry coronary artery disease cases, 1,490,966 European ancestry controls | ? | NR | 4E-47 | 46.398 | rs429358 | N/A | gallstones (EFO:0004210) coronary artery disease (EFO:0001645) |
PMID:37705021 |
None Available | GCST90103484 | ICD10 M54: Dorsalgia | 119,110 European ancestry cases, 909,847 European ancestry controls | C | 0.17 | 2E-11 | 10.699 | rs429358 | 0.96 | Back pain (HP:0003418) |
PMID:35110524 |
None Available | GCST90399695 | Chronic obstructive pulmonary disease | 1,503 Admixed American ancestry cases, 13,583 Admixed American ancestry controls, 484 South Asian ancestry cases, 21,464 South Asian ancestry controls, 1,978 African ancestry cases, 27,704 African ancestry controls, 19,044 East Asian ancestry cases, 310,689 East Asian ancestry controls, 58,559 European ancestry cases, 937,358 European ancestry controls | C | 0.1398 | 1E-8 | 8 | rs429358 | 0.049172 | chronic obstructive pulmonary disease (EFO:0000341) |
PMID:36777996 |
GWAS1444561_H | GCST90428119 | Body mass index | 342,566 European ancestry individuals | C | NR | 6E-10 | 9.222 | rs429358 | 0.0205752 | body mass index (EFO:0004340) |
PMID:38538606 |
GWAS1444607_H | GCST90432152 | Abdominal aortic aneurysm | 37,214 European ancestry cases, 997,776 European ancestry controls, 2,007 African ancestry cases, 88,331 African ancestry controls | ? | NR | 5E-39 | 38.302 | rs429358 | 0.1439 | Abdominal Aortic Aneurysm (EFO:0004214) |
PMID:37845353 |
None Available | GCST90319904 | Serum urate levels | 219,768 East Asian ancestry individuals, 677,373 European ancestry individuals, 132,182 individuals | T | NR | 6E-10 | 9.222 | rs429358 | 0.0198 | urate measurement (EFO:0004531) |
PMID:38658550 |
None Available | GCST90319906 | Serum urate levels | 677,373 European ancestry individuals | T | NR | 1E-8 | 8 | rs429358 | 0.0215 | urate measurement (EFO:0004531) |
PMID:38658550 |
None Available | GCST90472768 | Rapidly progressive Alzheimer's disease (typical) (case-control set 3) | 448 European, African American, Asian or American Indian/Alaska Native cases, 1,344 European, African American, Asian or American Indian/Alaska Native controls | ? | NR | 4E-10 | 9.398 | rs429358 | 1.822 | PMID:38184787 | |
None Available | GCST90472763 | Rapidly progressive Alzheimer's disease (typical) (case-control set 2) | 448 European, African American, Asian or American Indian/Alaska Native cases, 1,344 European, African American, Asian or American Indian/Alaska Native controls | ? | NR | 7E-10 | 9.155 | rs429358 | 1.802 | PMID:38184787 | |
None Available | GCST90472758 | Rapidly progressive Alzheimer's disease (typical) (case-control set 1) | 448 European, African American, Asian or American Indian/Alaska Native cases, 1,344 European, African American, Asian or American Indian/Alaska Native controls | ? | NR | 1E-9 | 9 | rs429358 | 1.788 | PMID:38184787 | |
GWAS1515891_H | GCST90455669 | Serum urate levels | 630,117 European ancestry individuals | T | 0.8452 | 7E-13 | 12.155 | rs429358 | 0.0231 | urate measurement (EFO:0004531) |
PMID:39406924 |
None Available | GCST90446168 | Cognitive processing speed | 2,266,733 European ancestry individuals | ? | NR | 2E-25 | 24.699 | rs429358 | N/A | cognitive function measurement (EFO:0008354) |
PMID:39242605 |
GWAS1524861_H | GCST90425278 | Dimethylaniline monooxygenase [N-oxide-forming] 3 levels | 2,549 European ancestry individuals | C | 0.227236 | 1E-37 | 37 | rs429358 | 0.4072 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425321 | Ataxin-10 levels | 2,549 European ancestry individuals | C | 0.222798 | 7E-19 | 18.155 | rs429358 | 0.2817 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1524866_H | GCST90425322 | Nuclear factor 1 A-type levels | 2,549 European ancestry individuals | C | 0.22359 | 5E-167 | 166.302 | rs429358 | 0.7749 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1524891_H | GCST90426457 | SPARC-related modular calcium-binding protein 1 (analyte X5694.57) levels | 3,334 European ancestry individuals | C | 0.199183 | 8E-33 | 32.097 | rs429358 | 0.3513 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1524935_H | GCST90426314 | Apolipoprotein E (isoform E2) levels | 3,506 European ancestry individuals | C | 0.200693 | 2E-47 | 46.699 | rs429358 | 0.4355 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426893 | Protein FAM209B levels | 3,506 European ancestry individuals | C | 0.201473 | 2E-17 | 16.699 | rs429358 | 0.2489 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1524984_H | GCST90426738 | E3 ubiquitin-protein ligase RNF128:region 1 levels | 3,506 European ancestry individuals | C | 0.20273 | 7E-60 | 59.155 | rs429358 | 0.4645 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1524998_H | GCST90426661 | Protein CEI levels | 3,506 European ancestry individuals | C | 0.200775 | 3E-224 | 223.523 | rs429358 | 0.8999 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525006_H | GCST90424802 | Acyl-coenzyme A thioesterase 12 levels | 2,549 European ancestry individuals | C | 0.225447 | 8E-49 | 48.097 | rs429358 | 0.4738 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425715 | Calcium/calmodulin-dependent protein kinase type II subunit beta levels | 3,506 European ancestry individuals | C | 0.201693 | 3E-16 | 15.523 | rs429358 | 0.2246 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425324 | 39S ribosomal protein L38, mitochondrial levels | 2,549 European ancestry individuals | C | 0.221773 | 5E-39 | 38.302 | rs429358 | 0.417 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525216_H | GCST90425325 | Pleckstrin homology domain-containing family O member 2 levels | 2,549 European ancestry individuals | C | 0.223316 | 7E-268 | 267.155 | rs429358 | 1.02 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525217_H | GCST90425330 | Phospholipase DDHD2 levels | 2,549 European ancestry individuals | C | 0.223332 | 4E-25 | 24.398 | rs429358 | 0.3224 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525227_H | GCST90427165 | CUB and zona pellucida-like domain-containing protein 1 levels | 3,334 European ancestry individuals | C | 0.198905 | 3E-12 | 11.523 | rs429358 | 0.2135 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525250_H | GCST90427300 | Apolipoprotein D (analyte X8262.20) levels | 3,334 European ancestry individuals | C | 0.199577 | 7E-16 | 15.155 | rs429358 | 0.2373 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525269_H | GCST90426540 | Proteasome activator complex subunit 1 levels | 3,506 European ancestry individuals | C | 0.201352 | 2E-41 | 40.699 | rs429358 | 0.3739 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525278_H | GCST90426373 | Small nuclear ribonucleoprotein F levels | 3,506 European ancestry individuals | C | 0.202846 | 1E-352 | 352 | rs429358 | 1.0554 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525324_H | GCST90425209 | Arginyl-tRNA--protein transferase 1 levels | 2,549 European ancestry individuals | C | 0.224458 | 4E-388 | 387.398 | rs429358 | 1.1776 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425213 | TBC1 domain family member 24 levels | 2,549 European ancestry individuals | C | 0.22487 | 1E-15 | 15 | rs429358 | 0.2354 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425217 | Protein bicaudal D homolog 1 levels | 2,549 European ancestry individuals | C | 0.22467 | 2E-12 | 11.699 | rs429358 | 0.2149 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424953 | Peroxisomal coenzyme A diphosphatase NUDT7 levels | 2,549 European ancestry individuals | C | 0.225806 | 1E-142 | 142 | rs429358 | 0.7754 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424960 | Spermatogenesis-associated protein 24 levels | 2,549 European ancestry individuals | C | 0.223878 | 2E-11 | 10.699 | rs429358 | 0.2255 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424972 | Phytanoyl-CoA hydroxylase-interacting protein levels | 2,549 European ancestry individuals | C | 0.226579 | 1E-15 | 15 | rs429358 | 0.2681 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425007 | Protein HID1 levels | 2,549 European ancestry individuals | C | 0.224159 | 1E-40 | 40 | rs429358 | 0.4286 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424890 | Phosphotriesterase-related protein levels | 2,549 European ancestry individuals | C | 0.22487 | 1E-15 | 15 | rs429358 | 0.2623 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424891 | Apolipoprotein E levels | 3,283 European ancestry individuals | C | 0.204967 | 1E-12 | 12 | rs429358 | 0.2234 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525578_H | GCST90427181 | Hemoglobin subunit theta-1 (analyte X7965.25) levels | 3,334 European ancestry individuals | C | 0.199549 | 6E-204 | 203.222 | rs429358 | 0.8952 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427224 | Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating levels | 3,506 European ancestry individuals | C | 0.201716 | 3E-28 | 27.523 | rs429358 | 0.3313 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525635_H | GCST90424709 | N-terminal EF-hand calcium-binding protein 3 levels | 2,549 European ancestry individuals | C | 0.22643 | 6E-81 | 80.222 | rs429358 | 0.6291 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424718 | Cytosolic arginine sensor for mTORC1 subunit 1 levels | 2,549 European ancestry individuals | C | 0.224193 | 1E-15 | 15 | rs429358 | 0.2603 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1696271_H | GCST90425232 | V-type proton ATPase subunit F levels | 2,549 European ancestry individuals | C | 0.223768 | 8E-15 | 14.097 | rs429358 | 0.2327 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525665_H | GCST90427044 | C-type lectin domain family 4 member D levels | 3,506 European ancestry individuals | C | 0.199067 | 6E-153 | 152.222 | rs429358 | 0.8259 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525671_H | GCST90427050 | RING finger protein 215:Extracellular domain levels | 3,506 European ancestry individuals | C | 0.194183 | 1E-134 | 134 | rs429358 | 0.7661 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421647 | Ribosomal protein S6 kinase alpha-1 levels | 3,506 European ancestry individuals | C | 0.200782 | 2E-29 | 28.699 | rs429358 | 0.3344 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525878_H | GCST90421685 | ADP-ribosylation factor-like protein 1 levels | 3,506 European ancestry individuals | C | 0.203279 | 1E-136 | 136 | rs429358 | 0.6983 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525883_H | GCST90421866 | Sulfotransferase family cytosolic 1B member 1 levels | 3,506 European ancestry individuals | C | 0.201387 | 1E-31 | 31 | rs429358 | 0.3502 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421893 | SH2 domain-containing protein 3C levels | 3,506 European ancestry individuals | C | 0.202109 | 5E-20 | 19.302 | rs429358 | 0.2602 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425433 | Endothelial monocyte-activating polypeptide 2 levels | 3,506 European ancestry individuals | C | 0.20222 | 4E-32 | 31.398 | rs429358 | 0.348 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525962_H | GCST90424739 | Zinc finger protein 483 levels | 2,549 European ancestry individuals | C | 0.228445 | 1E-107 | 107 | rs429358 | 0.694 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424754 | Phytanoyl-CoA hydroxylase-interacting protein-like levels | 2,549 European ancestry individuals | C | 0.224861 | 7E-13 | 12.155 | rs429358 | 0.2227 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525975_H | GCST90424696 | Coiled-coil domain-containing protein 24 levels | 2,549 European ancestry individuals | C | 0.241455 | 1E-128 | 128 | rs429358 | 0.7743 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424701 | Uridine-cytidine kinase 1 levels | 2,549 European ancestry individuals | C | 0.223257 | 7E-19 | 18.155 | rs429358 | 0.2902 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426195 | Moesin levels | 3,506 European ancestry individuals | C | 0.201274 | 5E-16 | 15.302 | rs429358 | 0.2541 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525991_H | GCST90426204 | Phosphoglycerate kinase 1 levels | 3,506 European ancestry individuals | C | 0.200231 | 2E-86 | 85.699 | rs429358 | 0.5679 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425077 | Serine/threonine-protein phosphatase 2A regulatory subunit B' levels | 2,549 European ancestry individuals | C | 0.222641 | 5E-14 | 13.302 | rs429358 | 0.2121 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1525999_H | GCST90425090 | F-BAR and double SH3 domains protein 1 levels | 2,549 European ancestry individuals | C | 0.224701 | 1E-33 | 33 | rs429358 | 0.3764 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426932 | Mitochondrial peptide methionine sulfoxide reductase levels | 3,506 European ancestry individuals | C | 0.199884 | 5E-20 | 19.302 | rs429358 | 0.3885 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526012_H | GCST90425011 | Myotubularin-related protein 7 levels | 2,549 European ancestry individuals | C | 0.22497 | 2E-302 | 301.699 | rs429358 | 1.0743 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425014 | Probable E3 ubiquitin-protein ligase TRIML1 levels | 2,549 European ancestry individuals | C | 0.224131 | 1E-46 | 46 | rs429358 | 0.4726 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526026_H | GCST90425894 | Mitogen-activated protein kinase 8 levels | 3,506 European ancestry individuals | C | 0.197941 | 6E-95 | 94.222 | rs429358 | 0.6188 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526206_H | GCST90422333 | Cardiotrophin-1 (analyte X13732.79) levels | 3,334 European ancestry individuals | C | 0.173693 | 3E-358 | 357.523 | rs429358 | 1.2123 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422324 | Interleukin-10 (analyte X13723.6) levels | 3,334 European ancestry individuals | C | 0.200831 | 3E-23 | 22.523 | rs429358 | 0.3127 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421784 | Regulator of G-protein signaling 7 levels | 3,506 European ancestry individuals | C | 0.201597 | 6E-18 | 17.222 | rs429358 | 0.2507 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526324_H | GCST90424239 | PRKCA-binding protein levels | 2,549 European ancestry individuals | C | 0.225989 | 9E-129 | 128.046 | rs429358 | 0.7464 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424243 | Uncharacterized protein C7orf24 levels | 2,549 European ancestry individuals | C | 0.222445 | 2E-11 | 10.699 | rs429358 | 0.2199 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526328_H | GCST90424257 | Ubiquitin thioesterase otulin levels | 2,549 European ancestry individuals | C | 0.219721 | 3E-512 | 511.523 | rs429358 | 1.3182 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526329_H | GCST90424268 | Protein Wnt-10b levels | 2,549 European ancestry individuals | C | 0.227709 | 3E-219 | 218.523 | rs429358 | 0.9537 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526335_H | GCST90424296 | [Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial levels | 2,549 European ancestry individuals | C | 0.225573 | 4E-42 | 41.398 | rs429358 | 0.4505 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426829 | Hemoglobin subunit zeta levels | 3,506 European ancestry individuals | C | 0.200721 | 5E-15 | 14.302 | rs429358 | 0.2262 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526370_H | GCST90427847 | Conserved oligomeric Golgi complex subunit 8 levels | 3,506 European ancestry individuals | C | 0.200578 | 4E-30 | 29.398 | rs429358 | 0.3225 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526372_H | GCST90425972 | 14-3-3 protein gamma (analyte X4179.57) levels | 3,506 European ancestry individuals | C | 0.201146 | 4E-31 | 30.398 | rs429358 | 0.3025 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426699 | Uncharacterized protein C14orf93 levels | 3,506 European ancestry individuals | C | 0.201757 | 2E-19 | 18.699 | rs429358 | 0.2599 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526558_H | GCST90421803 | Embryonal Fyn-associated substrate levels | 3,506 European ancestry individuals | C | 0.202979 | 3E-129 | 128.523 | rs429358 | 0.7008 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526566_H | GCST90421854 | GDP-L-fucose synthase levels | 3,506 European ancestry individuals | C | 0.196162 | 1E-92 | 92 | rs429358 | 0.6466 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526573_H | GCST90422048 | Tumor protein p53-inducible protein 11 levels | 3,506 European ancestry individuals | C | 0.201604 | 4E-214 | 213.398 | rs429358 | 0.9115 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421318 | Transmembrane protein 132C:Cytoplasmic domain levels | 3,506 European ancestry individuals | C | 0.197641 | 5E-24 | 23.302 | rs429358 | 0.2968 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421390 | Adhesion G-protein coupled receptor F1 levels | 3,506 European ancestry individuals | C | 0.200685 | 1E-34 | 34 | rs429358 | 0.3237 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526617_H | GCST90421398 | Mucosal addressin cell adhesion molecule 1 levels | 3,506 European ancestry individuals | C | 0.20052 | 8E-39 | 38.097 | rs429358 | 0.3809 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526624_H | GCST90421417 | Selenoprotein S levels | 3,506 European ancestry individuals | C | 0.201807 | 3E-123 | 122.523 | rs429358 | 0.7183 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526663_H | GCST90424316 | Forkhead box protein O1A levels | 2,549 European ancestry individuals | C | 0.224478 | 3E-326 | 325.523 | rs429358 | 1.0964 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426955 | Interferon alpha-14 levels | 3,506 European ancestry individuals | C | 0.201823 | 1E-57 | 57 | rs429358 | 0.4721 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426975 | Semaphorin-6C levels | 3,506 European ancestry individuals | C | 0.204156 | 5E-19 | 18.302 | rs429358 | 0.2558 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526910_H | GCST90422077 | Bcl-2-like protein 2 (analyte X13097.11) levels | 3,506 European ancestry individuals | C | 0.199337 | 1E-50 | 50 | rs429358 | 0.4422 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421698 | 14-3-3 protein beta/alpha (analyte X12414.31) levels | 3,334 European ancestry individuals | C | 0.199488 | 1E-19 | 19 | rs429358 | 0.2559 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421704 | ADP-ribosylation factor 6 levels | 3,506 European ancestry individuals | C | 0.201615 | 5E-16 | 15.302 | rs429358 | 0.2313 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526940_H | GCST90421422 | Leucine-rich repeat neuronal protein 1:Cytoplasmic domain levels | 2,721 European ancestry individuals | C | 0.224475 | 2E-858 | 857.699 | rs429358 | 1.4752 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526947_H | GCST90421437 | E3 ubiquitin-protein ligase CHFR levels | 3,506 European ancestry individuals | C | 0.200316 | 2E-172 | 171.699 | rs429358 | 0.8196 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526956_H | GCST90421476 | Mevalonate kinase levels | 3,506 European ancestry individuals | C | 0.204055 | 2E-138 | 137.699 | rs429358 | 0.722 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1526957_H | GCST90421479 | E3 ubiquitin-protein ligase RNF146 levels | 3,506 European ancestry individuals | C | 0.200058 | 1E-32 | 32 | rs429358 | 0.3617 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423644 | Laminin subunit alpha-3 levels | 2,549 European ancestry individuals | C | 0.222796 | 2E-15 | 14.699 | rs429358 | 0.2506 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527257_H | GCST90421729 | 1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase levels | 3,506 European ancestry individuals | C | 0.202315 | 2E-27 | 26.699 | rs429358 | 0.3284 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421745 | Nucleosome-remodeling factor subunit BPTF levels | 3,506 European ancestry individuals | C | 0.201026 | 9E-16 | 15.046 | rs429358 | 0.2358 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527266_H | GCST90421757 | Tubulin-specific chaperone A levels | 3,506 European ancestry individuals | C | 0.214529 | 1E-460 | 460 | rs429358 | 1.1857 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527272_H | GCST90421929 | Cold shock domain-containing protein C2 levels | 3,506 European ancestry individuals | C | 0.200261 | 8E-82 | 81.097 | rs429358 | 0.5553 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421955 | Diphosphoinositol polyphosphate phosphohydrolase 1 levels | 3,506 European ancestry individuals | C | 0.199359 | 2E-12 | 11.699 | rs429358 | 0.1875 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423154 | Serine--tRNA ligase, cytoplasmic levels | 2,721 European ancestry individuals | C | 0.226586 | 2E-29 | 28.699 | rs429358 | 0.3591 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423166 | Caspase recruitment domain-containing protein 18 levels | 2,549 European ancestry individuals | C | 0.224254 | 2E-29 | 28.699 | rs429358 | 0.3555 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423495 | Hydroxyacylglutathione hydrolase, mitochondrial levels | 2,721 European ancestry individuals | C | 0.224486 | 3E-14 | 13.523 | rs429358 | 0.2304 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423512 | Hypoxanthine-guanine phosphoribosyltransferase levels | 2,721 European ancestry individuals | C | 0.22344 | 2E-11 | 10.699 | rs429358 | 0.212 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527352_H | GCST90423951 | HCLS1-associated protein X-1 levels | 2,549 European ancestry individuals | C | 0.223249 | 7E-421 | 420.155 | rs429358 | 1.2249 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423967 | CDK5 regulatory subunit-associated protein 3 levels | 2,549 European ancestry individuals | C | 0.224506 | 1E-68 | 68 | rs429358 | 0.5644 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527357_H | GCST90423973 | DNA fragmentation factor subunit alpha levels | 2,549 European ancestry individuals | C | 0.22231 | 9E-17 | 16.046 | rs429358 | 0.2771 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425998 | Glucose-6-phosphate isomerase levels | 3,506 European ancestry individuals | C | 0.201699 | 5E-19 | 18.302 | rs429358 | 0.231 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426017 | C-reactive protein levels | 3,506 European ancestry individuals | C | 0.202446 | 2E-31 | 30.699 | rs429358 | 0.3494 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424813 | Mitochondrial import inner membrane translocase subunit Tim13 levels | 2,549 European ancestry individuals | C | 0.22495 | 2E-58 | 57.699 | rs429358 | 0.5256 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527426_H | GCST90424820 | N-acetylgalactosamine kinase levels | 2,549 European ancestry individuals | C | 0.223648 | 6E-29 | 28.222 | rs429358 | 0.3551 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424852 | NCK-interacting protein with SH3 domain levels | 2,549 European ancestry individuals | C | 0.222959 | 3E-19 | 18.523 | rs429358 | 0.2781 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527619_H | GCST90421969 | GTP-binding protein GEM levels | 3,506 European ancestry individuals | C | 0.202509 | 2E-49 | 48.699 | rs429358 | 0.4235 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421972 | NACHT, LRR and PYD domains-containing protein 10 levels | 3,506 European ancestry individuals | C | 0.200492 | 1E-17 | 17 | rs429358 | 0.249 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421983 | Syntaxin-10 levels | 3,506 European ancestry individuals | C | 0.202443 | 4E-17 | 16.398 | rs429358 | 0.2527 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421992 | Tropomodulin-2 levels | 3,506 European ancestry individuals | C | 0.200376 | 3E-24 | 23.523 | rs429358 | 0.2772 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421998 | Tropomodulin-3 levels | 3,506 European ancestry individuals | C | 0.201437 | 1E-14 | 14 | rs429358 | 0.2074 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527623_H | GCST90422011 | Retinol dehydrogenase 16 levels | 3,506 European ancestry individuals | C | 0.202734 | 6E-345 | 344.222 | rs429358 | 1.088 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421543 | ADP-ribosylation factor GTPase-activating protein 1 levels | 3,506 European ancestry individuals | C | 0.202993 | 2E-49 | 48.699 | rs429358 | 0.4227 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527686_H | GCST90423528 | MOB-like protein phocein levels | 2,721 European ancestry individuals | C | 0.225436 | 9E-169 | 168.046 | rs429358 | 0.8176 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423543 | Heparan sulfate glucosamine 3-O-sulfotransferase 4 (analyte X19370.30) levels | 2,721 European ancestry individuals | C | 0.226577 | 4E-14 | 13.398 | rs429358 | 0.2461 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424018 | Filamin-binding LIM protein 1 levels | 2,549 European ancestry individuals | C | 0.223421 | 4E-19 | 18.398 | rs429358 | 0.2955 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1527707_H | GCST90424187 | Ubiquitin thioesterase ZRANB1 levels | 2,549 European ancestry individuals | C | 0.223527 | 9E-82 | 81.046 | rs429358 | 0.605 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421127 | Stromelysin-2 (analyte X10479.18) levels | 3,334 European ancestry individuals | C | 0.200868 | 1E-14 | 14 | rs429358 | 0.233 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423283 | [Protein ADP-ribosylarginine] hydrolase levels | 2,721 European ancestry individuals | C | 0.225149 | 9E-30 | 29.046 | rs429358 | 0.337 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427863 | Pre-mRNA-processing factor 6:region 2 levels | 3,506 European ancestry individuals | C | 0.201477 | 3E-17 | 16.523 | rs429358 | 0.2311 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427891 | Eukaryotic translation initiation factor 4E type 2 levels | 3,334 European ancestry individuals | C | 0.198829 | 6E-13 | 12.222 | rs429358 | 0.2086 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426641 | Apolipoprotein C-II levels | 3,506 European ancestry individuals | C | 0.199594 | 2E-12 | 11.699 | rs429358 | 0.2164 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427666 | Galactoside 2-alpha-L-fucosyltransferase 2 levels | 3,506 European ancestry individuals | C | 0.19896 | 1E-18 | 18 | rs429358 | 0.3948 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422685 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (analyte X15474.7) levels | 2,721 European ancestry individuals | C | 0.223036 | 1E-20 | 20 | rs429358 | 0.2835 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528011_H | GCST90421578 | Transgelin-2 (analyte X11636.33) levels | 3,506 European ancestry individuals | C | 0.198841 | 1E-99 | 99 | rs429358 | 0.6202 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422286 | Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha levels | 3,506 European ancestry individuals | C | 0.201439 | 9E-15 | 14.046 | rs429358 | 0.2141 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528022_H | GCST90422309 | Dyslexia-associated protein KIAA0319-like protein levels | 3,506 European ancestry individuals | C | 0.200489 | 2E-40 | 39.699 | rs429358 | 0.3482 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528024_H | GCST90421351 | Testis-specific serine/threonine-protein kinase 1 levels | 3,506 European ancestry individuals | C | 0.200668 | 2E-108 | 107.699 | rs429358 | 0.6432 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528025_H | GCST90421352 | SWI/SNF complex subunit SMARCC1 levels | 3,506 European ancestry individuals | C | 0.203203 | 8E-90 | 89.097 | rs429358 | 0.6024 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423678 | Dihydropyrimidinase levels | 2,549 European ancestry individuals | C | 0.22487 | 3E-26 | 25.523 | rs429358 | 0.3632 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528052_H | GCST90422164 | Leukotriene B4 receptor 1 levels | 3,506 European ancestry individuals | C | 0.199441 | 4E-12 | 11.398 | rs429358 | 0.2075 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422223 | Acyl-CoA-binding domain-containing protein 7 levels | 3,506 European ancestry individuals | C | 0.199332 | 1E-32 | 32 | rs429358 | 0.3326 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421065 | Putative hydrolase RBBP9 levels | 3,506 European ancestry individuals | C | 0.200587 | 2E-18 | 17.699 | rs429358 | 0.25 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421075 | Neurofilament light polypeptide levels | 3,506 European ancestry individuals | C | 0.202054 | 1E-20 | 20 | rs429358 | 0.223 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528061_H | GCST90421076 | Steroidogenic acute regulatory protein, mitochondrial levels | 3,506 European ancestry individuals | C | 0.192855 | 4E-149 | 148.398 | rs429358 | 0.7645 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528088_H | GCST90422414 | COP9 signalosome complex subunit 2 levels | 3,506 European ancestry individuals | C | 0.203444 | 6E-30 | 29.222 | rs429358 | 0.3485 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528111_H | GCST90427907 | Nuclear distribution protein nudE homolog 1 levels | 3,506 European ancestry individuals | C | 0.202816 | 9E-80 | 79.046 | rs429358 | 0.6463 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427692 | Ubiquitin-conjugating enzyme E2 G2 levels | 3,506 European ancestry individuals | C | 0.203569 | 6E-24 | 23.222 | rs429358 | 0.2993 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528322_H | GCST90427696 | Quinone oxidoreductase-like protein 1 levels | 3,506 European ancestry individuals | C | 0.205882 | 4E-99 | 98.398 | rs429358 | 0.6376 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528331_H | GCST90427556 | Bile acid receptor levels | 3,506 European ancestry individuals | C | 0.196093 | 3E-207 | 206.523 | rs429358 | 0.9237 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422830 | FAS-associated death domain protein levels | 2,721 European ancestry individuals | C | 0.224497 | 8E-16 | 15.097 | rs429358 | 0.2368 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528369_H | GCST90421373 | DnaJ homolog subfamily B member 9 levels | 3,506 European ancestry individuals | C | 0.199481 | 3E-39 | 38.523 | rs429358 | 0.3826 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423690 | Visinin-like protein 1 (analyte X20197.14) levels | 2,549 European ancestry individuals | C | 0.223455 | 1E-15 | 15 | rs429358 | 0.2528 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528386_H | GCST90423720 | Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 levels | 2,549 European ancestry individuals | C | 0.223928 | 8E-556 | 555.097 | rs429358 | 1.3285 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528387_H | GCST90423726 | Ribonuclease P protein subunit p20 levels | 2,549 European ancestry individuals | C | 0.227108 | 2E-62 | 61.699 | rs429358 | 0.5312 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528416_H | GCST90422230 | Rho-related GTP-binding protein Rho6 levels | 3,506 European ancestry individuals | C | 0.194573 | 5E-309 | 308.302 | rs429358 | 1.1523 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528433_H | GCST90422443 | C-C motif chemokine 25 (analyte X14068.29) levels | 3,334 European ancestry individuals | C | 0.199368 | 5E-472 | 471.302 | rs429358 | 1.3677 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528455_H | GCST90422892 | Maleylacetoacetate isomerase levels | 2,721 European ancestry individuals | C | 0.22338 | 3E-35 | 34.523 | rs429358 | 0.3886 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528461_H | GCST90422983 | Short-chain specific acyl-CoA dehydrogenase, mitochondrial levels | 2,721 European ancestry individuals | C | 0.224299 | 4E-35 | 34.398 | rs429358 | 0.3954 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422989 | ADP-ribosylation factor-like protein 5B levels | 2,721 European ancestry individuals | C | 0.226557 | 1E-20 | 20 | rs429358 | 0.2766 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423465 | Homer protein homolog 1 levels | 2,721 European ancestry individuals | C | 0.222327 | 6E-20 | 19.222 | rs429358 | 0.2838 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427939 | Alcohol dehydrogenase 1B levels | 3,506 European ancestry individuals | C | 0.201706 | 2E-28 | 27.699 | rs429358 | 0.3312 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528477_H | GCST90427956 | Interferon-induced protein with tetratricopeptide repeats 2 levels | 3,506 European ancestry individuals | C | 0.204826 | 4E-48 | 47.398 | rs429358 | 0.4453 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427603 | Proteoglycan 3 levels | 3,506 European ancestry individuals | C | 0.200667 | 1E-20 | 20 | rs429358 | 0.2663 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528692_H | GCST90422756 | Keratin, type I cytoskeletal 19 levels | 2,721 European ancestry individuals | C | 0.225812 | 7E-136 | 135.155 | rs429358 | 0.7585 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423083 | DNA-directed RNA polymerase III subunit RPC9 levels | 2,721 European ancestry individuals | C | 0.2258 | 3E-17 | 16.523 | rs429358 | 0.2708 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90421167 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial levels | 3,506 European ancestry individuals | C | 0.201973 | 9E-13 | 12.046 | rs429358 | 0.2088 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422091 | SPARC-related modular calcium-binding protein 1 (analyte X13118.5) levels | 3,506 European ancestry individuals | C | 0.201062 | 8E-32 | 31.097 | rs429358 | 0.3321 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528782_H | GCST90423855 | Microtubule-associated proteins 1A/1B light chain 3 beta 2 levels | 2,549 European ancestry individuals | C | 0.221357 | 1E-116 | 116 | rs429358 | 0.7182 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1528797_H | GCST90422897 | Microtubule-associated protein RP/EB family member 3 (analyte X16885.49) levels | 2,721 European ancestry individuals | C | 0.225355 | 5E-21 | 20.302 | rs429358 | 0.2701 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422901 | Oxysterol-binding protein-related protein 9 levels | 2,721 European ancestry individuals | C | 0.223824 | 7E-14 | 13.155 | rs429358 | 0.2188 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422980 | ATP-dependent 6-phosphofructokinase, muscle type levels | 2,721 European ancestry individuals | C | 0.225057 | 3E-12 | 11.523 | rs429358 | 0.2396 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423447 | Homeodomain-only protein levels | 2,721 European ancestry individuals | C | 0.223281 | 3E-11 | 10.523 | rs429358 | 0.1954 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425825 | Chitotriosidase-1 levels | 3,506 European ancestry individuals | C | 0.199614 | 4E-14 | 13.398 | rs429358 | 0.2159 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422697 | Folate receptor gamma (analyte X15495.9) levels | 2,721 European ancestry individuals | C | 0.2218 | 2E-14 | 13.699 | rs429358 | 0.2478 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422725 | Calcineurin subunit B type 1 levels | 2,721 European ancestry individuals | C | 0.223606 | 1E-19 | 19 | rs429358 | 0.2777 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425531 | Apolipoprotein E (isoform E3) levels | 3,506 European ancestry individuals | C | 0.202754 | 6E-10 | 9.222 | rs429358 | 0.196 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423562 | Estradiol 17-beta-dehydrogenase 8 levels | 2,721 European ancestry individuals | C | 0.224796 | 6E-20 | 19.222 | rs429358 | 0.2505 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423592 | Importin subunit alpha-5 levels | 2,721 European ancestry individuals | C | 0.2258 | 2E-41 | 40.699 | rs429358 | 0.4295 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422133 | Redox-regulatory protein FAM213A levels | 3,506 European ancestry individuals | C | 0.201132 | 2E-15 | 14.699 | rs429358 | 0.2202 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529100_H | GCST90421181 | Serine protease inhibitor Kazal-type 13 levels | 3,506 European ancestry individuals | C | 0.198984 | 5E-114 | 113.302 | rs429358 | 0.6552 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423907 | Inositol-tetrakisphosphate 1-kinase levels | 2,549 European ancestry individuals | C | 0.223501 | 5E-26 | 25.302 | rs429358 | 0.3454 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529131_H | GCST90423472 | ADP-ribosylation factor 1 levels | 2,721 European ancestry individuals | C | 0.224871 | 6E-50 | 49.222 | rs429358 | 0.434 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529153_H | GCST90424070 | Clusterin-like protein 1 levels | 2,549 European ancestry individuals | C | 0.221913 | 7E-74 | 73.155 | rs429358 | 0.5784 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529393_H | GCST90427458 | DCN1-like protein 5 levels | 3,506 European ancestry individuals | C | 0.204295 | 4E-198 | 197.398 | rs429358 | 0.8269 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529399_H | GCST90427470 | Armadillo repeat-containing protein 5:Armadillo Repeat Domain 5 levels | 3,506 European ancestry individuals | C | 0.202103 | 3E-90 | 89.523 | rs429358 | 0.5812 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90425620 | Mitogen-activated protein kinase 1 levels | 3,506 European ancestry individuals | C | 0.200495 | 5E-15 | 14.302 | rs429358 | 0.2294 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423376 | Slit homolog 2 protein levels | 2,721 European ancestry individuals | C | 0.224619 | 2E-14 | 13.699 | rs429358 | 0.2389 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423915 | Calcium signal-modulating cyclophilin ligand levels | 2,549 European ancestry individuals | C | 0.2218 | 3E-26 | 25.523 | rs429358 | 0.3111 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529435_H | GCST90423922 | Eyes absent homolog 2 levels | 2,549 European ancestry individuals | C | 0.223789 | 1E-29 | 29 | rs429358 | 0.3556 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529438_H | GCST90423926 | Hydroxylysine kinase levels | 2,549 European ancestry individuals | C | 0.227309 | 8E-338 | 337.097 | rs429358 | 1.1376 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90426133 | Calcineurin levels | 3,506 European ancestry individuals | C | 0.200632 | 2E-18 | 17.699 | rs429358 | 0.2458 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423819 | Pseudouridine-5'-phosphatase levels | 2,549 European ancestry individuals | C | 0.223324 | 2E-12 | 11.699 | rs429358 | 0.1704 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90423849 | Prefoldin subunit 4 levels | 2,549 European ancestry individuals | C | 0.222488 | 2E-15 | 14.699 | rs429358 | 0.2486 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422570 | Eukaryotic translation initiation factor 4B levels | 3,506 European ancestry individuals | C | 0.199355 | 3E-13 | 12.523 | rs429358 | 0.1978 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422572 | RAC-beta serine/threonine-protein kinase (analyte X14685.17) levels | 3,506 European ancestry individuals | C | 0.203602 | 4E-31 | 30.398 | rs429358 | 0.327 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529469_H | GCST90424078 | Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase (analyte X21508.7) levels | 2,549 European ancestry individuals | C | 0.223147 | 4E-60 | 59.398 | rs429358 | 0.503 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529477_H | GCST90424534 | Mitogen-activated protein kinase 6 levels | 2,549 European ancestry individuals | C | 0.224247 | 3E-81 | 80.523 | rs429358 | 0.5479 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424550 | G antigen 2D (analyte X22968.9) levels | 2,549 European ancestry individuals | C | 0.221282 | 2E-21 | 20.699 | rs429358 | 0.3061 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427517 | Neurexin-2-beta levels | 3,506 European ancestry individuals | C | 0.200876 | 1E-14 | 14 | rs429358 | 0.2442 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529692_H | GCST90427543 | Transmembrane and coiled-coil domains protein 3:region 1 levels | 3,506 European ancestry individuals | C | 0.202765 | 9E-50 | 49.046 | rs429358 | 0.4341 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427077 | Killer cell immunoglobulin-like receptor 2DL5A (analyte X7799.3) levels | 3,334 European ancestry individuals | C | 0.199811 | 1E-14 | 14 | rs429358 | 0.2247 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427410 | Stromelysin-2 (analyte X8479.4) levels | 3,506 European ancestry individuals | C | 0.203143 | 3E-11 | 10.523 | rs429358 | 0.194 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427423 | Serine protease inhibitor Kazal-type 14 levels | 3,506 European ancestry individuals | C | 0.200951 | 2E-17 | 16.699 | rs429358 | 0.2476 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529785_H | GCST90426156 | Anterior gradient protein 2 homolog levels | 3,506 European ancestry individuals | C | 0.196511 | 6E-370 | 369.222 | rs429358 | 1.1304 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422609 | Neuromodulin levels | 2,721 European ancestry individuals | C | 0.224061 | 2E-11 | 10.699 | rs429358 | 0.2199 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1529830_H | GCST90424458 | DNA repair protein RAD51 homolog 3 levels | 2,549 European ancestry individuals | C | 0.224344 | 9E-28 | 27.046 | rs429358 | 0.3523 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90427251 | Sperm acrosome membrane-associated protein 3 levels | 3,506 European ancestry individuals | C | 0.203209 | 5E-24 | 23.302 | rs429358 | 0.298 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424616 | Catechol O-methyltransferase domain-containing protein 1 levels | 2,549 European ancestry individuals | C | 0.225568 | 9E-56 | 55.046 | rs429358 | 0.4994 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424623 | Uncharacterized protein C1orf50 levels | 2,549 European ancestry individuals | C | 0.224062 | 6E-15 | 14.222 | rs429358 | 0.2433 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1530100_H | GCST90424642 | LIM domain only transcription factor protein 4 levels | 2,549 European ancestry individuals | C | 0.224104 | 6E-358 | 357.222 | rs429358 | 1.1262 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1530101_H | GCST90424643 | BTB/POZ domain-containing protein KCTD2 levels | 2,549 European ancestry individuals | C | 0.223295 | 1E-244 | 244 | rs429358 | 1.0033 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90428035 | EMILIN-3:region 2 levels | 3,334 European ancestry individuals | C | 0.198432 | 3E-50 | 49.523 | rs429358 | 0.4706 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1530120_H | GCST90428040 | Interferon regulatory factor 6 levels | 3,506 European ancestry individuals | C | 0.201807 | 6E-184 | 183.222 | rs429358 | 0.803 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424334 | Protein BTG1 levels | 2,549 European ancestry individuals | C | 0.223253 | 4E-42 | 41.398 | rs429358 | 0.4528 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1530122_H | GCST90424351 | COP9 signalosome complex subunit 8 levels | 2,549 European ancestry individuals | C | 0.225131 | 2E-60 | 59.699 | rs429358 | 0.5218 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424408 | N-chimaerin levels | 2,549 European ancestry individuals | C | 0.223167 | 3E-19 | 18.523 | rs429358 | 0.2631 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424419 | Inositol hexakisphosphate kinase 2 levels | 2,549 European ancestry individuals | C | 0.224721 | 9E-12 | 11.046 | rs429358 | 0.22 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424441 | Protein naked cuticle homolog 2 levels | 2,549 European ancestry individuals | C | 0.223455 | 7E-16 | 15.155 | rs429358 | 0.2591 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422507 | 14-3-3 protein epsilon levels | 3,506 European ancestry individuals | C | 0.201237 | 1E-15 | 15 | rs429358 | 0.2374 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422546 | Protein FAM69C levels | 3,506 European ancestry individuals | C | 0.204823 | 1E-99 | 99 | rs429358 | 0.6049 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90422549 | Protein FAM210A levels | 3,506 European ancestry individuals | C | 0.201284 | 3E-52 | 51.523 | rs429358 | 0.4236 | protein measurement (EFO:0004747) |
PMID:39528825 |
GWAS1530162_H | GCST90424492 | Kinetochore protein Spc25 levels | 2,549 European ancestry individuals | C | 0.22386 | 3E-937 | 936.523 | rs429358 | 1.5381 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90424138 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B levels | 2,549 European ancestry individuals | C | 0.223548 | 1E-13 | 13 | rs429358 | 0.2223 | protein measurement (EFO:0004747) |
PMID:39528825 |
None Available | GCST90482628 | Accelerated cognitive decline | 1,064 European ancestry individuals | ? | NR | 8E-11 | 10.097 | rs429358 | 0.3 | cognitive decline measurement (EFO:0007710) |
PMID:38306043 |
GWAS1556302_H | GCST90472789 | Parkinson's disease (age of onset) | 1,048 Korean ancestry individuals, European ancestry individuals (see Blauwendraat, 2019) | C | NR | 0.000009 | 5.046 | rs429358 | 0.7379 | age of onset of Parkinson disease (OBA:2001009) |
PMID:39503264 |
None Available | GCST90475280 | estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed) | 398,886 European ancestry individuals | T | 0.8592 | 4E-15 | 14.398 | rs429358 | 0.0278 | PMID:39024449 | |
None Available | GCST90475282 | estimated glomerular filtration rate (eGFR, mean, inv-norm transformed) | 398,886 European ancestry individuals | T | 0.8592 | 9E-16 | 15.046 | rs429358 | 0.02805 | PMID:39024449 | |
None Available | GCST90475285 | estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed) | 398,886 European ancestry individuals | T | 0.8592 | 2E-11 | 10.699 | rs429358 | 0.02295 | PMID:39024449 |
External Database Links
Database | Acc Id | Source(s) |
GWAS Catalog | GCST90091729 | GWAS Catalog |
GCST90091749 | GWAS Catalog |
RGD Curation Notes
Note Type | Note | Reference |
---|